Synthesis and characterisation of peptide-polymer conjugate hydrogels for biomedical applications. by Mai, Cuc
  
 
 
Synthesis and Characterisation of Peptide-Polymer 
Conjugate Hydrogels for Biomedical Applications 
 
Cuc Thu Mai 
 
 
 
 
Submitted for the degree of  
Doctor of Philosophy  
at the University of Surrey 
Department of Chemistry 
Faculty of Engineering and Physical Sciences 
August 2018
i 
 
 Abstract 
This study involved two separate projects, both of which explored the application of RAFT 
polymerisation for the synthesis of well-defined star polymer-peptide conjugates and 
developed hydrogels from synthesised star polymer conjugates. 
The first project aimed to develop an in situ forming hydrogel from star poly(N-(2-
hydroxypropyl)methacrylamide) (PHPMA) via covalent cross-linking, catalysed by Sortase A 
enzyme (SrtA). The use of SrtA as a cross-linking enzyme for hydrogel-based tissue 
engineering has been only reported previously by Broguiere et al., Arkenberg and Lin. 1,2 Both 
groups employed mutant enzymes with enhanced kinetics to achieve fast gelation whereas a 
wild type SrtA was employed in this work. Well defined star PHPMA (Ð<1.30) were 
successfully functionalised with SrtA-peptide substrates via a two-step synthesis consisting of 
an aminolysis and followed by a radical thiol-ene addition reaction. Unfortunately, cross-linking 
of 4-arm star PHPMA conjugations mediated by SrtA did not yield gelation which could be due 
to the slow kinetics of wild type SrtA. 
The second project focused on developing thermo-responsive hydrogels of the self-
assembling peptide CFEFEFKFKK by doping the hydrogels with star (2-, 3-, and 4- arm) 
poly(N-isopropylacrylamide) (PNIPAM)/CFEFEFKFKK conjugates (C, cysteine; F, 
phenylalanine; E, glutamic acid; K, lysine). The work was based on a study by Maslovskis et 
al. who created the novel composite hydrogels containing FEFEFKFK peptide and linear 
PNIPAM-FEFEFKFK conjugates.3 Well-defined star PNIPAM (Ð<1.25) were modified via a 
three step synthesis consisting of an aminolysis, a vinylsulfone functionalisation, and finally 
Michael thiol-ene addition with CFEFEFKFK. The doping was found to introduce thermo-
responsiveness to the peptide hydrogels with a lower critical solution temperature (LCST) 
around 36 °C. This suggested that the hydrogels a potential application in human body. The 
hydrogels doped with 3-arm conjugate 46 kDa, 4-arm conjugate 17 kDa, or 2-arm conjugate 
4 kDa exhibited higher elasticity. This indicated that the peptides on the conjugates took part 
in the self-assembly with the free peptides  and that the polymer chains anchored and 
interacted with the peptide fibres through hydrogen bonding.  
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1 Chapter I: Introduction and Background 
1.1 General introduction 
This thesis describes two separate projects concerning the design and production of hydrogels 
for biomedical applications. The first focused on creating in situ cross-linking hydrogels of 
poly(N-2-hydroxypropyl methacrylamide) (PHPMA) for use as cell scaffolds for tissue 
engineering applications. The second aimed to introduce thermo-responsiveness into a self-
assembling peptide (CFEFEFKFKK) hydrogel by doping the gel with star thermo-responsive 
poly(N-isopropylacrylamide) (PNIPAM) conjugates and to modulate its mechanical properties 
at the same time.  
Hydrogels are water-swollen networks consisting of cross-linked polymers or supramolecular 
structures.4-6 Hydrogels can also be described as molecular scale porous materials which can 
absorb a large amount of water or biological fluid (up to 99% wt) while maintaining its 3D 
network.7-10 Materials for hydrogel preparation can be derived from natural or synthetic 
sources.11 In the early 1950s, Lim and Wichterle proposed the design of hydrogels for 
applications in ophthalmology.12 The main features of their hydrogels were: shape stability and 
softness similar to that of the surrounding tissues; stability under physiological conditions; and 
high permeability towards water-soluble nutrients and metabolites. Synthetic hydrogels which 
met these criteria were first used for contact lenses in the 1960s and have since been utilised 
as catheter coatings, wound dressings, and in drug delivery applications.7,12 Their applications 
in biomedicine, materials science, food science and more are dictated by their properties, such 
as ability to transport solvent or solute and their mechanical resistance.13 
In multicellular organisms, cells are structurally supported by a complex and bioactive scaffold, 
the extra cellular matrix (ECM).11 The ECM is involved in directing the fate of the cell including 
migration, differentiation, and apoptosis. Natural ECMs are nanofibrillar supramolecular 
networks that are mainly composed of two classes of macromolecules: fibrous proteins (e.g. 
collagen, elastin, fibronectin, and laminin) and glycosaminoglycans.10,14 These components 
are generated by cells. In addition to mechanical support, ECMs also provide bioactive cues 
for their microenvironments, serve as reservoirs for growth factor and are susceptible to 
degradation for cellular proliferation and neovascularisation.11,15 Given their high water 
content, tunable porosity, mechanical properties and compositional similarities to the native 
ECM, hydrogels have recently been developed as artificial ECMs.10,16 These insoluble cross-
linked networks allow effective capture and release of active agents and biomolecules.17  
The efforts to design an artificial cell micro-environment that can mimic the native ECM have 
been driven to meet the growing demand for tissue and organs transplants.10 However, the 
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implementation of conventional hydrogels in biomedical applications remains somewhat 
challenging as the inherent elasticity of the materials limits their delivery via injection or any 
non-surgical pathway. The majority of synthetic hydrogels are produced using radical 
polymerisation or condensation chemistry, and the precursors are generally incompatible with 
and toxic to biological systems.16 Recently, research has focused on in situ-forming or 
injectable hydrogels that can minimise the invasive procedures and ensure the viability of stem 
cells by eliminating undesirable diffusion of any toxic reagents.18 In this case, an aqueous 
solution of precursors, pharmaceutical reagents or cells is administered into the defective site 
using a syringe.19 The advantages of in situ forming hydrogels are site specificity, high 
moldability, and the ability to fill in the defective sites in tissues.19,20 The gelation can take place 
under physiological conditions through physical changes in response to pH, temperature, or 
ionic concentration, or by employing a chemical cross-linking reaction, such as enzyme 
catalysis, Michael addition or Schiff base formation.19  
Of the various chemical cross-linking methods, enzymatic cross-linking presents unique 
advantages including high biocompatibility, gelation under mild (physiological) conditions, and 
tunable mechanical properties.21 To date, several successes in developing in situ enzyme-
mediated hydrogel formation have been report using various enzymes, including tyrosinase 
horseradish peroxidase, and transglutaminase.21-23 Nevertheless, there are disadvantages 
associated with each enzyme. Details will be discussed later in section 1.4.1.8.  
Sortase A (SrtA) enzyme is well-known as a biological ligation tool used in immobilisation and 
engineering of proteins.24,25 However, its use in injectable hydrogels has not been well studied.  
In the first project described in this thesis, SrtA was utilised to catalyse the cross-linking of star 
PHPMA polymer/SrtA substrate peptide conjugates. 
The second project described in this thesis focused on the self-assembling peptide hydrogels 
based on the octapeptide motif FEFEFKFK. This amphipathic peptide contains a periodic 
pattern of charged and hydrophobic residues with half of the charged residues being positive 
(lysine) and half being negative (glutamic acid).  This configuration induces self-assembly of 
the peptide into β-sheets that later associate laterally into fibres and form physical hydrogels 
in water. Self-assembling peptide hydrogels are gaining tremendous interest for biomedical 
applications due to their stimuli-responsiveness, biocompatibility, manufacturability, and 
modularity. The purpose of this study was to modulate the mechanical properties and thermo-
responsiveness of this peptide hydrogel by introducing a star PNIPAM/self-assembling 
peptide conjugate into the peptide gel. It was postulated that the star polymer conjugate would 
participate in the self-assembly of the peptides creating cross-links between the peptide β-
sheet fibres and resulting in increased strength of the gel.  
3 
 
This thesis is divided into four chapters. This chapter presents a literature review on six main 
points: sources of polymers for hydrogel preparation, in situ cross-linking strategies, self-
assembling peptides, conjugation chemistries for protein/peptide-polymer conjugates, 
PHPMA and its biomedical applications, thermo-responsive polymers, PNIPAM and its 
biomedical applications. Chapter II discusses procedures and results on the synthesis of 
PHPMA-peptide conjugates and SrtA catalysed cross-linking of these conjugates. Chapter III 
presents research findings on the preparation of star PNIPMA/self-assembling peptide 
conjugates along with the thermal and mechanical properties of self-assembling peptide 
hydrogels doped with star PNIPAM conjugates. Chapter IV details the methods and 
procedures employed in this study. 
1.2 Polymers for biomedical hydrogels 
Based on the polymer origin, hydrogels can be classified into three categories: natural 
hydrogels, synthetic hydrogels, and natural/synthetic hybrid hydrogels.17 This section will 
describe the individual types of hydrogels. 
1.2.1 Natural hydrogels 
Natural polymers can be derived from mammals, bacteria and plants.17 These can be 
classified into four main groups: proteins, polysaccharides, protein/polysaccharide hybrid 
polymers, and DNA (Table 1-1).17 Collagen is the most abundant mammalian proteins in 
ECMs. There are at least 19 types of collagens, for example type I, type II, type III. Among the 
proteins, collagen type I, gelatin, elastin, and silk are the most commonly used as scaffold 
materials.26 
The characteristics of natural hydrogels that are desirable for making cell scaffolds that are 
biocompatible, biodegradable and can promote cell adhesion.27 The presence of natural 
ligands essential for cellular adhesion in mammalian-derived hydrogels helps reduce 
requirements for additional modifications for facilitating cell growth and spread.10  
For example, Kontturi et al developed an in situ forming type II collagen/hyaluronic acid 
hydrogel which was supplemented with the transforming growth factor β1 for cartilage tissue 
engineering.28 The chondrocytes-hydrogel constructs were cultured for 7 days and 
investigated for cell viability, proliferation, morphology, glycosaminoglycan production, and 
gene expression. They demonstrated that this hydrogel was able to maintain the viability and 
characteristics of chondrocytes, making the hydrogels a potential cell delivery system for 
tissue engineering.28 
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However, the limitations of naturally-derived hydrogels include poor mechanical properties, 
inherent batch-to-batch variability and the risk of carrying immunogenic factors which 
confound the effects of the scaffold on cell growth.17,29,30 Inflammation can cause the formation 
of granulation tissue, a foreign body response, and eventually the formation of a fibrous 
capsule separating the hydrogel from surrounding tissues. This would consequently reduce 
the effective use of hydrogels in tissue engineering, cell or drug delivery.31 
It is also a challenge to tune the mechanical properties of natural hydrogels since they either 
degrade or contract too quickly.17,30 For example, collagen is degraded by metallo-matrix 
proteases, specifically collagenase and serine protease. Chitosan can be metabolised by the 
human enzyme, lysozyme.32 
Natural hydrogel Polymers 
Protein 
Collagen, elastin, fibrin, silk, lysosome, MatrigelTM 
Genetically engineered proteins 
Polysaccharide Hyaluronic acid, alginate, chitosan, dextran 
Protein/polysaccharide 
Collagen/hyaluronic acid, laminin/cellulose, fibrin/alginate 
Gelatin/agarose, chitosan, alginate, dextran 
DNA X-, Y-, T-DNA, linear plasmid DNA 
Table 1-1 Natural polymers used for fabricating hydrogels for tissue engineering17 
1.2.2 Synthetic polymers 
Although synthetic polymers are generally more expensive than natural polymers, they 
possess more reproducible physical and chemical properties which is imperative for the 
fabrication of cell scaffolds.17,33 The use of synthetic polymers (e.g. polyurethanes, silicones, 
polyolefins, polydienes) in medical devices dates back to the 1890s. Synthetic polymers can 
be classified as biodegradable or non-biodegradable.27  
1.2.2.1 Non-biodegradable polymers 
Degradation of synthetic polymers is dictated by the nature of the chemical bonds that make 
up the polymer backbone.34 Generally, the C-C bond is chemically and biologically quite inert. 
The inert properties of the C-C bond can be modulated by oxidation of the carbon bonds. For 
example, ester and urethane bonds are more likely to degrade than ether, ketones and 
sulfones. Non-biodegradable hydrogels are normally produced from the copolymerisation of 
various monomers or macromonomers such as, 2-hydroxyethyl methacrylate (HEMA) 1, N-
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isopropylacrylamide (NIPAM) 2, N-(2-hydroxypropyl methacrylamide) (HPMA) 3, with cross-
linkers such as N,N’-methylenebis(acrylamide) (MBA) 4, ethylene glycol diacrylate (EGDA) 5 
and poly(ethylene glycol) diacrylate (PEGDA) 6 (Figure 1-1).17  
 
Figure 1-1 Structures of monomers (HEMA, NIPAM and HPMA) and cross-linkers (MBA, 
EDGA and PEGDA) for the synthesis of non-biodegradable hydrogels  
In many areas of biomedical applications, PEG (poly(ethylene glycol)) is the most widely 
studied polymer due to its unique properties such as solubility in both organic and aqueous 
solution, non-toxicity and low protein adhesion (Figure 1-2).17 Hydroxyl-terminated di- and 
multi-functional PEG polymers can be modified with various functional groups (e.g. azide, vinyl 
sulfone, maleimide, and thiol) and cross-linked into PEG hydrogels using chemical cross-link 
strategies which will be discussed later in this chapter.  
 
Figure 1-2 Poly(ethylene glycol)  PEG 7 
Yu et al. developed an in situ forming PEG hydrogel that was formed by cross-linking between 
tetramaleimide and tetrathiol PEG macromers under physiological conditions for the ocular 
delivery of Avastin(®) in the treatment of intraocular neovascularization diseases.35 The 
limitation of Avastin(®) is its short half-life in the human body, therefore it requires frequent 
administration. The hydrogel was incubated with L-929 fibrolast cells for 7 days and showed 
no cytotoxicity. Prolonged release of Avastin(®) in vitro by the hydrogels was observed for a 
period of up to 14 days. 
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Figure 1-3 In situ forming PEG hydrogels for the delivery of Avastin(®). Reproduced from 
reference 35 
1.2.2.2 Biodegradable polymers 
Since there are drawbacks in tailoring the biodegradability and mechanical properties of 
natural polymer-forming hydrogels, research has focussed on synthetic biodegradable 
polymers.17 For the preparation of biodegradable hydrogels, polyesters are most widely used, 
including poly(ε-caprolactone) (PCL), poly(lactic acid) (PLA), poly(glycolic acid), as ester 
bonds are degradable under biological conditions. Degradation of polyesters in the body are 
governed by hydrolytic or enzymatic degradation.36 For instance, PCL is metabolised by 
Rhizopus delemer lipase, and Pseudomonas lipase. Information about the degradation rate of 
the polymer is of great importance for the development of temporal mechanical support 
scaffolds in tissue engineering. For example, PLA has a slow degradation rate, therefore it is 
suitable for use in long-term orthodaepic implants such as plates, pins, rods, and screws.36  
Biodegradable hydrogels can be generated by photo-polymerisation of diacrylate or 
dimethacrylate macromers consisting of stable PEG blocks and hydrolytically labile PLA 
blocks 8 (Figure 1-4). The triblock macromeres are produced by ring opening polymerisation, 
terminated with (meth)acrylate through addition of acryloyl chloride or methacryloyl chloride, 
respectively, in the presence of trimethylamine.37  
 
Figure 1-4 Biodegradable PLA-PEG-PLA diacrylate macromer 8  
Burdick et al. developed a biodegradable PEG-based hydrogel by photo-polymerising 
macromer PLA-PEG-PEL diacrylate mixed with desired proteins.37 Osteoinductive growth 
factor was successfully encapsulated in the hydrogel. An in vitro study observed enhanced 
gene expression of osteoblast and collagen type I and significantly higher levels of both 
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mineralization and alkaline phosphatase when growth factors were delivered from a 25-wt% 
hydrogel. Ectopic mineralised tissue was produced as growth factor release from in vivo 
subcutaneous implant. 
1.2.3 Natural/Synthetic hybrid hydrogels 
Hybrid hydrogels can be made by covalent conjugation or copolymerisation of synthetic 
polymers and natural hydrogels. The synthetic part of the hydrogel provides tunable physical 
properties while the natural part provides biological functions.17 Many natural hydrogels such 
as collagen, fibrinogen and hyaluronic acid have been used to prepare hybrid hydrogels with 
synthetic polymers such as PEG, PNIPAM, and PVA.17 
For example, Dubbini et al. developed fast in situ forming hydrogels from thiol modified 
hyaluronic acid as cross-linkers and vinyl sulfone functionalized methacrylated triblock 
copolymers consisting of a central PEG chain flanked at both sides by copolymers of PNIPAM 
and poly(N-(2-hydroxypropyl methacrylamide) dilactate) (P(HPMAM-lac2) for the controlled 
release of peptide-based drugs.20 The hydrogels were formed by both a thermal gelling 
mechanism and Michael addition (Figure 1-5). They reported that mouse bone marrow derived 
stem cells and NIH 3T3 fibroblasts seeded on top of hydrogels remained viable and 
proliferated after 21 days. 
 
Figure 1-5 In situ forming hyaluronic acid/PEG-PHPMA-lac2 based hydrogel via thermal 
gelling and Michael addition. Reproduced from reference 20. 
The hydrogel network can be also fabricated with a variety of ECM component-derived 
peptides or bioactive molecules which make the hydrogel cell-adhesive, enzyme-sensitive, 
growth factor-binding, matrix protein-binding, immune-isolating and nitric oxide (NO)-bearing 
(Figure 1-6).17  
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Figure 1-6 Model of bioactive synthetic hydrogels. Reproduced from reference 17 
For example, Zhu et al. developed a bioactive PEG based hydrogel fabricated with a cyclic 
RGD (cRGD) peptide sequence, a cell-adhesive peptide for spatial organisation and 
enhanced cell binding for tissue engineering.38 The hydrogel was prepared by photo-
polymerisation of PEGDA modified RGD peptide monomer. Their study demonstrated that the 
cRGD-PEGDA hydrogel facilitated endothelial cellular binding and spreading over the 
hydrogel surface. 
1.3 Mechanical characterisation of hydrogels 
Different requirements for polymers for biomedical hydrogels are biocompatibility and 
nontoxicity, stability, biodegradability, mechanical properties, and viscosity.39 This section will 
discuss mechanical properties and mechanical characterisation of hydrogels. The mechanical 
properties of hydrogels are of crucial importance if it is to be implemented in a biological 
environment.40 In the field of tissue engineering, these properties play a role in the regulation 
of cell behaviour such as cell signalling, cell migration and cell proliferation.40,41 Many soft 
tissues and ECMs are found to be viscoelastic. Materials that are viscoelastic exhibit a 
combination of the properties of an elastic solid and a viscous liquid. For viscoelastic materials, 
conformational changes of the structure (i.e. deformation and reformation of the network) 
dissipate energy whereas purely elastic materials will store energy.13,40 Viscoelastic materials 
exhibit stress relaxation in response to a deformation, or creep in response to an applied 
mechanical stress. Depending on the strength of cross-links or bonding, the mechanical 
behaviour of hydrogels can be different. Covalently cross-linked hydrogels tend to manifest 
an elastic behaviour because of the persistence of the covalent bonds, while physical 
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hydrogels tend to exhibit viscoelastic behaviour due to the mechanism of breaking and re-
forming the cross-links.13 
Mechanical properties are primarily defined using the theories of time-independent rubber 
elasticity and time-dependent viscoelasticity to analyse the structure of hydrogels and 
estimate the effective crosslink density.41 The viscoelasticity can be expressed by the storage 
modulus G’ and the loss modulus G’’.13 G’ is a measure of stored energy, hence directly related 
to the elasticity of the hydrogel.13 G’’ is a measure of the energy loss by the sample through 
viscous dissipations, hence directly related to the viscosity of the hydrogel.13 A hydrogel 
behaves like a solid therefore it would possess a higher storage modulus G’ than the loss 
modulus G’’.42 
The optimal parameters can be determined using the mechanical properties of tissues or 
remodelled ECM as reference points.43 Hence, accurate methods are of importance for 
measuring the mechanical properties of tissues, fabricated hydrogels, and tissue-engineered 
constructs. Typically, the viscoelasticity of a hydrogel is measured using an oscillatory 
rheometer, which exerts a sinusoidal shear deformation and strain, and the resultant stress 
response is measured.40 The sample is placed between two parallel plates as depicted in 
Figure 1-7. The top plate rotates and imposes a time dependent strain on the sample as shown 
in equation 1-1 
 
𝛾(𝜔𝑡) =  𝛾𝑜. sin (𝜔𝑡)    Equation 1-1
44 
Where 𝛾 = strain, 𝜔 = oscillation frequency.  
Simultaneously, the time dependent stress σ(t) is determined by measuring the torque that 
the sample imparts on the bottom plate.44 For a sinusoidal stress deformation, the stress 
response of viscoelastic material is given by Equation 1-2. G’(ω) is the elastic modulus at ω 
frequency and G’’(ω) is the loss modulus at ω frequency. 
 
𝜎(𝜔𝑡) = 𝐺′(𝜔)𝛾𝑜 sin(𝜔𝑡) + 𝐺
′′
(𝜔)𝛾𝑜cos (𝜔𝑡)     Equation 1-2
44 
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Figure 1-7 Schematic representation of an oscillatory rheometer with sample placed 
between two parallel plates.  
The mechanical properties of the ECM can have a significant effect on the cell fate.45 
Therefore, it is vital to design engineered biomaterials whose stiffness closely matches to the 
targeted tissues.22 In in vitro experiments, hard cell culture substrates are usually glass or 
plastic surfaces which have moduli of several GPa while the native ECMs are much softer. 
For example, subendothelial layers have a modulus of 3 kPa. Brain and muscles have moduli 
of several 100 Pa and 3 kPa respectively. One of the major challenges in tissue engineering 
is to design biomaterials that can mimic the non-uniform elasticity of innate tissue, such as 
skin, cardiac, blood vessels, lung muscles.30 Sone innate tissues can respond to applied stress 
and display stiffening strain while synthetic hydrogels are likely to deform under variable 
loading. 
1.4 In situ cross-linking hydrogels 
Over the past decade, there has been significant progress in the development of 
biocompatible hydrogels for various applications such as cell-based drug delivery, sustainable 
protein release, and tissue engineering.46,47 In particular, injectable or in situ hydrogels have 
received tremendous attention compared to traditional hydrogels due to their remarkable 
advantages including less invasive administration, high moldability, and facile 
biofabrication.19,48,49 For successful in vivo application, the gelation (i.e. cross-linking of the 
precursor polymers) must occur under physiological conditions (i.e. 5.5≤pH≤7.5 and at 37 °C) 
and relatively quickly (i.e. seconds to minutes) following injection.50 In situ-forming hydrogels 
can be achieved via chemical cross-linking, physical cross-linking, and a dual mechanism.51 
This section will discuss both chemical and physical cross-linking mechanisms for the 
development of in situ hydrogels. 
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1.4.1 Chemically cross-linked hydrogels 
For biomedical applications, in situ chemical reactions must be carried out under physiological 
conditions and not produce any toxic side products.52 The cross-linking can take place via 
various chemistries such as photopolymerisation, click reaction, Michael addition reaction, or 
enzymatic reactions.16,51 The details are discussed below.  
1.4.1.1 Photo-polymerisations 
In situ formation of hydrogels via photo-polymerisation of macromers using UV-vis light has 
been widely employed for biomedical applications.51,53 The light generates reactive species, 
such as radicals, cations or anions, which can initiate the polymerisation.53 Radical photo-
polymerisation is by far the most common method used to prepare injectable hydrogels 
because the gelation can occur under mild conditions and provide the required spatiotemporal 
control by means of controlled polymerisation. The reactive groups used in this strategy are 
normally acrylates or methacrylates. Polymer systems investigated for in situ formation of 
hydrogels include PEG, gelatin, and hyaluronic acid.53 Figure 1-8 depicts the cross-linking of 
methacryloyl functionalised polymer initiated by different types of light exposure and different 
initiators. 
 
Figure 1-8 Cross-linked hydrogel formation from the photo-polymerisation of methacryloyl 
functionalised polymer chains. Reproduced from reference 53 
For example, Hiemstra et al. developed a fast in situ forming hydrogel from an aqueous 
solution of 8-arm poly(ethylene glycol)−poly(L-lactide) (PEG−PLLA) and poly(ethylene 
glycol)−poly(D-lactide) (PEG−PDLA) star block copolymers via a combination of 
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stereocomplexation and photo-polymerisation.54 Stereocomplexation resulted from the 
stereoselective van der Waals forces between two complementing stereoregular polymers, 
interlocking and forming a new composite.55 The hydrogel was formed within 1-2 min of mixing 
the two star polymers at concentrations in the range 12.5−17.5% (w/v) and subsequently 
photo-polymerised under UV light (350-400 nm) using Irgacure 2959 photoinitiator 9 at the 
very low concentration of 0.0003 wt%. The storage modulus increased from 5.9 to 9.6 kPa 
within 15 min of photo-polymerisation. Scheme 1-1 displays the activation mechanism of 
initiator 9. 
 
Scheme 1-1 UV-activated Irgacure 2959 photoinitiator 9.56 
Although cross-linking via photo-polymerisation has been proven to be biocompatible, the UV 
light and radical species might potentially affect the cells, proteins, or therapeutic reagents. 
Hence, this strategy is not suitable for tissues that are sensitive to UV light or radical species.57 
1.4.1.2 Azide-alkyne cycloaddition 
The azide-alkyne cycloaddition is a reaction between an azide and a terminal alkyne. This 
reaction has been extensively explored in the design of in situ forming hydrogels owing to its 
high selectivity and bioorthogonal chemistry.16,51 The reaction was first introduced by Huisgen 
and later optimised by Sharpless and co-workers who used Cu(I) as a catalyst.16 The reaction 
is described as a Cu(I)-catalysed azide-alkyne click reaction (CuAAC).16 CuAAC can take 
place at physiological temperature while the classic reaction which is non-catalysed requires 
high temperature to drive it to completion.  
 
Scheme 1-2 CuAAC click reaction16 
The first hydrogel prepared via CuAAC was reported by Ossipov et al.58 in 2006, in which the 
gelation occurred within one minute after mixing the polymer precursors in both DMSO and 
aqueous phases with the presence of 6×10-3 mol.L-1 Cu(I). There have been several 
successful studies in preparing injectable hydrogels via CuAAC, however the potential toxicity 
of Cu(I) has limited practical use of this hydrogel.16 However, Bertozzi et al. have managed to 
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achieve a high-selectivity azide-alkyne cycloaddition in the absence of Cu(I) catalyst under 
physiological conditions by using a strained alkyne such as cyclooctyne (Scheme 1-3).16,57 
 
Scheme 1-3 Click reaction between an azide and a cyclootyne16 
1.4.1.3 Michael type addition 
Michael type addition of a nucleophile to the β position of α,β-unsaturated carbonyl 
compounds such as ketones, aldehydes, or esters is widely used for the synthesis of 
bioconjugates and injectable hydrogels.16,51,59 The reaction is facile under physiological 
conditions due to the stable nature of the intermediate and corresponding low energy transition 
state leading to it (Scheme 1-4). 
 
Scheme 1-4 Michael addition16 
Nucleophiles capable of Michael addition are halide ions, cyanide ions, thiols, alcohols and 
amines, however, for biomedical applications, they must be non-toxic, hence thiols, alcohols 
and amines are more suitable for this method.16,57 Amongst these, thiols have been most 
widely investigated due to their stronger nucleophilicity than amines and alcohols.57 
Electrophiles in Michael addition reactions are normally acrylate-, methacrylate-, maleimide-, 
and vinyl sulfone-functionalised macromers or polymers.  
Acrylate is by far the most common electrophile used in this cross-linking pathway.57 However, 
maleimides and vinyl sulfones have been shown to offer higher addition rates and hence faster 
gelation due to the better stabilisation of the intermediate enolate.60 Bearat et al. reported in 
their study that the gel system 2 (Scheme 1-5), through thiol-vinyl sulfone Michael addition, 
had faster gelation kinetics, regardless of mixing time, compared to gel system 1, which used 
thiol- acrylate Michael addition.60 
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Scheme 1-5 Gelling system 1 comprises poly(NIPAM-co-cysteamine) 10 with poly(NIPAM-
co-HEMA-acrylate) 11 and gelling system 2 consists of poly(NIPAM-co-cysteamine) 10 with 
poly(NIPAM-cysteamine-co-vinyl sulfone) 13.60 
1.4.1.4 Hydrazone bond formation 
The hydrazone bond is formed by nucleophilic addition of a hydrazine group (or a derivative) 
to a ketone or aldehyde followed by elimination of water (Scheme 1-6).16,57,61 The hydrazone 
bond is a type of Schiff base, however its formation is faster and the product more 
hydrolytically stable compared to Schiff bases because of the enhanced nucleophilicity of the 
nitrogen atom due to the presence of an adjacent lone-pair-bearing nitrogen atom through the 
alpha effect.16,57  
 
Scheme 1-6 Hydrazone bond formation between hydrazine and an aldehyde.16 
This cross-linking method has attracted attention due to its versatility, simplicity, and non-
toxicity.61 It has been demonstrated by many studies that the gelation obtained via hydrazone 
bond formation occurs within seconds of mixing.16 Consequently, the cross-linked hydrogels 
can achieve relatively high elasticity compared to hydrogels prepared by other methods.16 In 
addition, due to the hydrolytic stability of the hydrazone bond the hydrogels generally exhibit 
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prolonged residence time in the human body up to several months.16 Regarding 
biocompatibility for biomedical applications, there is a concern over a potential cross-reactivity 
of aldehyde groups towards amines in the native tissues via Schiff base formation. To mitigate 
the problem, Patenaude et al.16 have investigated gelation via the cross-linking of ketone 
functionalised PNIPAM and hydrazine functionalised PNIPAM (Scheme 1-7). They observed 
that the gelation occurred significantly slower than with aldehydes and also required a higher 
degree of ketone functionalisation to attain similar gel strength (elastic modulus).16 This is 
because ketones are less reactive towards physiologically relevant functional groups 
compared to aldehydes.16  
 
Scheme 1-7 Hydrazone-cross-linked PNIPAM hydrogels.16  
1.4.1.5 Oxime formation 
The oxime bond is formed by a reaction between a hydroxylamine and a ketone or an aldehyde 
and can take place under biological conditions (Scheme 1-8).16 These products show better 
hydrolytic stability than Schiff bases and hydrazones but the reaction requires an acid catalyst 
to proceed at an appreciable rate because of the electron withdrawing effect of the adjacent 
electronegative oxygen atom.16 This does, however, permit the gelation of oxime hydrogels to 
be tuned by adjusting the pH of the precursor solutions.61 Grover et al.62 created a hydrogel 
from 8-arm aminooxy PEG and glutaraldehyde via an oxime cross-linking reaction, and they 
were also able to decreasegelation time from 30 min to 5 min by changing the pH of precursor 
solutions from 7.2 to 6.0. 
 
Scheme 1-8 Oxime formation16 
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Although there are several benefits of oxime hydrogel formation, the preparation of aminooxy 
functionalised precursors requires complex chemistry and potentially limits the application of 
this strategy.16  
1.4.1.6 Disulfide bond formation 
A disulfide bond is formed by reaction between two thiols which are protonated and in their 
reduced state (Scheme 1-9).16 Disulfide bonds are known for their vital role in protein folding 
and assembly.16 The dithiol cross-linked bond is formed in the presence of an oxidising agent, 
for example, oxygen is sufficient to drive the reaction.   
 
Scheme 1-9 Disulfide bond formation 
Alternatively, disulfide bonds can be formed by reaction between a thiol group and pyridyl 
disulfide substrate (PDS).16 Choh et al.63 developed cross-linked hydrogels by mixing 
hyalunoric acid pyridyl disulfide (HA-PD) and thiolated PEG in PBS buffer at 37 °C; the 
hydrogel formed within 4 to 5 min (Scheme 1-10).  
 
Scheme 1-10 Disulfide cross-linked hydrogels from hyalunoric acid pyridyl disulfide 18 (HA-
PD) and PEG di-thiol 19. Reproduced from reference 63 
Gelation via disulfide cross-linking has been demonstrated to insignificantly affect the 
cytocompatibility in vitro and biocompatibility in vivo.16 However, for protein delivery 
applications, there is a potential side reaction that can occur between the protein’s cysteine 
residues and the thiol groups of the precursors, possibly leading to protein denaturation.16  
1.4.1.7  [2+4] (Diels-Alder) cycloaddition 
The Diels-Alder reaction is a [4+2] cycloaddition between a diene and a dienophile that can 
occur without any catalyst and produces no by-products.61 Depending on the reactants, the 
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reaction can occur spontaneously at body temperature and in water due to the hydrophobic 
effect.16,61 The most common Diels-Alder reaction employed in tissue engineering is the 
cycloaddition between maleimide and furan groups as depicted in Scheme 1-11. 
 
Scheme 1-11 Diels-Alder reaction between a maleimide and a furan group.16 
The Diels-Alder reaction is highly attractive for in vivo applications due to its selectivity as well 
as the inertness of its functional groups towards chemical groups present in the body, except 
for the thiol groups present at very low concentration in proteins.16 
The main drawback of this chemistry for in situ-forming hydrogels is the slow rate of gelation 
which can be on the time scale from ten minutes to hours. The problem can be addressed by 
combining physical and chemical cross-linking systems into the injectable hydrogels.16 Wei et 
al.64 developed dual physical and chemical cross-linking hydrogels from a copolymer of N-
isopropylacrylamide, N-dimethylacrylamide, and 2-hydroxymethacrylate functionalised with N-
maleoyl alanine (dienophile) and a copolymer of N-isopropylacrylamide, N-
dimethylacrylamide, and fururyl methacrylate (diene) (Scheme 1-12). At first, physical 
hydrogel was formed as a result of PNIPAM chain collapse at 37 °C, which is above the low 
critical solution temperature (LCST). The physical hydrogel gradually changed into chemically 
cross-linked hydrogels through Diels-Alder reaction and the mechanical properties of 
hydrogels was improved.64 
 
Scheme 1-12 Physical and chemical cross-linking via Diels-Alder cycloaddition. Reproduced 
from reference 64 
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1.4.1.8 Enzymatic reactions 
Although progressive advances have been achieved for hydrogel systems derived from 
chemical or physical cross-linking, there is a growing interest in mild cross-linking methods 
using biological tools – enzymes, due to their high specificity.23,51,57 Some enzymes have been 
investigated for this purpose, such as horseradish peroxidase, transglutaminase and 
tyrosinase.23,57 The gelling mechanisms of these enzymes and the advantages/disadvantages 
of each method are discussed below. 
To date, transglutaminase and horseradish peroxide have been predominantly investigated 
for the in situ formation of hydrogels.23,51 Transglutaminase has been demonstrated to be 
effective with a variety of polymers, for example, PEG, elastin, and gelatin.23 Horseradish 
peroxidases are likewise highly attractive owing to their stability, easy purification, and 
availability from horseradish and also of recombinant forms.23  
Horseradish peroxidase belongs to a wide family of peroxidases.23 It catalyses the conjugation 
of phenol or aniline derivatives in the presence of hydrogen peroxide. The major advantage of 
this enzyme for in situ cross-linking is that gelation occurs within seconds. Moreover, it 
requires no co-factor. For example, Jin et al. developed in situ forming hydrogels from 
polysaccharide hybrids consisting of hyaluronic acid grafted with dextran-tyramine conjugates 
as shown in Scheme 1-13.65,66 The gelation was achieved in less than 2 min and the 
mechanical properties of hydrogels were tunable by adjusting the polymer concentration and 
degree of substitution of tyramine. The hydrogel has potential for cartilage tissue engineering. 
However, the use of horseradish peroxidase in vivo has not been fully tested.67 
 
Scheme 1-13 Horseradish peroxidase catalysed in situ cross-link of polysaccharide hybrids 
containing dextran (in black) and tyramine residues (in blue). Adapted from reference 65,68 
Transglutaminases are a wide family of thiol enzymes that catalyse covalent bond formation 
between a free amino group from a protein terminus or a lysine containing peptide and a γ-
carboxamide from a protein terminus or a glutamine-containing peptide without co-factor 
added, except for the requirement of Ca2+ binding in supraphysiological concentration 
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(Scheme 1-14).67 The enzymes are known to be involved in wound healing and blood clot 
formation. The most prominent member of the transglutaminase family is the fibrin-stabilising 
factor XIII which is involved in blood coagulation.  
Yung et al. developed a cross-linked gelatine hydrogels from gelatine solutions using microbial 
transglutaminase.69 They demonstrated that the resulting hydrogels were biocompatible for 
cell encapsulation. HEK293 cell encapsulated in the cross-linked gelatine hydrogel 
proliferated at a rate of 0.3 day-1.  
 
Scheme 1-14 Mechanism reaction catalysed by transglutaminase enzyme.67 
The gelation catalysed by the transglutaminase enzyme is relatively fast, from 5 to 20 min, 
however, transglutaminase is a short-lived protein.23 For example, the half-life of type 2 
transglutaminase is 11 h. Moreover, there is a risk regarding the use of transglutaminase in 
the human body as it is involved in chronic inflammatory disease in joints and activating pro-
inflammatory cytokines that can lead to mineralisation. 
Tyrosinase is a copper-containing enzyme which catalyses the oxidation of phenols in tyrosine 
residues, dopamine, into quinones. Quinones can take part in Michael additions with amino or 
hydroxyl groups to form the cross-links. Similar to horseradish peroxidase, enzymatic reaction 
by tyrosinase requires no co-factor.  
Chen et al. investigated the cross-linking of chitosan and gelatin catalysed by tyrosinase or 
transglutaminases and found that gelation catalysed by tyrosinase was much faster (Scheme 
1-15).70 However, the gelation catalysed by tyrosinase required chitosan which was 
mechanically unstable.   
 
Scheme 1-15 Mechanism of reaction catalysed by tyrosinase enzyme. Reproduced from 
reference 70 
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1.4.2 Physically cross-linked hydrogels 
Physical hydrogels, also referred to as self-assembling hydrogels, are formed by non-covalent 
interactions such as ionic interactions, hydrogen boding, and hydrophobic association.4,12,51 
These hydrogels are usually prepared under mild conditions and require no chemical reagents 
or reactive functional groups.71 In contrast to covalently cross-linked hydrogels, the physical 
cross-links are usually weaker and more susceptible to external stimuli, hence, the use of 
physical cross-linked hydrogels is limited in some applications that require resistance to 
strain.3 This section will give an overview of physical hydrogel formation through ionic 
interactions, hydrogen bonding, and hydrophobic interactions. 
1.4.2.1 Hydrogel formation through ionic interactions 
In this approach, hydrogels are formed by the electrostatic interactions between charged sites 
along the polymer backbones. Inotropic hydrogels are formed between polyanions and cations 
or polycations and anions. For example, below its isoelectric point, chitosan is a polycationic 
polymer of glucosamine residues (Figure 1-9) which forms a hydrogel when mixed with 
phosphate ions.   
Another type of ionic hydrogel is a polyion complex or polyelectrolyte complex.  These are 
formed upon mixing two oppositely charged macromolecules, polyanions and polycations 
(Figure 1-9).72 For example, Jin and Kim developed hydrogels from mixtures of positively 
charged type A gelatin and negatively charged chondroitin 6-sulfate.68 The resultant gel was 
demonstrated to provide a sustained release of model protein over 25 days with minimal initial 
burst. 
The stability of ionic hydrogels can vary according to the pH of the system.71 
 
Figure 1-9 Hydrogel formed by ionic interactions. Adapted from reference 72 
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1.4.2.2 Hydrogel formation through hydrogen bonding 
A hydrogen bond is formed through the interaction of an electron deficient hydrogen atom and 
an electronegative functional group bearing a lone pair.71 In the case of biopolymers and 
peptides, hydrogen bonds can stabilise the secondary structure of proteins and peptides and 
provide the directionality for the self-assembly of nanofibrils which consequently results in 
gelation.42 The mechanism of peptide self-assembly will be discussed in section 1.5 (page 22).  
Zhang et al.73 developed a hydrogel system from a mixture of poly(acryloyl 6-aminocaproic 
acid) and a copolymer of methacrylic acid and ethyl acrylate. These polymers are protonated 
and soluble under neutral conditions, while under acidic conditions, where carboxylic groups 
are not deprotonated, a  loosely cross-linked hydrogel network with 30% water content was 
formed through the inter-chain hydrogen bonding (Figure 1-10).42,73 
 
Figure 1-10 Proposed supramolecular polymer hydrogel network. Structures in yellow are 
poly(acryloyl 6-aminocaproic acid). Structures in purple are linear poly(methacrylic acid-co-
ethyl acrylate). Red parts are inter-chain hydrogen bonds. Reproduced from reference 73 
1.4.2.3 Hydrogel formation through hydrophobic interactions 
Hydrophobic interactions have been widely employed for the preparation of hydrogels. 
Hydrophobic hydrogels are normally prepared from a water-soluble polymer containing a 
hydrophobic part, such as end groups, side chains or monomer to form physical cross-links.42 
In aqueous solution, these polymers will usually form micelles with the hydrophobic core 
surrounded by hydrophilic polymer loops at low concentration.42,71 At a higher concentration, 
the hydrophilic parts will form bridges between micelles, creating a hydrogel network. The 
gelling condition depends on the structure of the block copolymer (e.g. length of hydrophobic 
part and hydrophilic part), and the components of the solution such as salts and surfactants.42 
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Figure 1-11 Triblock copolymer ABA with hydrophilic-hydrophobic-hydrophilic structure at 
different concentrations. Reproduced from reference 42 
1.5 Self-assembling peptide hydrogels  
Self-assembly is commonly found in nature for the construction of structurally complex and 
functionally diverse biological systems. Peptides serve as building blocks and scaffolds for 
many bioassemblies, such as collagen, actin, pearl, and keratin.74 Inspired by nature, several 
functional biomaterials have been developed and engineered through the self-assembly of 
artificial small peptide molecules.74 Peptide-based hydrogels are one of the most promising 
classes of materials for biomedical applications due to their unique advantages including 
excellent biocompatibility, diverse functionality, high designability, and stimuli-
responsiveness.4,74,75  
In aqueous solution, the self-assembly of peptides is driven by non-covalent forces including 
hydrogen bonding, hydrophobic interactions, π-π stacking, ionic interactions, cation-π 
interactions, and van de Waals interactions.4,6 The formation of hydrogels involves two stages: 
(1) the self-assembly of peptide monomers into fibrous structures; and (2) the entanglement 
and interactions of these fibres into a 3D hydrogel network (Figure 1-12).74,75 The hydrophobic 
effect is the major driving force for the assembly of protein folding and the self-assembly of 
peptides, but hydrophobic effects do not provide directionality for the self-assembly. Hydrogen 
bonds between peptide backbones provide directionality and stability for the protein secondary 
structure and β-sheet rich fibrous network.4,6 
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Figure 1-12 Self-assembly of peptides into different nano-structures. Reproduced from 
reference 76 
The supramolecular self-assembly of peptides is dictated by the way these individual peptides 
fold in aqueous solution. Therefore, the following sections will discuss different secondary 
structures of peptides including the α-helix, β-sheet and β-hairpin to give insights into how 
these structure can be used for self-assembly.77  
1.5.1 α-Helix 
The α-helix is a key secondary structure of peptides, formed by a single spiral chain of amino 
acids which is stabilised by hydrogen bonding between the oxygen of the carbonyl with the 
hydrogen atom of the amide group located four residues along the sequence.77-79 A general 
α-helix structure comprises the characteristic heptad motif repeat of abcdefg, in which the 
residues at positions a and d are hydrophobic, and the residues at positions e and g are 
charged (Figure 1-13A).4,78,80 On the helical structure, the side chains of the amino acids point 
outward from the surface of the α-helix. The helical structures are not thermodynamically 
stable but the self-assembly of α-helices can give rise to a more stable quaternary structure, 
called a coiled-coil structure. More α-helices can self-assemble into larger supramolecular 
assemblies such as nanofibrils and nanoparticles (Figure 1-13B).77,79 
 
Figure 1-13 (A) Helical wheel diagram of coiled-coil structure (B) Representative diagram of 
dimeric coiled-coil structure. Adapted from reference 79 
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1.5.2 β-sheet  
Another type of secondary structure is the β-sheet. In this structure, the peptide chain is 
stretched out and hydrogen bonding occurs, orthogonal to the direction of the peptide chain, 
with the next peptide. The β-sheet is thus formed by the lateral association of peptide strands 
through inter-chain hydrogen bonding between the amide groups on the backbone.  
Hydrophobic interactions, π-π stacking and electrostatic interactions can also occur between 
the side chain groups.4,81 The alignment of the β-strands can be parallel or antiparallel with 
the antiparallel form being more energetically stable (Figure 1-14).77 Two β-sheets can come 
together and exclude the aqueous medium between the hydrophobic faces, forming a β-sheet 
bilayer. 
 
Figure 1-14 Arrangement of amphipathic peptides into β-sheets and β-sheet bilayers. 
Reproduced from reference 81 
Multiple β-sheets can laminate to form a variety of structures including tape, ribbon, fibrils and 
fibres based on their packing density (Figure 1-15).82 
 
Figure 1-15 Schematic representation of peptides that form beta sheets and the self-
assembled structures that can be formed. A: a peptide sequence with alternating hydrophilic 
(X) and hydrophobic (Y) residues. B: assembly of the beta sheet peptides into a molecule 
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that contains both a hydrophilic and hydrophobic face. C: self-assembly of the beta sheet 
forming peptide into a tape, ribbon, fibril, and fibre based on their packing density.82 
Many β-sheet-forming motifs have been reported that are capable of forming hydrogels. They 
include silk fibroins, amphipathic peptides, amphiphilic peptides, and the “FF” motif from 
amyloid fibrils.4 This section will only focus on the amphipathic peptides which are relevant to 
the theme of the second project described in this study. 
Amphipathic peptides typically comprise of (ph) sequences with alternating polar (p) and non-
polar (h) residues. These form antiparallel β-sheets in water. The hydrophobic interactions 
between the β-sheets lead to the formation of β-sheet bilayers. In the β-sheet bilayer, the 
hydrophobic groups are buried inside the two sheets, and the hydrophilic residues point 
outward into the aqueous phase, therefore the fibrils from amphipathic peptides are highly 
soluble in water.4 The first amphipathic peptide, Ac-(AEAEAKAKA)2-NH2 (EAK16-II) (A – 
alanine, E – glutamic acid, K – lysine), which self-assembles into β-sheet rich fibrils that can 
induce gelation in water, was reported by Zhang et al.83 They later designed a series of ionic 
complementary peptides, Ac-(RARADADA)2-NH2 (R – arginine, A – alanine, D – aspartic acid), 
containing a periodic pattern of negatively and positively charged residues at position p and 
alanine at position h.4 Messersmith et al. later designed an amphipathic peptide, (FEFEFKFK)2 
(F – phenyl alanine, E – glutamic acid, K – lysine), containing aromatic residues at position h 
with the aim of introducing π-π stacking.4 The self-assembly of this peptide in water only takes 
place in the presence of salts NaCl, CaCl2, and KCl. Nilsson et al. investigated the shorter 
version of this peptide, FKFEFKFE, and reported the gelation of this short peptide in pure 
water.4 
1.5.3 β-hairpin  
Another important secondary structure of peptides is the β-hairpin, which occurs when a 
peptide chain contains a pair of turn inducing residues, such as proline followed by glycine or 
threonine.78 The basic structure of a β-hairpin peptide used for hydrogel formation is two 
locally amphiphilic arms consisting of alternating hydrophobic and hydrophilic amino acids 
connected by a turn sequence.84 The structure of a general turn sequence is depicted in  
Figure 1-16. In the turn sequence, the cyclic structure of proline (position i+1) causes a slight 
kink in the α-carbon backbone and this, along with the flexible glycine or threonine amino acid  
(position i+2), promotes the reversal of the direction of the peptide backbone.78 The loop is 
held tightly in place as a result of hydrogen bonding between two amine groups belonging to 
the amino acids at position i and i+3 before and after the turning sequence.78 
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Figure 1-16 Structure of turn sequence in β-hairpin peptide. Adapted from reference 78 
Kretsinger et al. have developed a 20 amino acid amphipathic peptide (MAX1) 34 that adopts 
that β-hairpin structure (Figure 1-17). MAX1 consists of alternating lysine (K) and valine (V) 
amino acids on two β-strands flanking a type II’ β-turn. At physiological pH, the lysine residues 
are protonated, causing electrostatic repulsion between the β-strands and consequently 
inhibiting hydrogel formation. The gelation can be induced either by increasing the pH to 9.0 
to neutralise lysine residues or by increasing the ionic strength at pH 7.0 to 150 nM to screen 
the charges.78 
 
Figure 1-17 (A) The folding into a β-hairpin of MAX1 peptide 34 and the self-assembly of 
these structures into a hydrogel network; (B) The folding sequence of MAX1. Reproduced 
from reference 85 
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1.6 Synthesis of protein/peptide-polymer conjugates through controlled 
radical polymerisation 
1.6.1 Introduction  
Protein/peptide-polymer conjugates have been studied extensively for many applications in 
biotechnology, nanomedicine, and pharmaceutical technology.86 The covalent conjugation of 
biomolecules such as proteins to synthetic polymers can alter some structural and functional 
properties of the biomolecules but can also introduce new features to the molecule that induce 
novel behaviours such as self-assembly, stimuli-responsive behaviour, and patterning 
behaviour.86 Owing to the increasing utility of protein/peptide-polymer conjugates in various 
biomedical applications, research has driven into developing homogeneous and well-defined 
polymer conjugates with uniform biohybrid properties and reproducible biological activity.86 
Recent advances in controlled radical polymerisation has offered excellent strategies to 
prepare the conjugates as the resulting polymers possess narrow molar mass (MM) 
distributions, targeted MMs, and can be attached to specific sites on the proteins/peptides.86-
91 The most commonly used controlled radical polymerisation methods are atom transfer 
radical polymerisation (ATRP) and reversible addition-fragmentation chain transfer 
polymerisation (RAFT).91 ATRP uses a transition metal catalyst to control the growth of 
polymer from an alkyl halide initiator, while RAFT uses a thiocarbonylthio containing chain 
transfer agent (CTA) to control the reversible chain transfer process. As the work described in 
this thesis employed RAFT polymers, the following review will only focus on RAFT 
polymerisation and the synthetic aspects of utilising this method. 
1.6.2 Reversible addition-fragmentation chain transfer polymerisation (RAFT) 
Conventional radical polymerisation has become one of the most widely used methods for the 
production of high molar mass polymers.92 The RAFT polymerisation method was first 
introduced by the CSIRO group in 1998.93 It quickly gained tremendous attention from the 
scientific research community due to its robustness and applicability to a wide range of 
monomers which undergo radical polymerisation after careful selection of RAFT agent and 
polymerisation conditions.92 RAFT polymerisation shares the same elementary steps as 
traditional radical polymerisation including initiation, propagation, and termination as shown in 
Scheme 1-16.  
The key feature that distinguishes RAFT polymerisation from classical living radical 
polymerisation is the fact that the majority of living chains are maintained in the dormant form 
thus avoiding termination.92 In the reversible chain transfer/propagation, the propagating 
radical Pn• adds to the thiocarbonylthio compound, followed by the fragmentation of the 
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intermediate radical to form a polymeric thiocarbonylthio compound (dormant species) and a 
new radical R•.92 R• reacts with monomers to generate a new propagating radical Pm•.92 The 
rapid equilibrium established between propagating radicals (Pn•, Pm•) and the dormant species 
offers equal probability for all chains to grow and therefore allows for a narrow molar mass 
distribution. When most of the monomer is consumed, or the polymerisation is intentionally 
stopped, the majority of chains remaining are dormant containing the thiocarbonylthio group.92 
 
Scheme 1-16 RAFT polymerisation mechanism with thiocarbonylthio chain transfer agent. 
Adapted from reference 92 
RAFT polymerisation represents a highly versatile platform for the synthesis of controlled 
polymers and polymer conjugates. The RAFT approach not only enables the synthesis of 
polymers with defined and spatially-controlled functionalities such as pendant groups, alpha-, 
and omega-end-groups but also allows the synthesis of polymers and polymer conjugates with 
various architectures such as stars, block copolymers, and branched polymers.86  
The structure of CTAs has a great influence in the integrity of the polymer, end group fidelity 
and polymer dispersity.94 Generally, monomers can be divided into two groups: more-activated 
monomer (MAM) and less-activated monomer (LAM) based on the structure of the monomers. 
MAMs typically consist of vinyl group conjugated to a carbonyl group or an aromatic ring, for 
example (meth)acrylamide, (metha)acrylate, styrenenics. LAMs normally contain carbon or 
oxygen/nitrogen with a lone pair adjacent to vinyl group, for example vinyl esters, ethylene, N-
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vinylpyrrolidone (NVP), and diallyldimethylammonium chloride. Propagating radicals made of 
MAM are less reactive in radical addition, hence more reactive RAFT agent is required. 
1.6.3 Modification of RAFT end group 
A key feature of RAFT polymerisation is that the RAFT functional group, which is present in 
the initial chain transfer agent, is retained in the final polymer product.95 In some 
circumstances, the removal of the thiocarbonylthio group may be desirable to achieve the 
desired functionality, or for use in subsequent processes post-polymerisation. Dakrong et al.96 
reported surprising results on the cytotoxic effects of different RAFT-synthesised PHPMA to 
various cell lines. At a concentration of 1000 µM, dithiobenzoate PHPMA was highly toxic to 
three cell lines CHO-K1, RAW264.7, and NIH3T3 over 24 h. Reducing the concentration to 
below 200 µM eliminated the toxicity. In some cases, the polymers may also release odour 
owing to the decomposition of the thiocarbonylthio group, and evolution of sulfur-containing 
compounds.95 Hence, the removal of RAFT end-groups may be required in some cases, 
particularly for biomedical applications. 
There has been a growing body of research looking into the transformation of RAFT end-
groups for the construction of biopolymer conjugates, block or graft copolymers, and functional 
nanoparticles.97 The ease of RAFT end-group modification using a variety of chemical 
reactions (Scheme 1-17) makes the method extremely versatile in the preparation of 
bioconjugates.95  
 
Scheme 1-17 RAFT end-group transformations (R'. = radical; [H] = hydrogen donor; M = 
monomer). NMP: nitroxide-mediated radical polymerisation. Reproduced from reference 95 
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1.6.4 Synthesis of protein/peptide-polymer conjugates from RAFT polymers 
The preparation of protein/peptide-polymer conjugates can be performed via two main 
strategies: (1) Bioconjugation via post-polymerisation, and (2) bioconjugation via in situ 
polymerisation.86,98 In the former approach, the conjugation of proteins or peptides to polymers 
is achieved by using RAFT polymers which contain reactive functional groups such as vinyl 
sulfone, maleimide, azide, or thiol. Functionalisation of RAFT polymers can be done either by 
using modified RAFT agents in the polymerisation or by modification of RAFT end groups.86,98 
In the latter, polymer conjugates are synthesised via in situ polymerisation using biomolecule-
modified monomers or RAFT agent.86 
1.6.4.1 Conjugation via post-polymerisation 
Post-polymerisation conjugation is the most common method.87 This pathway requires 
multiple steps including the preparation and purification of polymers, conjugation, and 
purification of the final conjugate, which leads to a decrease in the overall yield.86 In general, 
there are two common methods for the preparation of functionalised polymers via the post-
polymerisation approach: (1) polymer synthesis using modified RAFT agent with reactive 
functionalities towards biomolecules’ functional groups following the coupling of biomolecules 
to the polymer and (2) post-polymerisation modification of RAFT end-groups of the 
synthesised polymers.86 The presence of functionalities on biomolecules such as thiols, 
amines, carboxylic acids and alcohols can be exploited to perform a direct conjugation to the 
polymer.98 Examples for each method will be presented in the following section. 
1.6.4.1.1 Conjugation using amine-reactive polymers 
The most traditional method for the synthesis of polymer conjugates is to react amines or 
hydroxyl groups with carboxylic acid-modified polymers.86 Conveniently, several RAFT agents 
with carboxylic acid functional groups are available for the direct synthesis of carboxyl 
functionalised polymers.86 An activated form of the carboxylic acid group such as carbamate 
or carbonate must be used for the coupling and several examples are shown in Scheme 
1-18.86  
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Scheme 1-18 Coupling strategies using amine-reactive polymers. Adapted from reference 99 
In a study by Tao et al., a well-defined PHPMA was prepared via RAFT polymerisation using 
a thiazolidine-2-thione mid-functionalised RAFT agent 45 (approach 1) (Figure 1-18).100 The 
thiazolidine-2-thione functionalised polymer was successfully coupled to a lysozyme protein, 
yielding a branched polymer conjugate with an ‘umbrella-like’ polymeric structure.  
 
Figure 1-18 Thiazolidine-2-thione mid-functionalised RAFT agent 45 and schematic of 
umbrella-like structure of PHPMA-lysozyme conjugate. Reproduced from reference 86 
The limitation of this approach is that the conjugates may be formed heterogeneously due to 
the abundance of amine containing amino acid residues in the biomolecules.86,101 A possible 
solution to this problem is to adjust the pH of the conjugation reaction to only deprotonate the 
targeted α-amino group of the N-terminal residue.86  
1.6.4.1.2 Conjugation using thiol-reactive polymers 
Along with amines, thiols from cysteine residues are also frequently used for bioconjugations. 
Compared to amino groups, thiols are present to a lesser extent in biomolecules which allows 
for selective attachment and hence results in higher homogeneity.99 In proteins, cysteine 
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residues may exist as disulfide bridges and reducing them to expose free thiols sometimes 
leads to destruction of the protein’s native 3D structure.99 Two main routes for thiol-coupling a 
biomolecule to a polymer are (1) disulfide bond formation, and (2) alkylation via Michael 
addition (Scheme 1-19).99 
 
Scheme 1-19 Coupling strategies using thiol-reactive polymers. Adapted from reference 99 
Pyridyl disulfide (PDS) is an effective active group for an exchange reaction with thiols under 
mild conditions. As the formation of the disulfide bond upon thiol-PDS reaction is reversible, 
the utility of PDS may be useful for the preparation of reversible bioconjugates.86 PDS 
functionality can be introduced to RAFT agents to generate PDS-modified polymers. 
Examples of PDS-functionalised RAFT agents are shown in Figure 1-19. It is also possible to 
synthesise ω-PDS functionalised polymers by in situ aminolysis of RAFT end groups in the 
presence of 2,2’-dithiodipyridine.86 This method usually gives a high yield of PDS incorporation 
onto polymers without side reactions such as disulfide and thiolactone formation.86 
 
Figure 1-19 Examples of PDS-modified RAFT agents.100,102,103 
The major approach for cysteine modification is Michael addition with maleimides and vinyl 
sulfones.99 Both maleimides and vinyl sulfones are highly reactive towards thiols, making them 
good targets for bioconjugation.86 Polymers with maleimide or vinyl sulfone functionalities are 
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usually generated via modification of RAFT end groups. Li et al. prepared a ω-maleimide 
functionalised PNIPAM via a two-step synthetic route.104 RAFT PNIPAM was firstly 
aminolysed to yield thiol-terminated chains and later reacted with 1,8-bis-
maleimidodiethyleneglycol to generate maleimide-terminated polymer.104 The resulting 
polymer was successfully coupled to BSA and ovalbumin via Michael addition (Scheme 
1-20).104 The study showed that bioactivity of BSA was 92% of unmodified BSA.104 Similar 
synthetic method for ω-vinyl sulfone functionalised polymers was reported by Alconcel et al.105 
 
Scheme 1-20 Synthetic route to PNIPAM-protein conjugates via RAFT polymerisation, end 
group modification, thiol-maleimide Michael addition.104 
Another interesting conjugation approach is the Michael addition of disulfide to α,β-
unsaturated β’-monosulfone without the loss of the bridge (Scheme 1-21).99 The disulfide 
linkage is first reduced to free thiols under mild conditions such as tris[2-
carboxyethyl]phosphine (TCEP.HCL) or dithiothreitol. One of the two thiols attacks the double 
bond via Michael addition, the resulting enolate from which then eliminates the sulfonyl group 
to provide a new α,β-unsaturated ketone. Then, a second Michael addition of the remaining 
thiol completes the three carbon bridge.99  
 
Scheme 1-21 Mechanism of double Michael addition of disulfide to α,β-unsaturated β’-
monosulfone.99 
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1.6.4.1.3 Conjugation via indirect pathway 
In this approach, both polymers and biomolecules are modified to possess new functionalities. 
Chemical strategies for the conjugation include click reactions such as the thiol-ene click 
reaction, azide-alkyne cycloadditions (CuAAC), and oxime formation.86,99 The chemistries of 
these reactions were discussed earlier in section 1.4.1 (page 11).  
Kakwere et al. reported a successful conjugation of a low MM alkyne-functionalised PNIPAM 
to immunogenic peptides found in MUC1 protein via the CuAAC approach.106 Their synthetic 
route is shown in Scheme 1-22. Azido MUC1 peptide was prepared by Fmoc solid phase 
peptide synthesis on Wang resin (azidoglycine being used to install the azide group). 
 
Scheme 1-22 Synthesis of PNIPAM-MUC1 conjugate via CuAAC. Adapted from reference 
106 
Although CuAAC is a highly efficient reaction, the use of a copper catalyst may cause a 
concern for the conjugation of biomolecules which contain metal-complexing moieties.86 In this 
context, the thiol-ene reaction presents a better pathway to bioconjugations.86 It has been 
reported in many studies that in situ aminolysis of thiocarbonylthio RAFT end groups to thiols 
in the presence of previously-formed ene-containing biomolecules (e.g. maleimide, vinyl 
sulfone or acrylate) gave highly efficient bioconjugation.86 Boyer et al. demonstrated in their 
study that the simultaneous addition of thiol-reactive biomolecules during the aminolysis of 
RAFT end groups to thiols presented a robust and efficient approach for the direct conversion 
of RAFT polymers into bioconjugates.107 They presented two approaches involving in situ 
aminolysis and modification of thiol-terminated polymers. As shown in Scheme 1-23, the first 
route involved simultaneous aminolysis of RAFT polymers with amine, thiol disulfide exchange 
with 2,2’-dithiodipyridine to generate stable pyridyl disulfide (PDS)-functionalised polymers 
followed by conjugation.107 In the second route, thiol groups generated during the aminolysis 
process reacted simultaneously with maleimide functional groups on the biomolecule.107 The 
second route yielded non-reversible thioether-linked conjugates.107 
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Scheme 1-23 Synthesis of bioconjguates via in situ aminolysis of thiocarbonylthio RAFT 
polymers and thiol-specific addition. Reproduced from reference 107 
Incorporation of proteins onto PNIPAM polymer using oxime chemistry was reported by 
Vázquez-Dorbatt et al.108 In their study, a well-defined PNIPAM was prepared via RAFT 
polymerisation using a Boc-protected aminooxy trithiocarbonate RAFT agent. Following the 
removal of the protecting Boc group, the polymer’s aminooxy functional group was reacted 
with N’-levulinyllysine-modified BSA in solution (Scheme 1-24) or aldehyde-functionalised 
heparin on a gold surface via oxime bond formation.108 
 
Scheme 1-24 Synthesis of PNIPAM-BSA conjugate using oxime chemistry. Adapted from 
reference 108 
1.6.4.2 Conjugation via in situ polymerisation 
The disadvantages of bioconjugation via post-polymerisation are low yield of conjugation due 
to steric hindrance between bulky polymer chains and large biomolecules, difficulty in 
separating molecules with similar MM during purification, and challenges associated with poor 
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water-soluble polymers.91 Hence, bioconjugation via in situ polymerisation (the ‘graft-from’ 
method) was developed, in which the CTA is immobilised to the target protein or peptide by 
either the R-group or Z-group, and the polymer chain is grown in situ from the protein/peptide 
modified CTA (Scheme 1-25).86,91 It is said that the Z-group modified CTA is likely to be 
affected by steric hindrance, therefore may reduce the polymerisation efficiency while the R-
group approach reduces the steric hindrance.86 However, conjugates prepared using Z-group 
macroCTA are hydrolysable due to the labile C-S bond between the polymer chain and the 
biomolecule, which might be useful for some applications.86  
 
Scheme 1-25 Protein/peptide-polymer conjugate synthesis via graft-from method. Adapted 
from reference 109 
De et al. synthesised a bovine serum albumin (BSA) modified CTA (BSA-macroCTA) (R-group 
approach) and, from it, successfully generated a well-defined (PNIPAM) via RAFT 
polymerisation (Scheme 1-26).110 The modified protein derivatives were also tested for their 
esterase-like activity, the ability to hydrolyse 4-nitrophenylacetate, which was known to be 
dependent on the structural integrity of the protein. They reported that the BSA-PNIPAM 
conjugates 78 exhibited >90% retention of activity as compared to native BSA.. 
 
Scheme 1-26 Synthesis of BSA-macroCTA and graft-from via polymerisation of NIPAM 
monomer.110 
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Boyer et al. also successfully synthesised well-defined poly(ethylene glycol) acrylate (PEGA) 
and PNIPAM using BSA-macroCTA with the protein attached to the Z group (Scheme 1-27).101 
PNIPAM-BSA conjugate was shown to maintain 94% esterase-like activity compared to 
unmodified BSA.101 
 
Scheme 1-27 Synthesis of PNIPAM-BSA conjugate via RAFT polymerisation. Reproduced 
from reference 101 
Bioconjugation via in situ polymerisation presents many advantages over the post-
polymerisation conjugation method including higher conjugation yields, better control over the 
number of conjugation sites of the modified polymer, better defined conjugate with higher 
homogeneity and easier purification processes.86 However, there are issues regarding the 
polymerisation conditions which need to be carefully optimised to preserve the conformation 
and bioactivity of the conjugated biomolecules. Moreover, it is also vital to preserve the 
thiocarbonylthio structure in the CTA in the presence of amino residues in the biomolecules.86 
1.6.5 Sortase A enzyme as a catalyst for bioconjugations. 
Sortase A (SrtA) is a cysteine peptidase isolated from Staphylococcus aureus.25,111 SrtA is 
responsible for covalent anchoring of surface proteins to the peptidoglycan of Gram-positive 
bacteria.25,112 SrtA catalyses the transpeptidation by breaking the amide bond between 
threonine and glycine at an LPXTG recognition motif (L – leucine, P – proline, T – threonine, 
G - glycine) by means of an active site cysteine (cys184) generating a covalent acyl-enzyme 
intermediate (Scheme 1-28).25,33,113-121 The carboxyl group of threonine in the intermediate 
then undergoes nucleophilic attack by an amino group of an oligoglycine substrate to produce 
the ligated product.112 In the absence of an oligoglycine motif, the acyl-enzyme intermediate 
is hydrolysed by water.113 SrtA has been widely used for protein-protein ligation and 
immobilisation of protein on different surfaces because the enzyme catalyst is site-specific. It 
requires a minimal constraint on the nature of protein to be coupled requiring only introduction 
of a short motif sequence into the protein substrate.122 In the field of tissue engineering, SrtA 
has been also exploited for hydrogel fabrication. For example, Cambria et al. successfully 
grafted human epidermal growth factor, fused with a GGG ligation motif (GGG-EGF), into a 
PEG hydrogel containing an LPRTG substrate.123 In another study by Gau et al., poly(N-
vinylcaprolactam) (PVC) microgels containing the recognition sequence LPETG were 
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decorated with enhanced green fluorescent protein eGFP, carrying an N-terminal triglycine 
tag, via SrtA-mediated ligation.116  
 
Scheme 1-28 Mechanism of SrtA mediated ligation of polypeptides.113 
1.7 Poly(N-(2-hydroxypropyl)methacrylamide) (PHPMA) and its biomedical 
applications 
 
Figure 1-20 Chemical structure of PHPMA 
Poly(N-(2-hydroxypropyl)methacrylamide) (PHPMA) was first introduced by Kopeček and 
colleagues in the early 70s.124 Since then, PHPMA has attracted tremendous attention for the 
delivery of anti-cancer drugs, tumour-specific antisense oligonucleotides, and site specific 
delivery to the gastrointestinal (GI) tract because of its proven biocompatibility, non-toxicity, 
and non-immunogenicity.125,126 Well-defined PHPMA was first synthesised using controlled 
radical polymerisation, the ATRP method, by Teodorescu and Matyjaszewski in 1999.127 The 
first RAFT polymerisation of HPMA was reported by McComick’s group in 2005.125,128,129  
In many areas of biomedical applications, PEG is the most widely studied polymer due to its 
unique properties such as solubility in both organic and aqueous solution, non-toxicity and low 
protein adhesion.17 PEGylated modification of active recombinant proteins, peptides, and 
antibodies extends their biological half-life, increase solubility, and reduce toxicity, antigenicity 
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and immunogenicity while sustaining therapeutic effectiveness. On the contrary to the 
accepted general assumption that PEG is non-immunogenic, animal study shows that urease, 
ovalbumin, and some PEGylated agents can elicit antibody formation against PEG (anti-
PEG).130 Recent research has found that there is a 22-25% occurrence of anti-PEG in healthy 
blood donors in comparison to the 0.2% occurrence two decades earlier.  
PHPMA has increasingly been found to be superior to PEG due to its ease of synthesis via 
controlled radical polymerisations and the potential to fabricate it with diverse functionalities 
as pendent groups to optimise its properties, which is not possible with PEG.131,132 Moreover, 
PHPMA exhibits hydrolytic and chemical stability along with being tolerated by cells entrapped 
in the polymeric capsule.133  
PHPMA-based nanomedicines have been evaluated in clinical trials for therapeutic validation 
since the 1990s. These include HPMA copolymer-doxorubicin (DOX), HPMA copolymer–
DOX–galactosamine, HPMA copolymer–camptothecin, HPMA copolymer–paclitaxel, and 
HPMA copolymer–platinates.134 However, the clinical application of these conjugates is still 
limited to low MM bioactive molecules and by their assembly into random molecular 
structures.135 PHPMA is not biodegradable because the C-C bond cannot be metabolised by 
the body, thus the MMs of precursor polymers need to be carefully controlled to avoid 
bioaccumulation and to ensure renal excretion.50 Generally, MM cut-offs for renal clearance is 
in the range of 20 to 60 kDa. However, high MM polymer-drug conjugates are more favoured 
because they not only prolong the bio-distribution of the drug but also passively target the 
cancerous cells by the enhanced permeation effect.132 Kopeček’s group have recently 
proposed a novel strategy to synthesise a biodegradable backbone of PHPMA by use of a 
difunctional chain transfer agent in RAFT polymerization and subsequent chain extension by 
conjugation of a biodegradable peptide sequence via CuAAC or thiol-ene chemistry (Figure 
1-21).136 
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Figure 1-21 Backbone degradable PHPMA via copper-catalysed azide alkyne cycloaddition 
of telechelic PHPMA and enzyme degradable peptide sequences. Reproduced from 
reference 136 
PHPMA hydrogels have also been studied for tissue engineering applications. Woerly et al. 
synthesised a biocompatible hydrogel of PHPMA incorporating Arg–Gly–Asp (RGD) for 
promoting tissue regeneration and supporting axonal outgrowth in the injured adult rat spinal 
cord (Figure 1-22).137 The PHPMA-RGD hydrogel displayed similarities to the interconnected 
porous structures and viscoelastic properties of the neural tissues. Such a cell scaffold not 
only demonstrated reduction of necrosis but also encouraged tissue repair. Thus, PHPMA-
RGD is a promising hydrogel for neural tissue engineering because of its biocompatibility, 
good interfacial stability, and similar biochemical structure to the neural tissues.  
 
Figure 1-22 Schematic chemical representation of the structure of biodegradable PHPMA 
hydrogel containing the RGD peptide. Reproduced from reference 137  
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1.8 Thermo-responsive polymers  
1.8.1 Introduction 
Stimuli-responsive polymers are described as ‘smart’ materials that undergo a property 
change in response to variations in pH, temperature, and ionic strength.138,139 In the field of 
smart materials, thermo-responsive polymers have been studied extensively for biomedical 
applications because they are easily controlled by a temperature stimulus which can be 
applied in a non-invasive manner.139,140 Thermo-responsive polymers precipitate out of 
solution when the temperature is increased or decreased. If precipitation occurs upon heating, 
the mixture exhibits lower critical solution temperature (LCST) behaviour (Figure 1-23).139,140 
If a decrease in temperature leads to two immiscible liquid phases, the mixture exhibits upper 
critical solution temperature (UCST).139 This section will only focus on the LCST behaviour of 
thermo-responsive polymers. 
 
Figure 1-23 Phase diagram of LCST and UCST polymers in aqueous solution. Reproduced 
from reference 141 
1.8.2 Principle of LCST 
LCST can be explained by the altering of hydrophilicity upon temperature variation.142-144 Each 
point on the phase diagram curve is the cloud point temperature (Tc), at which the polymer 
exists as extended coils in solution, surrounded by a thin layer of water molecules around the 
hydrophilic parts of the polymer.143 The minimum of the curve corresponds to the LCST. 
As the temperature is increased above the Tc, there is a transition which is commonly 
accompanied by a change from a clear solution to a cloudy solution.143,144 From the 
thermodynamic point of view, this can be explained using the Gibbs free energy equation: 
∆Gmix = ∆Hmix - T∆Smix, where ∆Gmix, ∆Hmix, ∆Smix are the free energy, enthalpy and entropy of 
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the mixing process of polymer and water and T is temperature.139 Below the Tc, the free energy 
of mixing (∆Gmix) is negative, making the dissolution of the polymer spontaneous. The 
dissolution process is enthalpy-driven (∆Hmix<0) as the hydrogen bonds formed by the 
hydration shell are stronger and longer-lived than those in the bulk.138,142 At increased 
temperature, the hydrogen bonds break, resulting in the collapse of the hydration shells. The 
freeing of water molecules becomes less ordered, giving a rise to the entropy of the water and 
the overall entropy (∆Smix<0; T∆Smix becomes larger than the absolute value of ∆Hmix), making 
the free energy of mixing more positive and consequently manifesting the separation. The 
polymer chains therefore undergo coil-to-globule-to-aggregate transitions as displayed in 
Figure 1-24.139,142 
                  
Figure 1-24 LCST transition of polymers. Adapted from reference 142. 
1.8.3 LCST characterisation by differential scanning calorimetry  
Several techniques have been used to characterise the Tc of thermo-responsive polymers 
including calorimetry, dynamic light scattering, NMR spectroscopy, and turbidimetry.139 This 
section will discuss the calorimetry method because the work described in this thesis only 
employed calorimetry for Tc characterisation. 
Upon heating, the hydrogen bonds between water molecules and polymers break, thus the 
coil to globule transition is an endothermic process. As such it can be detected by calorimetry. 
The principle of this method is based on the measurement of the heat capacity between a 
sample cell and a reference cell.139 A thermogram provides information about the Tc at which 
the phase separation takes place. Tc represents an endothermic process and the energy 
associated with that process will be observed as a dip on the y axis in the thermogram (Figure 
1-25).139 The method also allows characterisation of the reverse phase transition upon cooling.  
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Figure 1-25 DSC thermograms of PNIPAM polymers in water. Reproduced from reference 
145 
1.8.4 PNIPAM and its biomedical applications 
 
Figure 1-26 Structure of poly(N-isopropyl acrylamide) PNIPAM 
Stimuli-responsive hydrogels have been the subject of research for biomedical applications 
as they show significant changes in biological, physical and chemical properties in response 
to external stimuli.146 PNIPAM is an amphiphilic polymer and was the first reported Tc thermo-
responsive polymer.147 It is renowned for a sharp phase transition at its Tc around 32 °C.140 
PNIPAM has been investigated extensively for many applications, especially drug delivery and 
cell growth. Vihola et al. investigated the cytotoxicity of PNIPAM and found that it was not toxic 
to cells in the concentration range from 0.01 to 10 mg.mL-1.148 The applications of PNIPAM 
mentioned above will be discussed in more detail below. 
1.8.4.1 PNIPAM for drug delivery  
Drug targeting has been widely used not only in basic science but also in clinical medicine, 
especially for cancer chemotherapy. An ideal drug delivery system meets two criteria: (1) 
selective delivery to the target site and, (2) controlled drug release at the target site.149 Stimuli-
responsive drug release is one way to achieve this. The delivery of drugs and chemical agents 
by stimuli-responsive polymeric carriers is a growing field of research and amongst the types 
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of carriers, temperature responsive hydrogels are one of the most studied.150 Figure 1-27 
presents different strategies to control the drug release. In the first strategy, a hydrophilic drug 
is incorporated in the hydrogel; when the temperature decreases below the Tc, the diffusivity 
increases and the drug can be released (Figure 1-27A). In the second case, a more 
hydrophobic drug is incorporated within the hydrogel; when the temperature rises above the 
Tc, the collapse of polymer chains leads to the release of the drug (Figure 1-27B). In the final 
case, there are heterogeneous hydrogels that can form a dense skin layer above Tc, 
preventing the release of the drug (Figure 1-27C).  
The drug can be incorporated into thermo-responsive polymer hydrogels by different methods. 
One method is to swell the dry polymer in a solution containing the targeted drug.150 In another 
method, the hydrogel can be prepared from a mixture of monomer, or polymer, cross-linker, 
initiator and the drug.150  
 
Figure 1-27 Strategies to control the release of drug based on thermo-responsive hydrogels. 
(A) Release of hydrophilic drug from hydrogel (B) Release of hydrophobic drug from 
hydrogel (C) Control of drug release by heterogeneous hydrogel drug coating. Adapted from 
reference 150 
PNIPAM has been widely used for drug delivery applications mainly due to its sharp phase 
transition and the closeness of its Tc, at about 32 °C, to physiological temperature.146,151 
Additionally, the Tc of PNIPAM can be tuned by copolymerising it with different monomers or 
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introducing various functional groups to the polymer chains.147,152 Co-polymerisation with more 
hydrophilic monomers can increase the Tc of the PNIPAM-based polymer, giving a transition 
temperature close to physiological temperature.153 Moreover, the Tc is influenced by the 
presence of salts and pH to some extent.154 Liu et al. showed that an increase of NaCl 
concentration from 0 to 1.0 wt% in aqueous solution resulted in a significant decrease in the 
Tc of PNIPAM.154  
PNIPAM is not biodegradable which may be problematic for some biomedical 
applications.152,155 To address this limitation, biodegradability can be introduced through 
copolymerisation of NIPAM monomer with biodegradable monomers.153 There is a growing 
interest in the area of biodegradable NIPAM-based hydrogels with degradation-dependent 
phase transition in which the Tc of PNIPAM hydrogels changes as the hydrogels break down. 
Li et al. synthesised a biodegradable hydrogel based on NIPAM, 2-hydroxyethyl methacrylate, 
dimethyl-Ɣ-butyrolactone acrylate, and PCL for cardiosphere-derived cell delivery.156 The 
resulting hydrogel possessed a Tc below 37 °C, hence rapidly formed a solid upon exposure 
to body temperature. As degradation takes place, the Tc of the hydrogel increased well above 
37 °C and the degradation products became soluble in the body fluid and could be eliminated 
from the body. The hydrogels showed physical properties suitable for myocardial injection and 
also promoted cardiosphere-derived cell proliferation as well as cardiac cell differentiation.156 
Nakayama et al. developed a biodegradable, thermo-responsive PNIPAM-based micelles for 
controlled drug release.149 The hydrophilic block of the micelle consisted of poly(N-
isopropylacrylamide-co-N,N-dimethylacrylamide) (p(NIPAM-co-DMAAm)) which has a Tc 
around 40 °C, while the hydrophobic part of the micelle was made of poly(D,L-lactide), poly(ε-
caprolactone) or poly(D,L-lactide-co-ε-caprolactone) which are biodegradable. Below the Tc, 
the thermo-responsive block forms an outer shell and the drug was incorporated in the inner 
core of the micelle. Above the Tc, the outer shell becomes more hydrophobic and collapses, 
resulting in drug release.149 
1.8.4.2 PNIPAM for gene delivery 
Gene therapy is one of the promising for many genetic diseases. In this technique, the delivery 
of genes into cells that will replace, repair or regulate the defective genes is one of the vital 
steps.144  However, DNA is negatively charged and hydrophilic, thus its transportation requires 
a carrier. Polymeric carrier has been demonstrated to be cheaper, safer, and easily tailored 
compared to nature’s carriers such as viruses or liposomes. The pathway of gene delivery 
using polymeric carrier involves three main steps: (1) DNA and polymer complexation, (2) 
addition of DNA/polymer complex to the cell, (3) the removal of complex from the cell, (4) 
incubation time until the results are observed (Figure 1-28).144 
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Figure 1-28 The main steps of gene delivery using a cationic polymer: (1) DNA complexation 
(2) complex traversing the cell membrane to the cytoplasm (3) DNA release into the 
cytoplasm and (4) DNA transfer into nucleus.144 
The use of thermoresponsive polymer in the carrier is shown to be advategous because it 
enhances the transfection of DNA to cells. Zhou et al. used using [poly(N,N-dimethylamino 
propyl acrylamide)-b-PNIPAAm]-star polymers as main components for the carrier.144 They 
performed the complexation of DNA and polymer carrier at room temperature below Tc of 
PNIPAM, and then deposited the complex on the cell membrance at 37 °C above Tc. 
1.8.4.3 PNIPAM for tissue engineering applications 
PNIPAM has also found use in cell sheet fabrication. By incorporating the thermo-responsive 
PNIPAM on to the cell culture substrate, the hydrophilicity of the cell culture sheet can be 
modulated with a temperature switch.152,153 Above the Tc of PNIPAM, the surface of the cell 
sheet becomes hydrophobic which facilitates cell adherence and proliferation at physiological 
temperature. When the temperature is below the Tc of PNIPAM, the cell sheet surface is 
hydrophilic which induces cell detachment, allowing for cell harvest without any enzymatic or 
mechanical treatment compared to convention cell harvesting.  
Mikos’s group developed a series of novel injectable PNIPAM-base thermo-gelling macromers 
that contain olefinic functionality avaiblable for thermally chemical cross-linking in vivo and 
that contain biocompatible hydrophobic domains.157 These macromes were prepared by 
radical copolymerisation of 4 monomers, pentaerythritol diacrylate monostearate (PEDAS), 
NIPAM, acrylamide, and 2-hydroxyethyl acrylate. Thermal gelation was observed for all 
macromer solutions (10% wt/v) upon heating up to 37 °C. It was shown that the thermal 
gelation and thermal cross-linking improved the stability of the resulting hydrogels, and that 
these macromonomers are promising for the design of injectable drug and cell delivery. 
Hatakeyama et al. designed a bioactive and thermo-responsive cell culture surface by 
immobilising a cell adhesive peptide (RGD) and the growth factor insulin onto a copolymer of 
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NIPAM and its analogue 2-carboxyisopropylacrylamide.158 The system was found to improve 
cell attachment and proliferation, and thus reduce the culture time. When the temperature was 
decreased below 20 °C, the cells were easily collected as contiguous tissue monolayers.158 
1.9 Project Aims  
There are two separate hydrogel design-based projects discussed in this thesis. 
In the first project, the aim was to develop in situ forming PHPMA hydrogels using Sortase A 
enzyme for covalently cross-linking star (3- and 4- arm) PHPMA-SrtA peptide substrate 
conjugates. The efficiency of SrtA catalysed ligation over time, at low concentration of 
precursor polymers, was first to be evaluated using gel permeartion chromatography (GPC) 
characterisation. Cytotoxicity of the enzyme and all starting polymer components was to be 
tested on liver cells. A schematic representation of PHPMA hydrogel formation is depicted in 
Scheme 1-29.    
 
Scheme 1-29 Formation of PHPMA hydrogels using SrtA enzyme for the in situ covalent 
cross-linking of star PHPMA-SrtA peptide substrate conjugates 
In the second project, the aim was to develop a thermo-responsive self-assembling peptide 
hydrogel (CFEFEFKFKK) by doping it with different thermo-responsive star (2-, 3-, and 4- arm) 
PNIPAM–CFEFEFKFKK conjugates. The hypothesis was that peptides from the star 
conjugates would take part in the self-assembly with the free peptides, resulting in the peptide 
fibres being anchored to the star polymers, hence improving the strength of the hydrogels 
(higher G’ value) (Scheme 1-30). This project also looked at how varying arm number and MM 
of star PNIPAM polymers affected the mechanical properties of the resulting hydrogels.  
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Scheme 1-30 β-sheet rich peptide hydrogel containing 4-arm PNIPAM-peptide conjugate. 
(A) Solution of free self-assembling peptide and 3-arm PNIPAM-peptide conjugate (B) Self-
assembly of the conjugates and free peptide and fibre formation (C) Peptide hydrogel 
network (D) Phase separation induced by temperature increase above LCST and the 
collapse of PNIPAM chains.  
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2 Chapter II: In situ forming 
poly(N-(2-hydroxypropyl)methacrylamide) hydrogels via Sortase 
A enzyme catalysed cross-linking 
2.1 Introduction and synthetic procedures 
In recent years, the enzyme-catalysed cross-linking method has emerged as a potential 
approach for in situ hydrogel development owing to its high efficiency, selectivity, and low 
cytotoxicity.47,48 To date, transglutaminase and horseradish peroxide are the most commonly 
used enzymes for this purpose, however it has limitations including poor stability, the risk of 
inflammation, and high cost for the production of recombinant proteins.23,51,159 SrtA enzyme 
has shown a great  promise in various applications such as purification, modification, and 
immobilisation of proteins.123 However, its role as a catalyst for cross-linking of hydrogels has 
only been reported previously by two groups, Broguiere et al. and Arkenberg and Lin.2 SrtA 
peptide substrates are absent in nearly all mammalian proteins, hence the use of SrtA should 
not adversely affect the structure and function of proteins in mammalian cells.2 Broguiere et 
al. also demonstrated that mutant SrtA were remarkably more stable than tranglutaminase 
enzyme and provided much faster gelation.159 Moreover, SrtA’s cytocompatibility and lack of 
immunogenicity were uncompromised.  
Arkenberg and Lin used a mutant enzyme SrtA7M that exhibited enhanced kinetic activity, 
compared to the wild type SrtA, for the cross-linking of PEG-peptide macromers (Figure 2-1). 
The primary hydrogel was later stiffened by mushroom tyrosinase, which oxidised tyrosine 
residues into di-tyrosine.  
 
Figure 2-1 Hepta-mutant variant sortase A (SrtA7M) catalysed the ligation of two PEG–peptide 
macromers (i.e. PEG-YLPRTG and NH2-GGGG-PEG) into a primary hydrogel network. 
Reproduced from reference 2 
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The project described herein aimed to use wild type SrtA to catalyse the cross-linking of star 
PHPMA-peptide conjugates as illustrated in Figure 2-2. 
 
Figure 2-2 Proposed SrtA-catalysed gelation of star PHPMA-peptides. 
As discussed previously (section 1.6.5, page 37), SrtA catalyses the transpeptidation reaction 
between two peptides containing sequence motifs LPXTG (X can be any amino acid) and 
oligoglycine.25,33,114-121 Several PHPMA star polymers were prepared via RAFT polymerisation 
to achieve well-defined polymers. The star polymers were firstly aminolysed to yield free thiol 
end termini and subsequently conjugated to SrtA peptide substrates via the thiol-ene addition 
reaction. Scheme 2-1 outlines the synthetic route for the preparation of 4-arm PHPMA-SrtA 
substrates conjugate. Research into each step will be described in the following sections. 
 
Scheme 2-1 Synthesis of 4-arm PHPMA-SrtA substrates conjugates. 
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2.2 Solid phase peptide synthesis of SrtA peptide substrates 
It was aimed to conjugate SrtA peptide substrates to polymer arms through post-
polymerisation modification of RAFT functional groups involving aminolysis and thiol-ene 
addition reaction. Hence, both peptide substrates required preparation with ene group 
functionalisation. For the LPXTG motif, the precise sequence LPETGG (E; glutamic acid, K: 
lysine) was chosen because the presence of glutamic acid was thought to enhance the 
solubility of the peptide in aqueous solution according to Chan et al.24 The simplest method 
for ene group funtionalisation of a peptide, made using Fmoc/tBu solid phase synthesis, is to 
couple an ene-containing carboxylic acid to either the free N-terminus or a free amino group 
on a side chain of the peptidyl resin. In this work, methacrylic acid was first used for N-terminus 
peptide functionalisation and acrylic acid was later used instead because acrylamide groups 
exhibited higher reactivity in the thiol-ene addition reaction Figure 2-3. 
 
Figure 2-3 Ene-functionalised LPETGG and GGKE recognition sequences 
For the GG recognition motif, the N-terminus has to be free for it to nucleophilically attack the 
acyl-intermediate formed when SrtA cleaves the bond between Thr- and Gly- on the LPXTG 
motif (Scheme 2-2). Therefore, the ene group, required for polymer conjugation, should not 
be positioned on the N-terminus like in the case of LPETGG but on the side chain of the lysine 
residue. The sequence chosen was GGK(ene)E with the inclusion of glutamic acid aimed to 
enhance the peptide’s solubility in water. 
 
Scheme 2-2 SrtA stranspeptidase mechanism. Reproduced from reference 160 
52 
 
2.2.1 Ene group functionalised LPETGG motifs 
Scheme 2-3 illustrates the Fmoc/tBu solid phase synthesis employed for the ene-
functionalised LPETGG motifs. As discussed above, two analogues methacryloyl- (ma-
LPETGG) 85 and acryloyl- (a-LPETGG) 86 were synthesised and the more efficient peptide 
with reactivity towards thiol-ene click reaction with thiol-terminated polymers was chosen.  
Each amino acid coupling was performed twice for 1 h cycles, except for the 1st amino acid 
coupling repeated for 3 times. The extent of coupling completion was tested using TNBS and 
Kaiser tests.161 The loading of 1st amino acid coupling was evaluated by measuring the mass 
of dry resin (65% for Fmoc-Gly-OH). After each amino acid coupling, unreacted free amines 
on the resin were capped with acetic anhydride 50/50 (v/v) for 15 min before Fmoc 
deprotection step.162 The coupling of methacrylic acid or acrylic acid to the peptidyl resin was 
carried out following the same conditions as the amino acids. 
  
Scheme 2-3 Fmoc/tBu solid phase peptide synthesis of LPXTG motifs ma-LPETGG and a-
LPETGG. Reaction conditions: (i) DIC, DMAP, DMF (ii) a) 20% piperidine, DMF b) Fmoc-
Gly-OH, TBTU, DIPEA, DMF (iii) a) 20% piperidine, DMF b) Fmoc-Thr(tBu)-OH, TBTU, 
DIPEA, DMF (iv) a) 20% piperidine, DMF b) Fmoc-Glu(tBu)-OH, TBTU, DIPEA, DMF (v) 
20% piperidine, DMF b) Fmoc-Pro-OH, TBTU, DIPEA, DMF (vi) a) 20% piperidine, DMF b) 
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Fmoc-Leu-OH, TBTU, DIPEA, DMF (vii) a) 20% piperidine, DMF b) methacrylic acid or 
acrylic acid, TBTU, DIPEA, DMF (viii) 95% TFA, 2.5% TIS, 2.5% H2O. 
After cleavage from the resin, the final peptides were collected from precipitation with cold 
diethyl ether several times and lyophilised from water to produce an off-white solid in 62% 
crude yield for ma-LPETGG 85 and 60% crude yield for a-LPETGG 86. The yields of the crude 
peptides was determined using the equation below, with mresin is the starting mass of resin 
used, Mpeptide is the molar mass of the final peptide, Wang resin loading is 1 mmol.g-1. 
𝑇ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙 𝑦𝑖𝑒𝑙𝑑 = 𝑅𝑒𝑠𝑖𝑛 𝑙𝑜𝑎𝑑𝑖𝑛𝑔 (𝑚𝑚𝑜𝑙. 𝑔−1) × 𝑚𝑟𝑒𝑠𝑖𝑛(𝑔)  × 𝑀𝑝𝑒𝑝𝑡𝑖𝑑𝑒 (𝑔. 𝑚𝑜𝑙
−1)  
%𝑦𝑖𝑒𝑙𝑑 =  
𝑚𝑐𝑟𝑢𝑑𝑒 𝑝𝑒𝑝𝑡𝑖𝑑𝑒
𝑇ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙 𝑦𝑖𝑒𝑙𝑑
    Equation 2-1 
Characterisation of the crude peptides was performed using  LC-MS, NMR, and FT-IR. FT-IR 
showed characteristic absorption bands for peptides, including 3227 cm-1 for O-H and N-H 
stretching, and 1651 cm-1 for amide C=O stretching. An absorption band for =C-H stretch at 
3079 cm-1 confirmed the presence of the double bond on the peptides. 
For ma-LPETGG 85 crude product, LC-MS analysis showed a [M+H]+ ion peak at m/z 641.3, 
indicating the presence of the desired peptide. Impuritieswere also detected in the MS 
chromatogram. One peak at with m/z 527.2 matched the mass for the peptide sequence with 
a Leu missing. Other impurities could not be identified. The 1H NMR spectrum showed two 
singlets at 5.36 and 5.70 ppm responsible for the vinyl protons, each integrating to 1 H. α-CH 
protons belonging to glycine residues were observed at 3.75 ppm integrating to 4.5 H.  Other 
α-CH protons from Thr, Pro, Glu and Leu were observed at 4.25 4.30, 4.35 and 4.60 ppm, 
respectively. 
For a-LPETGG 86, 1H NMR spectrum showed vinyl proton signals at 5.60 ppm (dd, J = 2.0, 
10.3 Hz) corresponding to H-l, and 6.10 ppm (dd, J = 2.0, 17.1 Hz) and 6.3 ppm (dd, J = 10.3, 
17.1 Hz) accounted for H-m1 (vinylic cis) and H-m2 (vinylic trans) respectively. This indicated 
that the acryloyl- group had been coupled to the peptide. MS analysis showed a peak at m/z 
627.3 matching a [M+H]+ ion. Similar to ma-LPETGG 85, there were also impurities derived 
from the target peptide sequence including one with Leu missing whose [M+H]+ ion was 
observed at m/z 513.2. 
It was calculated based on the integrals of vinyl protons in the region from 5.5 to 6.5 ppm that 
the coupling efficiencies of ene groups to peptide backbones of the crude for ma-LPETGG 85 
and a-LPETGG 86 were 81% and 55% respectively. These coupling efficiencies were 
calculated based on equations listed below.  
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Ene coupling efficiency on peptide 85 was calculated bases on equation 2-2, where I5.33 ppm 
and I1.04 ppm are the integrals of vinyl proton (H-m1) and methyl protons (H-c) at 5.33 and 1.04 
ppm (Figure 2-4). 
%𝑒𝑛𝑒 𝑐𝑜𝑢𝑝𝑙𝑖𝑛𝑔 𝑜𝑛  𝑝𝑒𝑝𝑡𝑖𝑑𝑒 𝟖𝟓 =
𝐼5.33 𝑝𝑝𝑚
𝐼1.04 𝑝𝑝𝑚/3
 × 100                    Equation 2-2 
Ene coupling efficiency on peptide 86 was calculated bases on equation 2-3, where I5.58 ppm 
and I1.04 ppm are the integrals of vinyl proton (H-l) and methyl protons (H-c) at 5.58 and 1.04 
ppm (Figure 2-4) 
%𝑒𝑛𝑒 𝑐𝑜𝑢𝑝𝑙𝑖𝑛𝑔 𝑜𝑛  𝑝𝑒𝑝𝑡𝑖𝑑𝑒 𝟖𝟔 =
𝐼5.58 𝑝𝑝𝑚
𝐼1.04 𝑝𝑝𝑚/3
 × 100                    Equation 2-3 
 
Figure 2-4 1H NMR spectra of ma-LPETGG 85 and a-LPETGG 86 (DMSO-d6, 400 MHz) 
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For reasons that could not be elucidated, coupling of acrylic acid to the peptidyl resin was not 
as efficient as methacrylic acid. Extended reaction time with acrylic acid and multiple couplings 
were attempted but no improvement was obtained.  
The presence of impurities including the Leu-deletion peptide would reduce the efficiency of 
the SrtA catalysed cross-linking of star PHPMA-peptide conjugates. However, at the time 
access to (semi-)preparative HPLC for purification was not available.  Hence, the peptides 
were used impure in the next synthetic step. Future work should look at the purification of 
these peptides. 
2.2.2 Ene group functionalised GG motifs 
Similar to LPXTGG motif, two analogues of GG motifs which were methacryloyl- and acryloyl- 
functionalised, GGK(ma)E 87 and GGK(a)E 88 were synthesised using the Fmoc/tBu strategy 
on Wang resin.161 The ene-functionalised GG motif was obtained by coupling methacrylic acid 
or acrylic acid to the free amino group on the Lys side as shown in Scheme 2-4. 
  
Scheme 2-4 Fmoc/tBu solid phase peptide synthesis of GG motifs GGK(ma)E and GGK(a)E. 
Reaction conditions: (i) DIC, DMAP, DMF (ii) a) 20% piperidine, DMF b) Fmoc-Lys(Mtt)-OH, 
TBTU, DIPEA , DMF (iii) a) 20% piperidine, DMF b) Fmoc-Gly-OH, TBTU, DIPEA, DMF (iv) 
20% piperidine, DMF b) Fmoc-Gly-OH, TBTU, DIPEA, DMF (v) (a) DCM/TFA/TIS 92:3:5 (b) 
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10% DIPEA, DMF v/v (vi) (a) acrylic acid or methacrylic acid, DIPEA, TBTU, DMF (b) 20% 
piperidine, DMF (vi) 95% TFA, 2.5% TIS, 2.5% H2O. 
The final peptides were precipitated with cold diethyl ether after their cleavage from the resin 
and lyophilised from water to produce off-white solids in 53% crude yield for GGK(ma)E 87 
and 50% crude yield for GGK(a)E  88 based on theoretical loading of the resin (Equation 2-
1). 
 
Figure 2-5 1H NMR spectra of GGK(ma)E 87 and GGK(a)E 88 peptides (D2O, 400 MHz). 
For GGK(ma)E 87 crude product, LC-MS analysis showed two peaks with m/z 229.5 and 
458.2 in MS matching the [M+2H]2+ and  [M+H]+ ions respect. There was also a peak at m/z 
915 which could be [2M+H]+. In the 1H NMR spectrum vinyl protons were observed at 5.36 to 
5.60 ppm integrating to 0.85 H each (Figure 2-5). Coupling efficiency of ene group (87%) was 
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calculated based on the integrals of methylene protons from glycine residue and vinyl proton 
using equation 2-4. 
For GGK(a)E 88, vinyl protons were observed at 5.6 and 6.2 ppm integrating to 0.55 H and 1 
H respectively (Figure 2-5). LC-MS showed a peak at m/z at 444.2 matching [M+H]+. One 
impurity that could be identified was the peptide with a Glu deletion: GGK(a) with m/z for 
[M+H]+ 315.1. Coupling efficiency of ene group (58%) was calculated based on the integrals 
of methylene protons from glycine residue and vinyl proton using equation 2-5. 
Ene coupling efficiency on peptide 87 was calculated bases on equation 2-4, where I5.36 ppm 
and I3.85 ppm are the integrals of vinyl proton (H-i1) and methylene proton (H-a4) at 5.36 and 
3.85 ppm respectively (Figure 2-5). 
%ene coupling on  peptide 𝟖𝟕 =
I5.36 ppm
I3.85 ppm/2
 × 100                    Equation 2-4 
Ene coupling efficiency on peptide 88 was calculated bases on equation 2-5, where I5.63 ppm 
and I3.89 ppm are the integrals of vinyl proton (H-h) and methylene proton (H-a4) at 5.63 and 
3.89 ppm respectively (Figure 2-5). 
%ene coupling on  peptide 𝟖𝟖 =
I5.63 ppm
I3.89 ppm/2
 × 100                    Equation 2-5 
In the case of the GG recognition motif, the impurity with one glutamic acid missing should not 
have a detrimental outcome for the SrtA catalysed ligation of PHPMA-peptide conjugates 
because the diglycine motif was still present for the ligation. Therefore, peptides 87 and 88 
were used as they were in the next conjugation step with PHPMA. 
2.3 HPMA monomer synthesis 
HPMA monomer 3 was synthesised following Kopeček’s procedure (Scheme 2-5).163,164 
 
Scheme 2-5 Synthesis of HPMA monomer. 
The crude product was re-crystallised twice from acetone and dried under vacuum to yield 
white crystals in 50% yield. HPMA 3 was characterised by NMR and FT-IR. Proton signals in 
the 1H-NMR spectrum matched the literature values.163 The methyl protons were observed as 
a strong doublet peak and a singlet peak at 1.22 and 1.98 ppm, respectively. Two singlet 
peaks integrating to 1H each at 5.36 and 5.74 ppm were correlated to the vinyl protons. The 
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IR spectrum showed strong vibrational peaks for the O-H and N-H bonds at 3300 and 3326 
cm-1, while the C=O amide bond stretch appeared at 1613 cm-1. 
2.4 Linear PHPMA 
Linear PHPMA was synthesised and used to test the thiol-ene click reactions with ene 
functionalised SrtA peptide substrates before conducting the modifications on star PHPMA 
systems. Linear PHPMA was prepared using RAFT agent 4-cyano-4-
(phenylcarbonothioylthio)pentanoic acid 91 as shown in Scheme 2-6.96,97 Following the 
conditions reported by Boyer et al., controlled polymerisation was carried out in acetate buffer 
pH 5.2.97 However, CTA 91 was only partially soluble in this buffer solution, thus a mixture of 
25% 1,4-dioxane and 75% acetate buffer (v/v) was used for the polymerisation to facilitate 
solubility of RAFT agent 91. The polymerisation of HPMA with CTA 91 was run for 4 h at 70 
°C. The product was purified by dialysis against water in a 1,000 MWCO membrane prior to 
lyophilisation in water to yield a fluffy pink powder. 
 
Scheme 2-6 Synthesis of linear PHPMA polymer 
The two linear PHPMA synthesised in this study are listed in Table 2-1. Both polymers were 
obtained with narrow molar mass distributions, Ð < 1.20. GPC analysis showed unimodal and 
almost symmetrical peaks for both polymers (Figure 2-8).  
Entry Sample Feed ratioa t (h) Mn(th)
b (Da) Mn(GPC) (Da) Mn(N(MR)
c (Da) Ðd Conversionc (%) 
1 92 100:1:0.1 4 8,870 14,385 8,877 1.08 60 
2 93 30:1:0.1 4 2,470 5,465 2,002 1.16 51 
Table 2-1 Linear PHPMA characterisations. a [HPMA]/[CTA]/[ACVA], b Calculated using equation Mn(th) 
= MCTA + conversion(MHPMA[HPMA]o/[CTA]o); c Determined by 1H-NMR; d Ð=Mw/Mn  
The experimental MM values (Mn(GPC)) were higher than theoretical values (Mn(th)). Absolute 
MMs were measured based on triple detection method not based on polymer standards, 
therefore the measurement errors caused by the differences in the structure of polymer 
standards and tested polymers could be ruled out. Mn(NMR) values determined based on 1H 
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NMR were found to be close Mn(th) values. One possible reason could be the loss of RAFT end 
group in the early stage of RAFT polymerisation by the radical coupling of the intermediates.  
 
Figure 2-6 1H NMR spectrum of the crude polymerisation of HPMA (D2O, 400 MHz). 
Monomer conversion was determined using the equation below, where I3.87 ppm and I5.38 ppm are 
the integrals of signals at 3.87 ppm and 5.38 ppm respectively (Figure 2-6). 
%conversion =  
I3.87 ppm − I5.38 ppm
I3.87 ppm
                  Equation 2-6 
Mn(NMR) was determined using the equation below, where I3.6 ppm and I2.38 ppm are the integrals 
of methine protons at 3.84ppm (H-g) and ethylene protons H-a and H-b together in the region 
from 2.20 to 2.38 ppm (Figure 2-7). 
Mn(NMR) = MHPMA × n +  MCTA 𝟗𝟏                           
Mn(NMR) = 143.18 ×
I3.6 ppm
I2.38 ppm/4
+  279.38                Equation 2-7 
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Figure 2-7 1H NMR spectrum of PHPMA 93 (D2O, 400 MHz) 
Boyer et al. and Scales et al. reported similar findings in which significant higher Mn(GPC) values 
were obtained than Mn(th) despite a narrow polydispersity being measured by GPC.97,163 In 
order to prove the ‘living’ character or the persistence of RAFT end functionality, Scales et al. 
synthesised an extended PHPMA block by polymerising HPMA 3  with the macro-RAFT of 
PHPMA (Mn(GPC) = 36,100 Da, Ð = 1.05) and obtained a well-defined extended polymer (Mn(GPC) 
= 98,800 Da, Ð = 1.08).163 Based on that result, it was assumed that the polymerisation of 
HPMA with CTA 91 had been controlled. 
The persistence of the RAFT functionality can be also proved by 1H NMR based on signals of 
aromatic protons H-k on the R group and methylene protons H-a and H-b from the Z-group as 
shown in Figure 2-7. Then,  
%RAFT functionality =
4×I7.82 ppm
2×I2.38 ppm
     Equation 2-8 
where I7.82 ppm is the integral of ortho aromatic protons at 7.82 ppm (H-k), I2.38 ppm is the integral 
of ethylene protons at 2.38 ppm (H-a and H-b). 
The % RAFT functionalities of PHPMA 92 and 93 calculated using equation 2-1 were 80% 
and 72%. These results were not ideal but acceptable. Polymer 92 was used for the 
preparation of linear PHPMA-peptide conjugates described in the following section. 
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Figure 2-8 GPC analysis of linear PHPMA polymers 92 and 93 (entry 1 and entry 2, Table 
2-1) 
2.5 Synthesis of star PHPMA via RAFT polymerisation 
2.5.1 Introduction and background information 
There are two main approaches to generate star polymers via RAFT polymerisation: arm-first 
method and core-first method.94,165,166 Each method presents advantages and disadvantages. 
In the project described herein, star PHPMA polymers were prepared via the core-first method. 
In the arm-first method, a star polymer is formed using a macroinitiator or macromonomer for 
chain extension with a cross-linker (Scheme 2-7).94,165 This approach allows the synthesis of 
star polymers with large, uniform, and highly functionalised core, however, the resultant 
polymers suffer from broad dispersity due to termination resulting from steric hindrance and 
the chain transfer process.94 
 
Scheme 2-7 Synthesis of star polymers via arm-first method. Reproduced from reference 94 
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In the core-first method, the star polymers are formed by polymerising the monomers with 
multifunctional RAFT agents.165,167 The core can be covalently bound to the RAFT agent’s R 
group or Z group. The corresponding star RAFT polymerisation can be classified as either the 
R-RAFT or Z-RAFT approach, respectively.168-170 The mechanism of R-RAFT and Z-RAFT 
polymerisations have been discussed in detail by Chaffey-Millar et al. and are depicted in 
Scheme 2-8.165,167,171  
 
Scheme 2-8 Mechanisms of R-RAFT and Z-RAFT polymerisations.167 
In the Z-RAFT approach, the stabilising Z group is connected to the core and the chain 
equilibrium takes place at the core site, thus preventing the formation of side products such 
as radical coupling products and linear RAFT polymers.168 Nevertheless, the position of the 
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thiocarbonylthio group in the centre of the star limits its post-polymerisation modification.168 In 
this study, star PHPMA polymers were prepared via the R-RAFT method. 
As discussed above, the R-RAFT approach usually suffers from the radical termination 
process,165,167,168 hence it is crucial to have the conditions chosen carefully to prevent the 
formation of side products, such as linear polymer chains, star-star coupling, and star-linear 
chain coupling polymers. An extensive study by Chaffey-Millar et al. provided an insight into 
design criteria for R-RAFT star polymerisation.167 
The criteria suggested by Chaffey-Millar’s group are listed below: 
(1) Minimisation of linear RAFT polymer product can be achieved by using a high rate of 
monomer propagation but a small delivery of radicals to the system.165,167 
(2) Minimisation of star-star coupling products can be achieved via control of initiation. 
The number of radical terminations can be prevented by reducing the quantity of 
initiator decompositions providing that RAFT agents are fully activated.   
(3) Minimisation of star-star coupling products can be achieved by increasing intermediate 
RAFT radical stabilisation. Chain growth and termination events have, respectively, 
first-order (∝ [P•]) and second-order (∝ [P]2) kinetics (where [P•] is concentration of 
polymer chain/arm radical). This means that e.g. a 2-fold reduction of [P•] will lead to 
a 2-fold reduction in the rate of polymerization, but a 4-fold reduction in the 
concentration of coupled products at the end of the polymerization. A slow 
fragmentation of intermediate RAFT radicals causes a reduction in the number of 
propagating radicals, leading to less radical termination reactions. Hence, a rate-
retarding RAFT agent (under the assumption that cross termination is absent) might 
help suppress star-star coupling events.165,167 
(4) Less arm numbers in the CTAs result in narrower MM distributions. 
2.5.2 Synthesis of 3-arm PHPMA 
R-RAFT star polymerisation has been applied to the polymerisations of several monomers, 
including styrene, methyl acrylate, methyl methacrylate, N-isopropyl acrylamide, vinyl acetate, 
and vinyl pyrrolidone.172 However, its use on the HPMA monomer has not yet been reported. 
The multifunctional R-RAFT agents used in this study (Scheme 2-9) have only been reported 
with the polymerisations of acrylamide, styrene, and methyl methacrylate.165,168,173,174  
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Scheme 2-9 RAFT polymerisation of HPMA using 3-arm R-RAFT CTA 94 
Although RAFT polymerisation can be applied to a wide range of monomer, a well-defined 
polymerisation of a given monomer still requires a careful selection of RAFT agents.175 The 
effectiveness of the CTA influences the integrity of the polymer, end group fidelity and polymer 
dispersity as discussed in section 1.6.2, page 27.94 HPMA monomer 3 belongs to MAM group 
so reactive CTAs would be more favourable for the polymerisation of HPMA 3. The most 
reactive RAFT agents are dithobenzoate and trithiocarbonate which are suitable for the 
polymerisation of HPMA.176 Trithiocarbonate was previously demonstrated to be effective in 
the RAFT polymerisation of HPMA 3 by Hong and Pan (Figure 2-9).177  
 
Figure 2-9 Trithiocarbonate RAFT agent used by Hong and Pan.177 
Since the 3-arm RAFT agent 94 was hydrophobic, aqueous solution would not be suitable for 
this polymerisation as in the case of linear PHPMA. Other solvent choices could be DMF, 
DMAc, methanol, and 1,4-dioxane.178-180 In this study, a mixture of 50% DMF and 50% 1,4-
dioxane (v/v) was used for the polymerisation of HPMA  3 because the star CTA 94 was most 
soluble in 1,4-dioxane and PHPMA’s dissolution was aided by DMF. 
Following the criteria listed above, R-RAFT polymerisation of HPMA monomer 3 was 
investigated and optimised by variation of four main factors: initiator, temperature, solvents, 
and feed ratios. Polymerisation conditions and polymer characterisations are listed in Table 
2-2.  
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Entry Sample Initiator T °C Feed ratioa 
t 
(h) 
Mn(GPC)
b 
(Da) 
Mn(th)
c 
(Da) 
Mn(NMR)
d 
(Da) 
Ðb 
Conversiond 
% 
1 N/A AIBN 70 70/1.0/0.1 24 - - - - 0 
2 96 AIBN 70 70/1.0/0.2 24 23,751 5,469 41,041 1.82 43 
3 97 AIBN 60 70/1.0/0.2 24 6,668 4,667 8,309 1.32 35 
4 98 ACVA 70 70/1.0/0.1 24 22,630 5,670 36,811 1.35 45 
5 99 ACVA 60 70/1.0/0.1 24 6,275 4,467 7,460 1.30 33 
6 100 ACVA 60 125/1.0/0.1 6 12,780 9,750 16,832 1.32 48 
7 101 ACVA 60 150/1.0/0.1 6 17,328 11,898 17,196 1.25 50 
8 102 ACVA 70 150/1.0/0.1 6 15,928 12,972 19,648 1.42 55 
9 103 ACVA 60 200/1.0/0.1 6 26,601 19,200 23,209 1.24 63 
Table 2-2 Results for polymerisation of HPMA with 3-arm CTA. a [HPMA]/[CTA]/[Initiator]; b By GPC, 
Ð=Mw/Mn; c theoretical MM (Mn(th)) calculated using equation 2-10; d Determined by 1H NMR 
spectroscopy 
Monomer conversion was calculated based on the 1H NMR spectrum of the crude polymer 
mixture using equation 2-9, where I3.68 ppm and I5.31 ppm are the peak areas of methine protons 
H-e from HPMA units at 3.68 ppm and a vinyl proton signal from unreacted monomer at 5.31 
ppm respectively (Figure 2-10). 
%Conversion = (I3.68 ppm − I5.31 ppm) I3.68 ppm⁄ × 100%  Equation 2-9 
 
Figure 2-10 1H NMR spectrum of crude 3-arm PHPMA mixture (DMSO, 400 MHz). 
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Mn(NMR) was determined based on the 1H NMR spectrum of purified PHPMA using equation 
below, where I3.68 ppm and I1.09 ppm are the integrals of methine proton H-b of monomer units and 
methyl proton signals H-h belonging to Z group of the RAFT agent respectively (Figure 2-11). 
Mn(NMR) = 60 × (I3.68  ppm I1.09 ppm⁄ ) × M𝐻𝑃𝑀𝐴 + MCTA            Equation 2-10 
MHPMA  = 143.18 g.mol-1, MCTA 94 = 1160 g.mol-1 
 
Figure 2-11 1H NMR spectrum of purified 3-arm PHPMA 103 (DMSO, 400 MHz). 
In the first attempt, polymerisation of HPMA in DMF (entry 1, Table 2-2) was initiated with 
AIBN at 70 °C with a [CTA]/[AIBN] ratio of 10:1. The reaction did not yield any polymer. A 
doubled amount of AIBN ([CTA]/[AIBN] ratio of 5:1) was used to drive the polymerisation, 
however, an ill-defined polymer 96 (entry 2, Table 2-2) was obtained with Ð of 1.82. This 
suggested that an uncontrolled polymerisation had occurred. The Mn(th) value of 96 was much 
smaller than the Mn(GPC) and Mn(NMR) values, which was likely caused by dead polymers formed 
by termination events. This was further demonstrated by GPC analysis, in which the trace 
revealed a shoulder for a low MM species at high retention time (Figure 2-12). The shoulder 
can be accounted for by the low MM polymers formed by linear-linear coupling or star-linear 
coupling which are usually found in star polymer synthesis by controlled radical 
polymerisation.165,171,173,181  
In another attempt, the polymerisation was performed at the lower temperature of 60 °C to 
eliminate the formation of the radical termination products (entry 3, Table 2-2).182 It is clearly 
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seen from the GPC trace that the MM distribution of polymer 97 was much improved compared 
to 96 and the shoulder for the low MM species also disappeared. Moreover, the discrepancy 
between Mn(GPC) and theoretical Mn(th) value was reduced, indicating that the polymerisation 
was better controlled and with higher RAFT end group retention. Lowering temperature led to 
a decrease in the polymerisation rate, and hence a lower conversion and lower MM achieved 
in the time.175  
 
Figure 2-12 GPC analysis of polymers 96-99 in entries 2, 3, 4, and 5 (Table 2-2) 
In another tests, ACVA initiator was used as an alternative to AIBN (entry 4 and 5, Table 2-2). 
Even though ACVA and AIBN have a similar half-life at the same temperature, only a half 
amount of ACVA was needed for the polymerisation.183 The resultant polymers 98 and 99 
exhibited narrower MM distributions compared to 96 and 97 (Figure 2-12). In particular, the 
presence of termination side products was less for polymer 98 compared to polymer 96. This 
could be rationalised by the fact that lower concentration of radicals being generated 
minimised the chances of radical-radical terminations.184 For this reason, ACVA was then used 
instead of AIBN. 
It was later aimed to produce higher MM star polymers by increasing HPMA monomer 
concentration (entry 6-9, Table 2-2). Higher monomer concentration would accelerate the rate 
of polymerisation. Hence, shorter reaction time was applied in order to prevent side products 
because termination events tend to take place at high monomer conversion.165,166,168,185  
GPC analysis (Figure 2-13) revealed decreasing intensity of low MM shoulders as 
[HPMA]/[CTA] ratios increased (entry 6-9, Table 2-2). Broader MM distribution accompanied 
with more pronounced shoulder for high MM species for polymer 102 compared to polymer 
101 again demonstrated that high temperature increases termination events. GPC 
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chromatogram resulting from polymer 103 shows a unimodal and nearly symmetrical peak, 
suggesting that the polymerisation was controlled. Although the dispersity was much improved 
for these polymers 100-103, absolute MM values by GPC were still higher than Mn(th) values. 
This could be due to the potential loss of RAFT functional groups during polymerisation.186 
Also, there might have been a loss of linear RAFT polymers during purification process, which 
was not detected by GPC. 
 
Figure 2-13 GPC analysis of 3-arm PHPMA samples 100-103 (entry 6-9, Table 2-2). 
Polymer 103 (entry 9, Table 2-2) with narrowest MM distribution was chosen for the future use 
in polymer-peptide conjugate synthesis in section 2.6.2. 
2.5.3 Synthesis of 4-arm PHPMA  
Following the conditions for 3-arm PHPMA synthesis, 4-arm PHPMA polymers were prepared 
using 4-arm CTA 84 as shown in Scheme 2-10. 
Scheme 2-10 Synthesis of 4-arm RAFT PHPMA 
Optimised conditions for 3-arm PHPMA synthesis described above were applied for the 
preparation of 4-arm PHPMA. The polymerisation was carried out in 50% 1,4-dioxane/ 50% 
DMF solvent mixture (v/v) at 60 °C using ACVA initiator. The final polymer was precipitated 
from cold diethyl ether several times to remove impurities and dried under vacuum to yield a 
yellow powder. Polymer characterisations are shown in Table 2-3. 
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Entry Sample Feed ratiosa t (h) 
Mn(GPC) 
b 
(Da) 
Mn(NMR)
c 
(Da) 
Mn(th)
d 
(Da) 
Ðb
 Conversion
e 
% 
1 104 70/1.0/0.1 24 8,145 7,249 6,733 1.44 52 
2 105 150/1.0/0.1 6 18,297 14,408 14,622 1.39 61 
3 106 250/1.0/0.1 6 29,099 29,585 28,046 1.26 89.5 
Table 2-3 Results for polymerisation of HPMA with 4-arm CTA.a [HPMA]/[CTA]/[ACVA]; b By 
GPC Ð=Mw/Mn; c Determined by 1H NMR of crude PHPMA mixture using equation 
conversion % = 
I3.68 ppm−I5.31 ppm
I3.68 ppm
×100 where I5.31ppm and I3.68ppm are the integrals of vinyl 
proton at 5.31 ppm and the combined polymer/monomer signal at 3.68 ppm; d Calculated 
using equation Mn(th) = MCTA + conversion(MHPMA[HPMA]o/[CTA]o); e Determined by 1H NMR 
spectroscopy 
The structure of the resulting 4-arm PHPMA was verified by 1H-NMR and FT-IR spectroscopy. 
The 1H-NMR spectrum shows the typical features of PHPMA with methine protons (H-e) at 
3.68 ppm (Figure 2-14). 
 
Figure 2-14 1H NMR spectrum of 4-arm PHPMA 104 in entry 3, Table 2-3 (DMSO, 400 
MHz). 
The GPC curve of polymer 104 (entry 1, Table 2-3) shown in Figure 2-15 revealed a small 
kink at low retention time corresponding to high MM star-star coupling by-products which was 
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not observed in the GPC analysis of 3-arm PHPMA polymers described previously (Figure 
2-13).  
 
Figure 2-15 GPC analysis of 4-arm PHPMA in entry 1, 2, and 3, Table 2-3. 
It was hoped to reduce the radical termination events and high MM by-products while keeping 
the monomer conversion around 50% by increasing the monomer concentration and reducing 
the polymerisation time. As can be seen from Figure 2-15, more concentrated monomer 
polymerisations (entries 2 and 3, Table 2-3) produced narrower MM distributions with less 
pronounced shoulders for high MM by-product. There was presence of tails for low MM 
species instead. This could be explained by the formation of low MM star-like polymers during 
the radical coupling events as displayed in Scheme 2-8.  
Overall, Mn(th) values were in a close agreement with Mn(NMR), suggesting a high retention of 
RAFT functionality. However, both of which were smaller than Mnn(GPC) values. For polymer 
106, the Mn(GPC) value was in a good agreement with Mn(th) and Mn(NMR) as shown in Table 2-3. 
This suggested that the RAFT end groups were remained intact throughout.  
Polymer 106 with the lowest Ð value (entry 3, Table 2-3) was chosen for the future use in 
PHPMA-peptide conjugates in section 2.6.2. 
2.6 PHPMA/SrtA peptide substrates conjugates 
As discussed in section 1.6.4 (page 30), there are several pathways to conjugate a protein or 
a peptide to a RAFT polymer. Amongst those, thiol-ene reaction has shown a great potential 
especially in the field of polymer conjugation, and hydrogel fabrication. The incorporation of 
ene containing peptides by reaction with thiol end groups can be performed via different 
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approaches, such as Michael addition, thermally initiated radical addition, and photo-initiated 
addition.187-189 There are several features associated with the thiol-ene reaction that make it a 
facile and versatile process. The reaction can be performed under various conditions including 
by a radical initiated pathway, via Michael style, which is mediated by a nucleophile, base or 
acid, and in the absence of catalysts in highly polar solvents such as water and DMF.190 In this 
study, PHPMA-peptide conjugates were prepared through both Michael thiol-ene addition in 
the presence of the nucleophilic catalysts and radical-initited thiol-ene reaction. 
2.6.1 Linear PHPMA-SrtA substrate conjugates 
2.6.1.1 Linear PHPMA-LPETGG conjugate 
The conjugation of ma-LPETGG 85 to linear PHPMA 92 was carried out based on a one-pot 
method reported by Boyer et al., in which the ω-end group, dithiobenzoate, was aminolysed 
by n-butylamine to yield a free thiol group. This thiol-terminated polymer PHPMA-SH was 
sequentially reacted with ene-functionalised peptide 85 in the same reaction vessel without 
purification (Scheme 2-11).97 Since thiols are susceptible to oxidisation, this one pot method 
might be advantageous as it negates isolating the intermediate thiol species which would risk 
contact with oxygen. 
 
Scheme 2-11 One-pot aminolysis/Michael thiol-ene addition of linear RAFT PHPMA and ma-
LPETGG  
In their study, one-pot aminolysis and Michael thiol-ene addition of PHPMA with 1,6-
hexanediol diacrylate gave approximately 90% conjugation.97  
 
Scheme 2-12 One-pot aminolysis/thiol-ene reaction of PHPMA with 1,6-hexanediol 
diacrylate.97 
PHPMA 92 and ma-LPETGG 85 were dissolved in DMF and degassed to remove oxygen 
which could lead to thiol-thiol disulfide formation. Additionally, the reducing agent (tris(2-
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carboxyethyl)phosphine hydrochloride) (TCEP.HCl) was added to further prevent the 
oxidation of thiols as well as to aid the thiol-ene reaction as a nucleophilic catalyst.187,191 
Alkylamine was used in excess as a part of it neutralised HCl from TCEP.HCl and also served 
as a nucleophilic catalyst for the Michael thiol-ene reaction.191 Upon aminolysis, the solution 
lost its pink colour and turned light yellow. The peptide solution in DMF was injected into the 
polymer solution via syringe once the pink colour disappeared. The product polymer was 
purified by dialysis in 1,000 g.mol-1 MWCO membrane against water for 2 days prior to 
lyophilisation. The final product was a white solid while the starting polymer was a pink solid, 
indicating the complete removal of the dithiobenzoate group. A UV-Vis scan also showed the 
loss of RAFT group at 303 nm (Figure 2-16). 
 
Figure 2-16 UV-Vis spectra of (A) Linear PHPMA (3 mg.mL-1), (B) Linear PHPMA-SH (3 
mg.mL-1). 
Nucleophilic catalysts were used instead of base catalysts for the Michael thiol-ene reaction. 
The reason was that the kinetics of the base-catalysed Michael reaction depends on the base 
strength and pKa of the thiols while nucleophilic catalysts can increase the rate of reaction by 
orders of magnitude compared to base catalysed thiol-ene addition.187,192 The mechanisms of 
both base-catalysed and nucleophile-catalysed Michael thiol-ene reactions are illustrated in 
the scheme below. 
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Scheme 2-13 Mechanism of base-catalysed and nucleophile-catalysed Michael thiol-ene 
reaction. EWG = electron withdrawing group. Reproduced from reference 187 
The reaction conditions are listed in Table 2-4. For the first attempt at conjugation (entry 1, 
Table 2-4), the Michael thiol-ene coupling was performed at 25 °C for 24 h. 1H NMR 
characterisation revealed no presence of proton signals from the peptide, suggesting that the 
peptide coupling was not successful. It was then hoped to boost the thiol-ene reaction by 
heating up the thiol-ene reaction at 60 °C for 24 h (entry 2, Table 2-4). The reaction was still 
unsuccessful. This failure in conjugating peptide to the polymer could be rationalised by the 
fact that the methacrylamide functional group exhibited poor chemical reactivity in the thiol-
ene reaction. This can be attributed to the less electron deficient nature of C=C bonds in the 
methacrylamide derivative.193 Shu et al. tested the chemical reactivity of cysteine with different 
α,β-unsaturated carbonyl derivatives and found the following order of reactivity: 
acrylate>>methacrylate>acrylamide>methacrylamide.194 
Entry [HPMA]/[n-butylamine]/[TCEP.HCl]/[ene] T (°C) t (h) Coupling efficiency by NMR 
1 1 : 10 : 5 : 10 25 24 0% 
2 1 : 10 : 5 : 10 60 24 0% 
Table 2-4 One-pot aminolysis and Michael thiol-ene addition of linear PHPMA and ma-
LPETGG. 
There might be a competition between the Michael additions of thiol terminate PHPMA to ma-
LPETGG 85 (thia-Michael) and n-butylamine to ma-LPETGG 85 (aza-Michael) in the one-pot 
method, consequently reducing the efficiency of peptide conjugation.192,195 In this study, it was 
difficult to evaluate whether there was coupling of n-butylamine to thiol terminated PHPMA 
using 1H NMR spectroscopy because butyl signals would be likely overlapped by polymer 
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McKee et al. investigated the kinetics of three different reactions: aminolysis of trithiocarbonate 
by hexylamine, thia-Michael reaction of n-dodecylthiol with 3-(acryloyloxy)-2-hydroxypropyl 
methacrylate, and aza-Michael reaction of hexylamine to 3-(acryloyloxy)-2-hydroxypropyl 
methacrylate.196 They discovered that aminolysis and thia-Michael reaction of methacrylate 
derivatives possessed much faster kinetics compared to aza-Michael reaction.196 However, 
the same study model for methacrylamide or acrylamide derivatives has not yet been done.  
The Michael thiol-ene reaction has been demonstrated to be governed by various factors 
including structure of the thiol, structure of the ene-containing compound, catalyst, and 
solvent.193 In the current study, it was assumed that the interference of aza-Michael reaction 
in the one-pot method was negligible, hence a more reactive ene-containing peptide was used 
to improve the efficiency of peptide conjugation to PHPMA.  Acrylamide-functionalised 
LPETGG peptide 86 (a-LPETGG) was used as the alternative to methacrylamide derivatives 
as shown in Scheme 2-14. 
 
Scheme 2-14 One-pot aminolysis/Michael thiol-ene addition of linear RAFT PHPMA and ma-
LPETGG 
The same conditions described above (Table 2-4) were applied to the synthesis of PHPMA-
a-LPETGG 109 (Table 2-5). 
Entry [HPMA]/[n-butylamine]/[TCEP.HCl]/[ene] T (°C) t (h) 
Mn(GPC)  
(kDa) 
Ða Coupling efficiencyb 
1 1 : 10 : 5 : 10 25 24 - - 0% 
2 1 : 10 : 5 : 10 60 24 15.1 1.12 87% 
Table 2-5 One-pot aminolysis/Michael thiol-ene addition of linear PHPMA 92 and a-LETGG 
86. a By GPC, Ð =Mw/Mn. b Determined by 1H NMR spectroscopy using equation 2-11. 
In entry 1 (Table 2-5), one-pot aminolysis/ Michael thiol-ene synthesis was conducted at room 
temperature but the conjugation was again unsuccessful as shown by 1H NMR spectroscopy. 
In the second attempt (entry 2, Table 2-5), the reaction mixture was heated at 60 °C for 24 h 
after the addition of peptide 86. This time 1H NMR showed successful incorporation of peptide 
to polymer chain as shown in Figure 2-17B. Peptide protons were present at 4.17 ppm (H-b) 
and 4.36 ppm (H-a3, H-a4, H-a5), which aligned well with those in the 1H NMR spectrum of a-
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LPETGG (Figure 2-17A). Moreover, the absence of vinyl protons at 5.70 and 6.2 ppm in Figure 
2-17B indicated that unreacted a-LPETGG peptide did not exist in the final product.  
 
Figure 2-17 1H NMR spectra of peptide a-LPETGG 86, linear PHPMA-a-LPETGG conjugate 109 (entry 
2, Table 2-5), and linear PHPMA 92 
The linear PHPMA used in this section was the polymer 92 in entry 1, Table 2-1. The number 
of monomer units calculated from 1H NMR was 60. Coupling efficiency was determined using 
the equation below, where I4.17 ppm, I3.84 ppm are the integrals of proton signals at 4.17 ppm (H-
b peptide) and 3.84 ppm (H-a (polymer)). 
Coupling efficiency = 
I4.17 ppm
I3.84 ppm
60⁄
× 100%                             Equation 2-11 
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Figure 2-18 shows GPC traces of starting PHPMA 92 and PHPMA-a-LPETGG 109. It can be 
clearly seen that the conjugate remained at the narrow MM distribution of its polymer 
precursor. Moreover, the conjugate eluted slightly earlier compared to the starting material, 
indicating a larger hydrodynamic volume and hence higher MM. The optimised conditions in 
entry 2, Table 2-5 were later used for the preparation of star PHPMA-a-LPETGG. 
 
Figure 2-18 GPC traces of starting linear PHPMA 92 (entry 1, Table 2-1) and linear PHPMA-
a-LPETGG 109 (entry 2, Table 2-5) 
2.6.1.2 Linear PHPMA-GGKE conjugate 
 
Scheme 2-15 One-pot aminolysis/Michael thiol-ene addition of linear PHPMA 92 and 
GGK(a)E 88 
To prepare PHPMA-GGKE conjugate 110, the conditions established above for the synthesis 
of linear PHPMA-a-LPETGG 109 (section 2.6.1.1, page 71) were applied. As discussed 
above, acrylamide functionality exhibited better reactivity in the Michael thiol-ene reaction 
compared to methacrylamide derivative, hence the GGK(a)E analogue was used to prepare 
the linear PHPMA-GGKE conjugate. 
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Figure 2-19 Chemical structure of GGK(ma)E 87 and GGK(a)E 88 
Table 2-6 shows the conditions for one-pot aminolysis/ thiol-ene of linear PHPMA 92 and 
GGK(a)E 88. 
Entry [HPMA]/[n-butylamine]/[TCEP.HCl]/[ene] T °C t (h) Coupling efficiency  
1 1 : 10 : 5 : 10 60 24 0% 
Table 2-6 One-pot aminolysis/Michael thiol-ene addition of linear PHPMA 92 and GGK(a)E 
88. 
Despite many attempts, the conjugation was unsuccessful according to 1H NMR. In the case 
of a-LPETGG 86, the acrylamide functionality was positioned on the N-terminus, whereas in 
GGK(a)E 88, it was attached to the side chain of the lysine residue, leaving both the C- and 
N-termini free (Figure 2-19). Under the basic conditions of the Michael thiol-ene reaction, the 
free amines on peptide molecules could potentially compete with thiols from the polymer in 
Michael style addition to the ene bonds.192,195 
A radical-initiated thiol-ene addition was used as an alternative to the base-catalysed, polar 
Michael thiol-ene pathway. Radical thiol-ene reactions can be initiated either by a photoinitator 
(e.g. 2,2-dimethoxy-2-phenyl acetophenone (DMPA)) or classical thermal initiators (e.g. AIBN, 
ACVA).197 The mechanism for a radical thiol-ene addition is depicted in Scheme 2-16.  
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Scheme 2-16 Mechanism of radical-mediated thiol-ene addition. Adapted from reference 198 
According to previous studies, modification of RAFT polymers via radical thiol-ene reaction 
was conducted as a two-pot synthesis, in which thiol-terminated polymers were prepared via 
aminolysis and purified separately.197,199 Linear PHPMA 92 was first aminolysed with n-
butylamine in the presence of a small amount of reducing agent TCEP.HCl at room 
temperature for 2 h. The thiol-terminated PHPMA (PHPMA-SH) 111 was then precipitated in 
cold ether several times before drying under vacuum to yield a white solid. UV-Vis scan 
showed the absence of an absorption of dithiobenzoate at 303 nm, indicating the complete 
removal of RAFT groups by aminolysis.  
Scheme 2-17 presents two synthetic routes to PHPMA-GGKE 110 via the radical-mediated 
thiol-ene method which are photo-initiated and thermal radical-initiated thiol-ene reactions. 
TCEP.HCl was used again in the reaction to prevent the formation of the disulfide bonds. 
 
Scheme 2-17 (A) Photo-initiated thiol-ene reaction of PHPMA-SH and GGK(a)E peptide, (B) 
Thermal radical-initiated thiol-ene reaction of PHPMA-SH and GGK(a)E. 
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Table 2-7 outlines synthetic conditions used for both photoinitiated and thermal radical-
initiated thiol-ene reactions. 
Entry [PHPMA]/[I]/[ene]/[TCEP.HCl] Initiator T °C t (h) 
Mn(GPC) 
(kDa) 
Ð 
Coupling efficiency  
1 1 : 0.5 : 10 : 3 DMPA 25 1 - - 0 % 
2 1 : 0.5 : 10 : 3 DMPA 25 3 - - 0 % 
3 1 : 0.5 : 10 : 3 AIBN 60 24 23.2 1.16 137 % 
4 1 : 0.5 : 10 : 3 AIBN 60 3 20.4 1.13 87 % 
Table 2-7 Conditions for radical-mediated thiol-ene reaction of PHPMA-SH 111 and 
GGK(a)E 88 using photoinitiator (DMPA), and thermal initiator, AIBN. Mn(GPC) of starting linear 
PHPMA 92 was 19.3 kDa, Ð 1.10. 
The photoinitiated thiol-ene reaction conditions (entry 1, Table 2-7) were based on a method 
reported by Nicolaÿ.199 The reaction was initiated by UV light at 365 nm for 1h at room 
temperature in the presence of DMPA as a photoinitiator. The mechanism of the initiation of 
DMPA under UV light is illustrated below: 
 
Scheme 2-18 Initiation mechanism of DMPA.200 
The first attempt at photoinitiated thiol-ene reaction (entry 1, Table 2-7) was unsuccessful 
according to 1H NMR. In the second reaction, a longer reaction time under UV was hoped to 
improve the yield (entry 2, Table 2-7). However, the conjugate did not form.  
For the thermal radical initiation approach (entry 3, Table 2-7), the incorporation of peptide to 
PHPMA was initiated by AIBN at 60 °C for 24 h. The reaction was successful according to 1H 
NMR (Figure 2-20).These results were in contrary to findings reported by Uygun et al., who 
stated that thiol-ene addition reaction of small molecules initiated by photochemical initiator 
was more efficient than by thermal radical initiator.200 This could be potentially due to the 
difference in reaction kinetics between macromolecules and small molecules. 
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Figure 2-20 1H NMR spectra of (A) GGK(a)E peptide 88 and (B) linear PHPMA-GGKE  110 
in entry 3, Table 2-7. 
As can be seen from Figure 2-20B α-CH protons (H-a1, H-a2) from peptide sequence at 4.15 
and 4.26 ppm are present while vinyl signals are not present in the region from 5.87 to 6.14 
ppm. This indicates that the peptide was successfully incorporated onto the polymer. This was 
further confirmed by the presence of new signals belonging to thioether protons (H-b, H-c) at 
2.50 ppm.97 The characteristic signal of methylene protons H-a from HPMA monomer units 
was observed at 3.84 ppm. 
Coupling efficiency was calculated using the equation below, where I4.15 ppm, I4.26 ppm, and I3.84 
ppm are the integrals of protons H-a1, H-a2, and H-a at 4.15, 4.26 and 3.84 ppm respectively. 
The number of monomer units of starting PHPMA was 60 according to 1H NMR (Table 2-1). 
Coupling efficiency = 
(I4.15 ppm + I4.26 ppm)/2
I3.84 ppm/60
 × 100%                  Equation 2-12  
Strangely, the coupling efficiency in entry 3 (Table 2-7) was greater than 100%. There was 
likely an error associated with small peaks based on 1H NMR. Still, it is also possible that the 
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acylamide-peptide polymerised in a homopropagation process as illustrated in the scheme 
below.197  
 
Scheme 2-19 Homopropagation in radical-mediated thiol-ene reaction.197 
In order to limit the homopropagation events, the reaction time was reduced to 3 h as shown 
in entry 4, Table 2-7. This time the coupling efficiency obtained was 87% according to 1H NMR 
(appendix A29).  
GPC traces showed that the polymer conjugates (entry 3, 4, Table 2-7) almost maintained the 
narrow MM distribution of the starting polymer (Figure 2-21). Relatively small shoulders for 
high MM species were observed for both conjugates. By-products from homopropagation 
process described above could be responsible for this. 
 
Figure 2-21 GPC traces of linear PHPMA-GGKE 110 (entry 3 and 4, Table 2-7) and starting 
linear PHPMA 92 
The conditions for the conjugation in entry 4, Table 2-7 were later used for the preparation of 
star PHPMA-GGKE. 
2.6.2 Star PHPMA-LPETGG and PHPMA-GGKE conjugate 
Optimised conditions established for linear PHPMA-LPETGG 109 and linear PHPMA-GGKE 
110 above were applied to prepare star PHPMA-LPETGG and PHPMA-GGKE conjugates. 
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2.6.2.1 3-arm PHPMA-LPETGG 
The 3-arm PHPMA-LPETGG conjugate was first prepared using a one-pot aminolysis/thiol-
ene reaction synthesis of 3-arm PHPMA with a-LPETGG peptide as shown in Scheme 2-20. 
In entry 1, Table 2-8, 3-arm PHPMA 103 was aminolysed with n-butylamine in the presence 
of peptide a-LPETGG 86 and TCEP.HCl in DMF for 1 h at room temperature. The vessel was 
than later heated at 60 °C for 16 h. The final polymer was purified by dialysis against water for 
2 days before lyophilisation to yield a white powder.  
 
Scheme 2-20 One-pot aminolysis/ Michael thiol-ene addition reaction of 3-arm RAFT 
PHPMA 103 and a-LPETGG peptide 86. 
Entry [end group]a/[n-butylamine]/[ene]/[TCEP.HCl] T °C t (h) Mn(GPC) (kDa) Ð 
Coupling 
efficiency 
1b 1 : 10 : 10 : 5 60 24 16.2 1.44 56% 
2c 1 : n/a : 10 : 5 60 24 15.4 1.38 95% 
Table 2-8 Conditions for Michael thiol-ene reaction. a RAFT end group for one-pot method, -
SH group for two-pot method, b One-pot aminolysis/Michael thiol-ene reaction method, c 
Two-pot aminolysis/thiol-ene reaction method. Mn(GPC) of starting 3-arm PHPMA 103 was 
26.6 kDa, Ð = 1.24. 
In the first attempt, the 1H-NMR spectrum of the conjugate showed the presence of α-CH 
hydrogens belonging to amino acid residues (H-b, H-a3, H-a4, and H-a5) at 4.18 and 4.35 
ppm in (Figure 2-22A, B). The vinyl proton signals were absent from the spectrum, suggesting 
that unreacted peptide was completely removed by dialysis. This indicated the successful 
incorporation of peptide onto the polymer. 
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Figure 2-22 1H NMR spectra of 3-arm PHPMA-LPETGG conjugates (A) from one-pot method entry 1 
(B) from two-pot method entry 2 (Table 2-8) and a-LPETGG peptide 86 (D2O, 400 MHz).  
Coupling efficiency was derived as below, Where I4.17 ppm and I3.84 ppm are the integrals of proton 
signals at 4.17 ppm (H-b) and 3.84 ppm (H-a). n is the total number of monomer units of the 
star PHPMA. In this reaction, n = 162 for 3-arm PHPMA 103 in entry 9, Table 2-2. 
% coupling efficiency =  
number of peptides
 3×number of 3-arm star polymers
× 100  
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% coupling efficiency =
I4.17 ppm
3 ×
I3.84 ppm
n
× 100  
 
% coupling efficiency =
n
3
×
I4.17 ppm
I3.84 ppm
× 100                            Equation 2-13 
However, the coupling efficiency was only 56%. A lower efficiency can be accounted for by 
the fact that the star polymer structure has more steric hindrance effects compared to linear 
polymer chains, leading to less chance for the nucleophilic attack of the intermediate enolate 
on thiols (Scheme 2-13).  
Another factor that should be also taken into account is the competition from the thiol-
terminated by-product formed during the aminolysis of trithiocarbonate groups (Scheme 2-21) 
in the Michael thiol-ene addition reaction.201 
 
Scheme 2-21 Aminolysis of trithiocarbonate-terminated polymer with n-butylamine 
In order to improve the coupling efficiency of peptide to the star polymer, the reaction could 
either be allowed to run for a longer time or be conducted as a two-pot method, in which the 
thiol-terminated PHPMA is prepared separately. The latter approach was selected (entry 2, 
Table 2-8). In this, the coupling efficiency was improved to 95% according to 1H NMR (Figure 
2-22B).  
The MM distribution of the two conjugates obtained in entry 1 and entry 2 (Table 2-8) were 
analysed using GPC and compared to the starting star PHPMA. Mn(GPC) of both conjugates 
were smaller than Mn(GPC) of the original polymer, especially in the case of the conjugate 
obtained from the one-pot method (entry 1, Table 2-8). As can be seen from Figure 2-23, both 
conjugates eluted roughly at the same time and significantly later than the starting polymer 
and the thiol-terminated polymer PHPMA-SH. This implied that the conjugates possessed 
much smaller hydrodynamic volumes than the starting polymer. However, the coupling of 
peptide molecules to polymer chain ends would not significantly affect the total volume of the 
whole molecule as it can be observed in the GPC traces of linear PHPMA-LPETGG 109 
versus linear PHPMA 92 (Figure 2-18). It was hypothesised that the ester core in the star 
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structure could possibly have been hydrolysed under the basic conditions, leading to the 
breakdown of the molecule hence reducing the molecular volume.  
 
Figure 2-23 GPC traces of 3-arm PHPMA 103, 3-arm PHPMA-SH, polymer conjugates in 
entry 1 and 2 (Table 2-8), and the polymer obtained from hydrolysis test. 
An experiment was performed to test this hypothesis where peptide was excluded from the 
reaction mixture, and the solution of 3-arm RAFT PHPMA, TCEP.HCl, and n-butylamine in 
DMF was heated to 60 °C for 24 h. The resulting polymer was purified and characterised using 
GPC. As shown in Figure 2-23, the obtained polymer from the hydrolysis test eluted at roughly 
the same time as the other conjugates, indicating a decrease in the molecular volume. This 
result correlated well with the hypothesis.  
Seeking to avoid the use of nucleophilic n-butylamine, it was envisaged that the radical 
coupling might avoid hydrolysis of the ester core (Scheme 2-22).  
 
Scheme 2-22 Radical-mediated thiol-ene reaction of 3-arm PHPMA-SH 114 and a-LPETGG 
86. 
The radical thiol-ene addition of a-LPETGG 86 to 3-arm PHPMA-SH 114 was performed using 
the optimised conditions established above for the synthesis of linear PHPMA-GGKE (entry 
4, Table 2-7). Table 2-9 outlines two radical thiol-ene reactions which were performed under 
different reaction times. 
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Entry [-SH]/[ene]/[TCEP.HCl]/[AIBN] t (h) Mn(GPC) (kDa) Ð Coupling efficiency 
1 1 : 10 : 5 : 1 1 29.3 1.27 59 % 
2 1 : 10 : 5 : 1 3 28.3 1.30 96% 
Table 2-9 Radical-mediated thiol-ene addition of a-LPETGG to 3-arm PHPMA-SH. Mn(GPC) of starting 3-
arm PHPMA 103 was 26.6 kDa, Ð 1.24 (entry 9, Table 2-2).  
 
Figure 2-24 1H NMR spectra of 3-arm PHPMA-LPETGG conjugates from entry 1 and 2 (Table 2-9) and 
a-LPETGG peptide 86 (D2O, 400 MHz).  
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1H NMR revealed successful conjugation of peptide to the polymer with a coupling efficiency 
of 66% for the 1 h reaction (entry 1, Table 2-9) and 94% for 3 h reaction (entry 2, Table 2-9). 
GPC traces showed that the narrow MM distributions of the starting polymers remained for 
both conjugates and their elution times were almost the same as those of the starting PHPMA 
103 (Figure 2-23). This indicated that the star structures in the conjugates remained intact. 
 
Figure 2-25 GPC traces of 3-arm PHPMA 103 and polymer conjugates 113 obtained from 
radical-mediated thiol-ene method (entry 1 and 2, Table 2-9). 
2.6.2.2 4-arm PHPMA-LPETGG 
4-arm PHPMA-LPETGG conjugate 115 was prepared using the conditions optimised in the 
previous section for 3-arm polymer conjugate 113. The synthesis was performed using the 
sequential aminolysis/radical-mediated thiol-ene reaction method (Scheme 2-23). 
 
Scheme 2-23 Synthetic route to 4-arm PHPMA-LPETGG conjugate 115 
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Table 2-10 outlines the conditions for the radical thiol-ene addition of a-LPETGG 86 to 4-arm 
thiol-terminated PHPMA. 
Entry [-SH]/[ene]/[TCEP.HCl]/[AIBN] t (h) Mn(GPC) (kDa) Ð Coupling efficiency
a 
1 1 : 10 : 5 : 1 3 28.3 1.30 95 % 
Table 2-10 Conditions of the radical-mediated thiol-ene addition of a-LPETGG to 4-arm 
PHPMA-SH. a Determined by 1H NMR. Mn(GPC) of starting 4-arm PHPMA was 29.1 kDa, Ð 
1.26 (entry 3, Table 2-3). 
Figure 2-26A shows the 1H NMR spectrum of the conjugate with signals in the region from 
4.17 to 4.48 ppm corresponding to α-CH protons derived from the peptide sequence. The 
coupling efficiency was determined using the equation below, where I4.17 ppm and I3.83 ppm are 
the integrals of proton signals at 4.17 ppm (H-b) and 3.83 ppm (H-a), respectively. n is the 
total number of monomer units of the star PHPMA. In this study, 4-arm PHPMA 106 was used 
with n = 166 (entry 3, Table 2-3). 
 % coupling efficiency =
n
4
×
I4.17 ppm
I3.83 ppm
× 100    Equation 2-14 
 
Figure 2-26 1H NMR spectra of 4-arm PHPMA-LPETGG 115 conjugate and a-LPETGG 
peptide 86 (D2O, 400 MHz). 
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Figure 2-27 shows the GPC traces of 4-arm PHPMA-LPETGG 115 obtained above and 
starting 4-arm PHPMA 106. The conjugate still exhibited a narrow MM distribution but it was 
slightly broader than the starting polymer. This could possibly be due to the occurrence of 
homopropagation as illustrated in , leading to uneven addition of peptide sequence to polymer 
arms.197 
 
Figure 2-27 GPC traces of 4-arm PHPMA 106 and 4-arm PHPMA conjugate 115. 
2.6.2.3 3-arm PHPMA-GGKE 
Successful conjugation of GGK(a)E 88 peptide to 3-arm PHPMA polymer 103 was achieved 
using the same conditions established above for 3-arm PHPMA-LPETGG 113. The synthesis 
route was the two-pot method in which 3-arm PHPMA 103 was first aminolysed with n-
butylamine in the presence of TCEP.HCl in DMF for 3 h at room temperature. The thiol 
terminated polymer was collected by precipitation in cold diethyl ether three times and 
subsequently dried under vacuum. The addition reaction of GGK(a)E 88 to 3-arm PHPMA-SH 
was initiated by AIBN in DMF at 60 °C for 3 h. The resulting conjugate 116 was purified by 
dialysis against water for 2 days prior to lyophilisation to yield a white powder. 
Scheme 2-24 presents the sequential aminolysis and radical-mediated thiol-ene reaction of 3-
arm PHPMA 106 and GGK(a)E 88 that was employed. 
 
Scheme 2-24 Synthetic route of 3-arm PHPMA-GGKE 
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Table 2-11 shows the conjugation conditions and the product’s characterisations. 
Entry [-SH]/[ene]/[TCEP.HCl]/[AIBN] t (h) Mn(GPC) (kDa) Ð Coupling efficiency
a  
1 1 : 10 : 5 : 1 3 29.3 1.30 95 % 
Table 2-11 Conditions for radical-mediated thiol-ene reaction of GGK(a)E 88 and 3-arm 
PHPMA-SH. a Determined by 1H NMR using equation 2-15. Mn(GPC) of starting 3-arm PHPMA 
103 was 26.6 kDa, Ð 1.24 . 
 
Figure 2-28 1H NMR spectra of 3-arm PHPMA-GGKE 116 and GGK(a)E 88 peptide (D2O, 
400 MHz). 
As can be seen from the 1H NMR spectrum in Figure 2-28 the presence of α-CH proton signals 
at 4.25 ppm along with new signals at 2.52 and 2.60 ppm responsible for the thioether protons 
(H-c, H-d), confirm that GGK(a)E peptide 88 was successfully incorporated onto the polymer 
103. 
Coupling efficiency was calculated using the equation below, where I4.25 ppm is integral of 
protons H-a1 and H-a2 together at 4.25 ppm and and I3.84 ppm is integral of H-a belonging to 
91 
 
HPMA units at 3.84 ppm. The number of monomer units (n) of starting PHPMA 103 was 162 
(entry 9, Table 2-2). 
% 𝑐𝑜𝑢𝑝𝑙𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 =
𝑛
3
×
𝐼4.25 𝑝𝑝𝑚
𝐼3.84 𝑝𝑝𝑚
× 100                   Equation 2-15  
The MM distribution of 3-arm PHPMA-GGKE 115 characterised by GPC is shown in Figure 
2-29. The conjugate maintained the narrow MM distribution of the starting polymer 103. 
 
Figure 2-29 GPC traces of 3-arm PHPMA 103 and 3-arm PHPMA-GGKE 115 
2.6.2.4 4-arm PHPMA-GGKE 
The 4-arm PHPMA-GGKE conjugate 167 was also successfully prepared using sequential 
aminolysis and radical-mediated thiol-ene reaction following conditions established for 3-arm 
PHPMA-GGKE 115 (Scheme 2-25). 
 
Scheme 2-25 Synthetic route to 4-arm PHPMA-GGKE 117 
Conditions for the thiol-ene addition reaction of GGK(a)E 88 to 4-arm PHPMA-SH are outlined 
in Table 2-12. 
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Entry [-SH]/[ene]/[TCEP.HCl]/[AIBN] t (h) Mn(GPC) (kDa) Ð Coupling efficiency
a  
1 1 : 10 : 5 : 1 3 28.9 1.30 97.5 % 
Table 2-12 Conditions for radical-mediated thiol-ene reaction of GGK(a)E and 4-arm 
PHPMA-SH. a Determined by 1H NMR. Mn(GPC) of starting 4-arm PHPMA 106 was 29.1 kDa, 
Ð 1.26 (entry 3, Table 2-3). 
 
Figure 2-30 1H NMR spectra of 4-arm PHPMA-GGKE 118 and GGK(a)E 88 peptide (D2O, 
400 MHz). 
The incorporation of peptide GGK(a)E 88 onto 4-arm PHPMA was confirmed by the presence 
of α-CH peptide protons H-a1 and H-a2 together at 4.25 ppm in 1H NMR spectrum (Figure 
2-30). A broad peak in the region from 2.49 to 2.57 ppm was responsible for thioether protons 
H-b and H-c. 
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Coupling efficiency was calculated using the equation below, where I4.25 ppm is the integral of 
protons H-a1 and H-a2 together at 4.25 ppm and I3.86 ppm 3.86 ppm. n is the number of 
monomer units of starting PHPMA. In this experiment, 4-arm PHPMA 106 was used with n = 
166 (entry 3, Table 2-3). 
% coupling efficiency =
n
4
×
I4.25 ppm
I3.86 ppm
× 100 
Analysis by GPC indicated that the MM distribution of 4-arm polymer conjugate 118 remained 
narrow (Figure 2-31). The conjugate 118 eluted almost at the same time as the starting 
polymer 106, and its shape closely matched to that of the original polymer 106. This also 
indicated that the star structure of conjugated 118 remained intact. 
 
Figure 2-31 GPC traces of 4-arm PHPMA 106 and 4-arm PHPMA-GGKE 118. 
2.7 SrtA mediated ligation/cross-linking of PHPMA-peptide conjugates 
2.7.1 SrtA expression and purification 
SrtA enzyme was expressed using plasmid transformed into Escherichia coli 
BL21(DE3)pLysS. A His6 tag was incorporated for affinity purification with nickel-nitrilotriacetic 
acid (Ni-NTA) resins as had been reported previously.24 Following the expression the cell 
pellets were collected by centrifugation. The cells were later lysed in lysis buffer to release the 
proteins and centrifuged to collect the cleared lysate. SrtA was purified by Ni-NTA using a 
gravity-flow column and the purified SrtA was analysed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). Figure 2-32 shows the SDS-PAGE analysis 
of SrtA purification. The gel staining clearly indicates the presence of a high concentration of 
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SrtA-His6 enzyme. SrtA-His6 moving anomalously in SDS-PAGE had been reported previously 
by Chan et al.,24 giving a higher MM according to SDS-PAGE, ~27 kDa, than the ESI-MS 
literature value reported by Ton-That et al., ~22 kDa.202 A MALDI-TOF-MS instrument was not 
available at the time for accurate MM characterisation.  
The enzyme was later concentrated and buffer exchanged with storage buffer (50 mM Tris, 
100 mM NaCl pH 7.5) using PierceTM protein concentrator PES with 10 kDa MWCO 
(ThermoFisher Scientific). Concentrated SrtA was stored at -80 °C for later use. 
    
Figure 2-32 SDS-PAGE image of SrtA expression and purification, (A) Protein ladder, (B) 
Protein lysate, (C) Flow through solution, (D) Resin wash buffer solution, (E) SrtA elution 
fraction 1st, (F) SrtA elution fraction 5th  
2.7.2 Quantification and kinetic analysis of SrtA 
2.7.2.1 Quantification of purified SrtA 
The concentration of SrtA was quantified using BCA protein quantification assay. This assay 
is a detergent-compatible formulation based on bicinchoninic acid (BCA) for the colorimetric 
detection and quantitation of total protein. The method involves a reduction of Cu2+ to Cu1+ by 
protein in an alkaline medium with the highly sensitive and selective colorimetric detection of 
the cuprous cation (Cu1+) by bicinchoninic acid. The calibration curve was established using 
albumin standard solutions (Appendix A37).  
A          B          C          D           E          F 
200 - 
150 - 
120 - 
100 - 
  85 - 
70 - 
60 - 
50 – 
 
40 - 
30 - 
25 - 
20 - 
15 - 
10 - 
Daltons 
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The concentration of purified SrtA was determined to be 501 mg/ml (around 23 mM). The total 
yield was 100 mg of SrtA. 
2.7.2.2 Activity assay of SrtA 
The aim of this enzyme assay described here was to evaluate the activity of purified SrtA and 
determined the enzyme units. 
Fluorescence resonance energy transfer (FRET) was used to evaluate the enzyme kinetics. 
FRET is based on the distant dependent excitation energy which is transferred non-radiatively 
from an excited fluorophores, the donor to another fluorophore, the acceptor.203,204 The donor 
and the acceptor are normally attached to the ends of substrate with a distance less than 10 
nm. The donor produces signal upon excitation and get quenched by the acceptor, resulting 
in FRET. The cleavage of the substrate by the protease lead to the disruption of the energy 
transfer and the ratio of donor to acceptor fluorescence emission changes when both 
chromophores are fluorescent, or the fluorescent intensity increases when the acceptor is a 
quencher. Protease activity is examined using FRET as shown in Figure 2-33. 
 
Figure 2-33 Mechanism of conventional FRET probe for protease activity. Adapted from 
reference 205 
The enzyme activity of prepared SrtA was verified against purchased SrtA in the SensoLyte® 
520 Sortase A activity assay kit (AnaSpec Inc.). The kits employ a novel internally quenched 
5-FAM/QXL® FRET substrate for the detection of protease activity. The FRET substrate is 
cleaved by the enzyme into two separate fragments resulting in the release of 5-FAM 
fluorescence, which can be monitored at excitation/emission = 490/520 nm. 
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Kinetic analysis of purified SrtA was run over 60 min as shown in Figure 2-34. The linear slope 
of the curve was used to determine the initial reaction rate. 
RFU can be converted to concentration using the equation from the standard curve of relative 
fluorescence units vs fluorescence concentration (Appendix A38). The equation for the 
standard curve is shown below: 
RFU = 109356.C5-FAM + 4839.1 where C5-FAM (µmol.L-1) is the concentration of fluorescence 
compound. 
C5-FAM = 0.0359t + 0.296  
 
Figure 2-34 Kinetic analysis of diluted SrtA samples. RFU: relative fluorescence units. 
The reaction mixture consisted of 50 µL diluted SrtA and 50 µL 5-FAM/QXLTM520 SrtA 
substrate. The enzyme unit of the diluted SrtA sample in 100 µL reaction well was determined 
using the equation below: 
Enzyme unit = Initial rate x Volume of reaction  
                     = 0.0359 (µmol.L-1.min-1) x 100 x 10-6 L = 3.59 x 10-6 (µmol.min-1) 
                     = 3.59 x 10-6 unit 
The positive controls contained purified SrtA enzyme at the concentration of 0.09 nM or 2x10-3 
mg.mL-1. For the stock solution, the enzyme unit can be determined as follows, 
Enzyme unit per mg of enzyme = 3.59 x 10-6 unit/(2 x 10-3 mg.mL-1x 50 x 10-3 mL) 
                                                   = 0.036 unit.mg-1 
This value demonstrated that the prepared SrtA possessed relatively low activity. For the 
supplied SrtA in the assay kit, its enzyme activity was calculated to be 0.085 unit/mg. 
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2.7.3 SrtA mediated cross-linking of star PHPma-LPETGG and PHPMA-GGKE 
2.7.3.1 Investigation of SrtA catalysed cross-linking using GPC 
Due to the poor kinetics of SrtA and its limited source, the cross-linking of star PHPMA-
LPETGG and PHPMA-GGKE was first investigated with diluted concentration of SrtA using 
GPC to detect high MM products formed via SrtA ligation. The test experiment was conducted 
using 3-arm PHPMA-peptide conjugates 114 and 117 with ratios [SrtA]/[-LPETGG]/[-GGKE] 
of 0.28 : 1.0 : 0.9. Concentrations of SrtA, 3-arm PHPMA-LPETGG 114, and 3-arm PHPMA-
GGKE 117 in PBS pH 7.5 reaction buffer were 200 µM, 0.72 mM, and 0.65 mM respectively. 
Enzyme unit of SrtA in the final reaction was 6.36 x 10-3 U.mL-1. Excess PHPMA-LPETGG 
conjugate 114 was used, compared to PHPMA-GGKE 117, to prevent the reverse of the 
ligation reaction due to the accumulation of released aminoglycine fragments.206,207  
As soon as SrtA was added to the polymer solution, the solution turned cloudy instantly, 
suggesting a reaction was taking place (Figure 2-35). The mixture was agitated at 250 rpm for 
24 h at room temperature. No gelling was observed in the end.  
                                    
Figure 2-35 (A) Reaction mixture with SrtA, (B) Polymer solution without SrtA 
After 24 h mixing, the clear supernatant containing soluble polymers was collected by 
centrifugation, and later loaded onto Ni-NTA resin for SrtA removal. The eluted polymer 
solution was dialysed against water to remove salts prior to lyophilisation. 
GPC analysis of the purified polymers in the supernatant is shown in Figure 2-36. 
A                      B 
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Figure 2-36 GPC analysis of polymer mixture after reaction with SrtA, (A) Signals from 
refractive index (RI) detector,  (B) Signals from right angle light scattering (RALS) detector. 
Signals from an RI detector, a concentration sensitive detector, showed that the soluble 
polymers collected after the reaction with SrtA presented as a unimodal peak and eluted at 
nearly the same time as the two starting polymers, which means there were no high MM 
polymers detected by the RI detector (Figure 2-36A). However, high MM species were picked 
up by the light scattering detector as shown in Figure 2-36B. This suggested that SrtA 
catalysed cross-linking did occur but in very low yield and the concentration of the cross-linked 
product was too low to be detected by the RI detector. 
2.7.3.2 SrtA catalysed gelation of 4-arm PHPma-LPETGG and 4-arm PHPMA-GGKE 
Piluso et al. reported a successful conjugation of DNA-binding protein (Tus) to a self-
assembling peptide GGFEFEFFKFK using SrtA prepared from the same strain plasmids as in 
this project.208 They achieved 40% yield of conjugation using [SrtA] : [GG tag] : [LPE tag] ratios 
of 10:1:0.9 with SrtA concentration of 446 µM. Enzyme unit of their SrtA source was not 
mentioned in their report. In this project, the cross-linking of 4-arm PHPMA conjugates 116 
and 118 catalysed by SrtA was designed based on the conditions reported by Piluso et al.208 
The mixture turned cloudy as soon as SrtA was added to the polymer solution. No gelling 
occurred after 24 h. However, there were aggregates formed which resembled cross-linked 
products (Figure 2-37). Even though gelation was not successful, it was evident that the SrtA 
catalysed cross-linking of star PHPMA-SrtA substrate conjugates had taken place.  
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Figure 2-37 Photo of aggregates from the reaction mixture with SrtA. 
The failure of gelation of PHPMA-peptide conjugates can be accounted for by the poor kinetics 
of the wild type SrtA. Several groups have focused on evolving SrtA to improve its conjugation 
efficiency on proteins and antibodies.115,209 Chen et al. designed a pentamutant variant SrtA5M 
with 140-fold increase in activity.210 Some have independently generated calcium-independent 
heptamutant variant sortase A (SrtA7M) by combining a Ca2+-independent mutations with 
SrtA5M.209  
In the most recent study, Broguiere et al. achieved a fast gelation of 2% w/v content of 4-arm 
PEG/SrtA peptide conjugates using 20 µM pentamutant SrtA. In another work, Arkenberg and 
Lin reported a gelation of 8-arm PEG/SrtA peptide conjugates  catalysed by a (SrtA7M).2 The 
fastest gelation of 60 s was achieved at 600 µM of SrtA and 1% wt of each polymer conjugates. 
This demonstrates that SrtA can be a potential tool for in situ forming hydrogels and this should 
be tested with the star-peptide conjugates in future research. 
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2.8 Summary and conclusions 
In this study, well-defined star (3-, 4-arm) polymers of N-(2-hydroxypropyl)methacrylamide 
were successfully synthesised via a core-first method of RAFT polymerisation using star 
trithiocarbonate chain transfer agents for the first time. The polymerisation was performed in 
a solvent mixture of 1,4-dioxane and DMF (50/50 v/v) because star trithiocarbonate CTAs 
dissolved better in 1,4-dioxane. It was aimed to produce well-defined star PHPMA by 
controlling the monomer conversion in the range of 50 to 60% through using high 
[HPMA]/[CTA] ratios and short reaction times. It was discovered that more controlled 
polymerisation was achieved at lower temperature 60 °C and shorter reaction time of 6 h 
compared to reaction at 70 °C for 24 h. This could be rationalised by the fact that radical 
terminations are promoted at high temperature and at high monomer conversion. Using 
[HPMA]/[CTA]/[ACVA] ratios of 200/1.0/0.1, a well-defined 3-arm PHPMA (Mn(GPC)=26,601 Da, 
Ð 1.24) was obtained at monomer conversion of 63% after 6 h reaction. Under similar 
conditions (60 °C, 6 h), 4-arm PHPMA (Mn(GPC)=29,099 Da, Ð 1.26) was achieved at much 
higher monomer conversion, 89% but the overall MM distribution remained narrow with a Ð of 
1.26 when using [HPMA]/[CTA]/[ACVA] ratios of 250/1.0/0.1.  
These star polymers were subsequently modified to have SrtA recognition peptide motifs 
(LPETGG and GGKE) coupled to each end of polymer arms. SrtA recognition motifs were 
synthesised to have ene functionality for the thiol-ene addition reaction with the thiol-
terminated PHPMA. Methacrylamide and acrylamide functionalised peptides (ma-LPETGG, 
a-LPETGG, GGK(ma)E, and GGK(a)E) were successfully prepared using the Fmoc/tBu 
method on Wang resin. Due to the unavailability of preparative HPLC at the time, these 
peptides were used without purification. The reactivity of ma-LPETGG and a-LPETGG in the 
thiol-ene reaction with linear thiol terminated PHPMA was investigated and found out that 
acrylamide functionalised peptide resulted in more efficient coupling compared to the former. 
Hence, a-LPETGG and GGK(a)E were selected for the preparation of star PHPMA 
conjugates. For 3-arm PHPMA-a-LPETGG, a one-pot aminolysis/Michael thiol-ene method, 
with the thiol-ene addition reaction involving heating at 60 °C for 24 h, yielded the conjugate 
with coupling efficiency of 95% confirmed by 1H NMR. However, GPC analysis of the polymer 
conjugate gave a lower Mn(GPC) value compared to the initial 3-arm PHPMA, indicating a 
breakdown of star structure through hydrolysis of the ester core. Therefore, it was aimed to 
proceed with the ligation for a shorter reaction time. To do that, the faster thiol-ene addition 
was performed via a radical-initiated pathway. For this approach, star PHPMA-SH were 
produced, via aminolysis with n-butylamine, and purified separately prior to the conjugation. 
Overall, 96% coupling of a-LPETGG and GGK(a)E to 3- and 4-arm  PHPMA was achieved 
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using AIBN as thermal initiator at 60 °C for 3 h. GPC analysis confirmed that all conjugates 
retained their star shape structure. 
SrtA-His6 enzyme was expressed using a plasmid transformed into Escherichia coli 
BL21(DE3)pLysS. The enzyme was successfully purified using Ni-NTA resin with the final 
yield of 100 mg and characterised by SDS-PAGE. Fluorescence assay using novel internally 
quenched 5-FAM/QXL® FRET substrate was performed to evaluate the enzyme activity. The 
enzyme unit was measured to be 0.036 unit/mg, which was relatively low.  
SrtA mediated cross-linking of 3-arm PHPMA-LPETGG and 3-arm PHPMA-GGKE was first 
performed at dilute concentration of SrtA ( ([SrtA]/[-LPETGG]/[-GGKE] of 0.28 : 1.0 : 0.9) and 
the formation of cross-linked polymer was investigated by GPC analysis. The SrtA enzyme 
was removed from the polymer mixture by Ni-NTA resin before dialysis purification. A peak for 
a high MM species was detected by the LS detector however it was undetected by the 
concentration RI detector. This implied that the cross-linking did take place but with a poor 
yield.  
Gelation of 4-arm PHPMA-LPETGG and PHPMA-GGKE was investigated using 
[SrtA]/[LPETGG]/[GGKE] ratios of 10:1:0.9 with a SrtA concentration of 446 µM. Gelation was 
not successful but there were aggregates formed in the mixture, suggesting the cross-linking 
of star PHPMA conjugates catalysed by SrtA did occur. Failure in gelation can be explained 
by the slow kinetics of the SrtA employed in this study. In addition, the presence of impurities 
in a-LPETGG peptide to some extent affected the efficiency of the cross-linking. 
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2.9 Future work 
In the future, the development of SrtA catalysed in situ cross-linking of star PHPMA conjugates 
can be optimised in a number of ways. Firstly, by improving the purity of SrtA recognition 
peptides (LPXTGG and GG motifs): these sequences can be synthesised using a peptide 
synthesiser and purified using preparative HPLC. This would ensure that all the conjugated 
peptide tags on the polymer arms have the right sequence of amino acid for the SrtA 
conjugation. Secondly, by boosting the gelation rate: a mutant SrtA variant with faster kinetics 
than the wild type SrtA could be used instead.  
From here, future work would involve further characterisation of the resultant hydrogels in 
terms of mechanical properties, hydrogel morphology and cytotoxicity. The mechanical 
properties of the resultant hydrogels can be evaluated by rheometer. In addition, the effect of 
SrtA concentration, polymer concentration, polymer arm number and length on the gelation 
rate and the stiffness of the hydrogels can be also studied. In other words, future work could 
involve looking at the design of tunable PHPMA hydrogels for tissue engineering. 
Further future work would be to apply the model to another polymer system such as a 
hyperbranched polymer. The advantages of hyperbranched polymers are a three-dimensional 
globular architecture, good solubility, low viscosity, and easy modification because of the 
abundance of terminal functional groups.211 Hyperbranched PHPMA can also be prepared by 
copolymerisation of HPMA 3 and cross-linker, dimethyl crylate ethylene glycol 118 using RAFT 
polymerisation as shown in Scheme 2-26. Subsequently, peptide conjugation to the 
hyperbranched polymer 119 could be achieved through the thiol-ene addition of cysteine 
containing peptide CLPETGG 122 and GGCE 123 to the methacrylate functional groups on 
the polymer. 
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Scheme 2-26 Proposed synthesis of hyperbranched PHPMA-CLPETGG/GGCE conjugates. 
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3 Chapter III: Self-assembling peptide/thermo-responsive 
PNIPAM-peptide conjugate composite gels 
3.1 Introduction 
A response to external stimuli leads to changes in properties and functions on the molecular 
to macroscopic levels and the process is central to how the biological system works.212 Stimuli-
responsive hydrogels which can change their properties drastically in response to changes in 
temperature, pH, ionic strength, etc. have attracted a great deal of attention in the field of 
tissue engineering and drug delivery. Amongst those, thermo-responsive hydrogels are of 
special interest. PNIPAM is by far the most commonly used polymer for thermo-responsive 
hydrogel preparation.212 
The project described in this chapter focuses on designing thermo-responsive self-assembling 
peptide (FEFEFKFK, 35) hydrogels and tailoring their mechanical properties. Tuning the 
stimuli-responsiveness and viscoelasticity of hydrogels is of great interest for tissue 
engineering applications, especially in designing cell scaffolds.13 As discussed in section 1.5 
(page 22), the gelation of the self-assembling peptides is governed mostly by non-covalent 
interactions.4 Therefore, these materials tend to suffer from low mechanical performance, thus 
limiting their utility in some biomedical applications that require resistance to strain.3  While 
tailoring the mechanical properties of covalently cross-linked hydrogels can be achieved 
through different cross-linking strategies, it is otherwise challenging for peptide hydrogels. 
Because it demands exquisite control over the supramolecular interactions involved in the 
self-assembly process.213  Studies by Maslovskis et al.3 and Xia et al.214 presented different 
pathways to tailor the mechanical performance of the self-assembling peptide hydrogels.  
Maslovskis et al.3 developed a thermo-responsive peptide hydrogel by doping FEFEFKFK 35 
peptide hydrogel with a linear PNIPAM-FEFEFKFK conjugate. They concluded that the 
introduction of the conjugate did not affect the phase transition of PNIPAM and the polymer 
chains did not interfere with the self-assembly of the peptide monomers. Rheological study 
showed a significant increase in hydrogel stiffness (higher storage moduli G’) of the composite 
hydrogel in comparison to the unmodified pure peptide hydrogel. They suggested that the 
polymer adopted a fibrillary arrangement around the surface of the peptide fibres (Scheme 
3-1) due to hydrogen bonding interactions between the polymer and the peptide.  
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Scheme 3-1 Schematic representation of the self-assembly mechanism of the β-sheet 
forming peptide/peptide-polymer conjugate mixture. Reproduced from reference 3 
Xia et al. examined fluorescent hydrogels based on the assembly of KFEFKFEF-bipyridine 
conjugates, the bipyridine acting as a ligand for europium ions as shown in Scheme 3-2.214 
After introducing metal ions to the matrix, the G’ of the resulting hydrogels were improved. It 
was postulated that the metal-ligand crosslinking provided additional interactions, making the 
peptide fibres thicker and more entangled and hence stabilising the network.  
 
Scheme 3-2 Molecular structures of the KFEFKFEF-bpy peptide and the structures of the 
KFEFKFEF -bpy-Eu peptide. Adapted from reference 214 
Following on from the previous study by Maslovskis et al.3, the project described in this chapter 
aimed to investigate the effect of doping star PNIPAM/self-assembling peptide conjugates into 
the peptide hydrogel on its thermo-responsiveness and mechanical properties. The 
hypothesis was that the star conjugates would undergo the self-assembly with the free peptide 
and possibly act as cross-linkers to enhance the mechanical properties of the hydrogels as 
displayed in Scheme 3-3.  
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Scheme 3-3 β-sheet rich peptide hydrogel containing 3-arm PNIPAM-peptide conjugate. (A) 
Solution of free self-assembling peptide and 3-arm PNIPAM-peptide conjugate (B) Self-
assembly of the conjugates and free peptide and fibre formation (C) Peptide hydrogel 
network (D) Phase separation induced by temperature above LCST and the collapse of 
PNIPAM chains. CGC: critical gelation concentration. 
It was thought that the higher number of cross-links would increase the storage modulus of 
the network. Regarding the LCST, rising temperature should stiffen the hydrogels in contrast 
to the linear PNIPAM-peptide conjugate/peptide composite hydrogels reported by Malovsksis 
et al.3 This can be rationalised on the basis that above the LCST the chains of each star 
polymer collapse towards the core, pulling the peptide fibres closer to each other and resulting 
in a denser network. In the linear system, the PNIPAM chains did not cross-link and only added 
the thickness to the peptide fibres. A similar self-assembling pattern was expected for 4-arm 
PNIPAM-conjugate/peptide hydrogels (Scheme 3-4). 
 
Scheme 3-4 β-sheet rich peptide hydrogel containing 4-arm PNIPAM-peptide conjugate. (A) 
Solution of free self-assembling peptide and 4-arm PNIPAM-peptide conjugate (B) Self-
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assembly of the conjugates and free peptide and fibre formation (C) Peptide hydrogel 
network (D) Phase separation induced by temperature above LCST and the collapse of 
PNIPAM chains. CGC: critical gelation concentration. 
3.2 Synthetic routes 
As discussed in the background information (section 1.6.4, page 30), polymer-
peptide/biomolecule conjugates can be prepared either via in situ RAFT polymerisation of 
monomers and biomolecules modified with a CTA or via post-polymerisation modification of 
RAFT polymers. In a study by Maslovskis et al., linear PNIPAM-FEFEFKFK conjugates 125 
were synthesised via free radical polymerisation of NIPAM monomer 2 with thiol-modified 
peptide HS-FEFEFKFK 124 as a CTA.3  
 
Scheme 3-5 Free radical polymerisation of NIPAM monomer 58 with thiol-modified 
FEFEFKFK 124.3,215 
However, this pathway can be only used to prepare linear polymer conjugates because star 
polymer synthesis required a multifunctional CTA. Moreover, the limitation of free radical 
polymerisation is that there is no control over the MM distribution.89 In this project, it was aimed 
to synthesise well-defined star PNIPAM conjugates with a known arm number, hence RAFT 
polymerisation was selected to prepare star PNIPAM.  
Bioconjugation to linear RAFT polymers was reported in many previous studies. Thomas et 
al. successfully performed the Michael addition between thiol groups on cysteine residues of 
mCherry protein and maleimide functionalised PNIPAM polymer 127.216 Maleimide 
functionalisation was obtained using CTA 126 containing a protein reactive moiety, maleimide, 
protected as a Diels-Alder adduct before use. Their synthetic route is shown in Scheme 3-6.  
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Scheme 3-6 Synthesis of PNIPAM-mCherry protein-polymer diblock copolymer. Reproduced 
from reference 216                                                             
Grover et al.217 reported a similar approach but using the Michael addition reaction between  
thiol groups on BSA and a vinyl sulfone modified PEGA polymer 129  shown in Scheme 3-7. 
The vinyl sulfone functionalised PEGA polymer 129 was synthesised through post 
modification of RAFT PEGA polymer.  
 
Scheme 3-7 BSA conjugation onto PEGA polymers. Reproduced from reference 217 
In this current project, star PNIPAM/self-assembling peptide conjugates were also prepared 
using a post-polymerisation modification method. Star PNIPAM polymers with various MMs 
were prepared via R-RAFT controlled radical polymerisation using 3-arm and 4-arm RAFT 
agents as reported previously for star PHPMA (section 2.5.2, page 63). The conjugation of 
self-assembling peptide FEFEFKFK 35 to the polymer arms was carried out via two different 
approaches.  
In the first approach, the star polymers were firstly aminolysed with n-butylamine and purified 
to yield thiol-terminated polymers PNIPAM-SH, which were purified and subsequently reacted 
with methacrylamide-functionalised peptide, ma-FEFEFKFK 131 via the thiol-ene reaction. 
The thiol-ene reactions were conducted via either the Michael pathway or a radically initiated 
pathway as illustrated in Scheme 3-8. 
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Scheme 3-8 First approach for 4-arm PNIPAM-FEFEFKFK conjugate synthesis via thiol-ene 
reaction between thiol-terminated PNIPAM and ma-FEFEFKFK 131 
In the second approach, the peptide conjugation was performed using a similar pathway to 
that reported by Grover et al.217 as shown in Scheme 3-7. In this approach, vinyl sulfone, an 
efficient thiol-reactive functional group was introduced to the thiol terminal of the star polymers 
via thiol-ene reaction (Scheme 3-9).60 For the self-assembling peptide, a cysteine amino acid 
was incorporated to the N terminal of the sequence to provide thiol functional groups for the 
conjugation. Addition of a lysine amino acid to the C terminal was aimed to improve the 
solubility of the peptide in water at physiological pH.208 Self-assembling peptide CFEFEFKFKK 
132 was synthesised using Fmoc/tBu solid phase method on Wang resin.161  
 
Scheme 3-9 Second approach for 4-arm star PNIPAM-CFEFEFKFKK conjugate.  
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3.3 RAFT polymerisation of NIPAM 
3.3.1 Synthesis of 3-arm PNIPAM 
Similar to the synthesis of 3-arm PHPMA, 3-arm PNIPAM was synthesised using 3-arm CTA 
94 via R-RAFT polymerisation as shown in Scheme 3-10. ACVA was used as an initiator for 
the polymerisation based on the optimised conditions for 3-arm PHPMA (section 2.5.2, page 
63). 
 
Scheme 3-10:  Synthesis of 3-arm PNIPAM polymers 
Star acrylamide synthesis via R-RAFT polymerisation has been reported previously.218-221 In 
comparison to HPMA monomer 3, NIPAM monomer 2 is more hydrophobic and presents more 
options for choosing a solvent for polymerisation reactions. Various solvents have been used 
for R-RAFT polymerisation of NIPAM 2, such as 1,4-dioxane, DMF, and THF.166,218-220 DMF 
was not selected for RAFT polymerisation of NIPAM here because it is likely to be 
contaminated with free dimethylamine, a decomposition product of DMF, which can aminolyse 
the trithiocarbonate group in the RAFT agent and consequently reduce the control over the 
polymerisation.  
Wang et al. reported the closest system to the reaction presented in Scheme 3-10. They used 
THF for their polymerisations and achieve well-defined PNIPAM.220 THF is widely used as a 
solvent for organic reactions and is less toxic compared to DMF.222 Therefore, THF was 
selected for the synthesis of star PNIPAM in this current project. 
The conditions tested for polymerisation from 3-arm CTA 94 and the resulting polymer 
characterisation results are listed in Table 3-1. 
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Entry Sample Feed ratiosa 
Time 
(h) 
Mn(GPC)
b 
(Da) 
Mn(NMR)
c 
(Da) 
Mn(th)
d 
(Da) 
Ðb 
Conversionc 
% 
1 133 250/1.0/0.1 4 52,408 36,698 29,450 1.27 99 
2 134 250/1.0/0.1 2 43,165 37,144 26,621 1.09 90 
3 135 200/1.0/0.1 2 29,048 25,591 20,400 1.11 85 
4 136 100/1.0/0.1 4 10,881 11,570 9,308 1.24 72 
5 137 100/1.0/0.1 2 8,467 8,856 8,289 1.15 63 
Table 3-1 Results for polymerisation of NIPAM with 3-arm CTA 94 in THF at 70 °C; a 
[NIPAM]/[CTA]/[ACVA]; b By GPC, Ð = Mw/Mn; c Determined by 1H NMR spectroscopy; d 
Calculated using this equation Mn(th) = MCTA + conversion(MNIPAM[NIPAM]o/[CTA]o) 168,186 
       
Figure 3-1 1H NMR spectrum of a crude polymerisation mixture which included unreacted 
monomer and polymerisation solvent (400 MHz, DMSO-d6). 
Monomer conversion was calculated based on the 1H NMR spectrum of the crude polymer 
mixture using equation 3-1, where I3.98 ppm is the integral of methine proton H-c and H-c’ 
together, I5.52 ppm is the integral of vinyl proton signal H-a’ belonging to unreacted monomer 
(Figure 3-1). 
%conversion = (I3.98 ppm − I5.52 ppm)/I3.98 ppm × 100    Equation 3-1 
The 1H NMR spectrum in Figure 3-2 is of a purified 3-arm PNIPAM polymer. It shows a 
characteristic signal at 1.14 ppm originating from methyl hydrogens (H-d). A broad peak at 4.0 
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ppm was responsible for methine hydrogen (H-c). Methylene hydrogens H-g and H-f on Z 
groups were observed at 3.33 and 1.22 ppm respectively. 
 
Figure 3-2 1H NMR spectrum of purified 3-arm PNIPAM polymer 137 (from entry 5, Table 
3-1) (500 MHz, CDCl3). 
Mn(NMR) was determined from the 1H NMR spectrum of purified 3-arm PNIPAM using Equation 
3-2, where I4.0 ppm and I3.3 ppm are the peak areas of methine proton H-c of the backbone polymer 
and methylene proton signal H-g belonging to the Z group of the RAFT agent respectively 
(Figure 3-2). MNIPAM = 113.18 g.mol-1, MCTA = 1159.99 g.mol-1. 
 Mn(NMR) =
I4.0 ppm
I3.3 ppm
6⁄
× MNIPAM +  MCTA                    Equation 3-2 
It was expected that polymerisation of NIPAM 2 would give a higher conversion compared to 
that of HPMA 3 as acrylamides exhibit higher propagation rate coefficients than 
methacrylamides.175 As expected, monomer conversion in entry 3 (Table 3-1) reached 85% in 
only 2 h, compared to only 60% in 6 h for 3-arm PHPMA 103 (entry 9, Figure 3-3).  
GPC traces for all polymer samples in Figure 3-3 revealed shoulders at high MM as an 
indication of star-star radical coupling by-products (Scheme 2-8). The shoulder was especially 
pronounced for polymer 133 in entry 1 (Table 3-1) where a high monomer conversion of 99% 
was obtained. It suggested that the radical-radical terminations took place at high monomer 
conversions as reported elsewhere.223 In contrast to 3-arm PHPMA polymerisation (section 
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2.5.2, page 63), the GPC traces for star PNIPAM polymers showed no shoulders for low MM 
by-products, suggesting that low MM star-like and linear polymer by-products were little 
produced in the polymerisation.167 This result is supported by similar results by others showing 
that high propagation rate monomers suppress the formation of linear by-products.167,171  
For the optimisation, it was aimed to stop the polymerisation at lower conversions at around 
60% by reducing polymerisation time in order to prevent star-star radical terminations. This 
strategy was successful as the dispersity for polymers 134, 135, and 137 in entries 2, 3 and 5 
(Table 3-1) were lower with Ð<1.2, and their GPC analysis showed less broad shoulders at 
high MM compared to polymers 133 and 136 (entry 1 and 4, Table 3-1). Theoretical Mn(th) 
values, calculated based on monomer conversion, were all smaller than the Mn(GPC) values. 
The discrepancies also became larger as monomer conversion increased. This can be 
explained as resulting from the star-star termination events being more likely to happen at 
high monomer conversion, as reported elsewhere.171 
  
Figure 3-3: GPC traces of 3-arm PNIPAM polymers (entry 1-5 as in Table 3-1) 
At this stage polymers were used as they were, but future work should look at optimisation of 
the polymerisation conditions in order to produce star PNIPAM with less high MM by-products. 
Polymers 134, 136 and 137 were used in the preparation of PNIPAM-peptide conjugates.               
3.3.2 Synthesis of 4-arm PNIPAM  
4-arm PNIPAM polymers were synthesised using 4-arm RAFT agent 84 as shown in Scheme 
3-11. Following the conditions for 3-arm PNIPAM polymerisation, the synthesis of 4-arm 
PNIPAM was performed in THF at 70 °C using ACVA as initiator. 
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Scheme 3-11 Synthesis of 4-arm PNIPAM polymers  
The tested conditions and characterisation results of the 4-arm PNIPAM polymers obtained 
are displayed in Table 3-2. 
Table 3-2 Results for polymerisation of NIPAM 2 with 4-arm CTA 84 in THF at 70 °C; a 
[NIPAM]/[CTA]/[ACVA]; b By GPC in DMF + 0.01 M LiBr with triple detectors; c Determined 
by 1H-NMR spectroscopy; d Calculated using this equation: Mn(th)= MCTA + conversion 
(MNIPAM[NIPAM]o/[CTA]o)168,186 
 
Figure 3-4 1H NMR spectrum of purified 4-arm PNIPAM 138 (400 MHz, CDCl3). 
Mn(NMR) was determined from the 1H NMR spectrum of purified 4-arm PNIPAM using equation 
3-3, where I4.0 ppm and I3.3 ppm are the peak areas of methylene proton H-c of the backbone 
Entry Sample Feed ratiosa Time (h) 
Mn(GPC) 
b 
(Da) 
Mn(NMR)
c 
(Da) 
Mn(th)
d 
(Da) 
Ðb Conversionc  
1 138 100/1.0/0.1 2 14,836 13,406 8,539 1.08 62% 
2 139 200/1.0/0.1 2 22,726 22,121 17,820 1.13 72% 
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polymer and methylene proton signal H-e belonging to the Z group of the RAFT agent 
respectively (Figure 3-4). MNIPAM = 113.18 g.mol-1, MCTA 84 = 1522.60 g.mol-1. 
𝑀𝑛(𝑁𝑀𝑅) =
𝐼4.0 𝑝𝑝𝑚
𝐼3.3 𝑝𝑝𝑚
8⁄
× 𝑀𝑁𝐼𝑃𝐴𝑀 +  𝑀𝐶𝑇𝐴   Equation 3-3 
It was aimed to achieve a monomer conversion of around 60% to minimise the formation of 
star-star radical coupling by-products, therefore, both polymerisations were carried out for only 
2 h. Overall, both polymers exhibited narrow MM distributions with Ð<1.15, however, GPC 
analysis still revealed the presence of star-star by-products (Figure 3-5). As expected, the 
higher monomer conversion (72%) obtained for the polymerisation in entry 2 (Table 3-2) led 
to a broader MM distribution of polymer 139 as well as a more pronounced shoulder for high 
MM by-products on the GPC trace compared to polymer 138 in entry 1 (Table 3-2). As for the 
3-arm polymers, Mn(th) values were smaller than Mn(GPC) and Mn(th) values, indicating a loss of 
RAFT end groups through star-star radical terminations. 
 
Figure 3-5 GPC traces of 4-arm PNIPAM polymers 138 and 139 (Table 3-2). 
Polymers 138 and 139 were used for the preparation of PNIPAM-peptide conjugates. Future 
work should look at optimisation of the star polymerisation to reduce the star-star coupling 
events and produce more well-defined 4-arm PNIPAM. 
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3.3.3 Synthesis of bifunctional PNIPAM 
3.3.3.1 Synthesis of bifunctional RAFT agent 
There are various methods for the preparation of multifunctional RAFT agents.224-226 One 
pathway is to attach monofunctional RAFT agents to a linker. Gao et al. prepared the 
bifunctional macro-RAFT 143 through esterification of a carboxylic acid containing RAFT 
agent 140 with PEG diol 142 as shown in Scheme 3-12.224 
 
Scheme 3-12 Preparation of bifunctional macro-RAFT agent reported by Gao et al. 
For the research described in this thesis, bifunctional RAFT agent 146 was prepared by 
reacting an N-hydroxysuccinimide ester modified RAFT agent 144 with bisamine 145 as 
shown in Scheme 3-13. The reaction conditions were based on a report by Oyeneye et al.227 
 
Scheme 3-13 Synthesis of bifunctional RAFT agent 146 227 
The final product 146 was obtained in a relatively good yield of 67% and purity was confirmed 
by NMR and FT-IR. In LC-MS, the [M]+ ion was detected at m/z 730.9 (60%) and fragment [M-
C7H7N2S2]+ at m/z 547.4 (100%). 
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Figure 3-6 1H NMR spectrum of bifunctional RAFT agent 146 (CDCl3, 300 MHz). 
The 1H-NMR spectrum demonstrated the successful incorporation of RAFT agent 144 onto 
the two amino ends of the bisamine 145 (Figure 3-6). The symmetry of the bisamine 145 
remained after the reaction, which accounted for three methylene hydrogen atoms H-h (t, J = 
5.27 Hz), H-I (t, J = 5.27 Hz), H-k(s) integrating to 4H each at 3.38, 3.49 and 3.55 ppm 
respectively. Methyl protons (H-d) appeared as a strong singlet integrating to 7.89H at 3.61 
ppm, while methyl hydrogens (H-c) adjacent to nitrogen atoms in carbamothioylthiol groups 
showed up as a singlet integrating to 5.12H in a more deshielded region due to the electron 
withdrawing effect of the carbamothioylthiol groups. The signal for H-f was observed as a 
doublet of doublet (J = 6.36, 9.36 Hz) integrating to 3.25H at around 2.48 ppm. Two multiplets 
integrating to 2H each at around 2.2 and 2.5 ppm were responsible for H-e because they are 
diastereotopic, causing different magnetic environments for each proton. Aromatic-bonded 
hydrogen atoms (H-a, H-b) were observed as two doublet of doublet (J = 1.6, 4.5 Hz) 
integrating to 4H at 8.70 and 7.18 ppm respectively. 
3.3.3.2 Bifunctional PNIPAM 
The synthesis of bifunctional PNIPAM is presented in Scheme 3-14 as below. 
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Scheme 3-14 The synthesis of bifunctional PNIPAM 147. 
RAFT agent 146 containing dithiocarbamate functional group which belongs to switchable 
RAFT agent group.176,228 Switchable RAFT agent allows the polymerisation of both MAMs and 
LAMs. Dithiocarbamates that contains electron-withdrawing groups adjacent to nitrogen or 
where the nitrogen lone pair is part of an aromatic ring system are effective with MAMs but 
inhibit polymerizations of LAMs. The reactivity of these “switchable” RAFT agents is modulated 
by using appropriate acid or base to switch between the activated pyridinium form, suitable for 
control of the polymerization of MAMs, and the deactivated pyridine form, suitable for the 
polymerization of LAMs (Scheme 3-15).176 
 
Scheme 3-15 Switchable RAFT agents. Reproduced from reference 176 
Polymerisation of NIPAM 2 with bifunctional CTA 146 was performed in THF at 70 °C in the 
presence of p-toluenesulfonic acid (TsOH) with [TsOH]/[RAFT group] of 1:1 following 
conditions reported by Stace et al.228  
Polymer characterisations are listed in Table 3-3. 
Sample [NIPAM]/[CTA]/[ACVA]/[TsOH] t (h) 
Mn(GPC)
a 
(Da) 
Mn(th)
b 
(Da) 
Mn(NMR)
c
 (Da) 
Ðb Conversionc 
142 75 : 1 : 0.1 : 2.0 2 5,031 4,040 2,428 1.19 40 
Table 3-3 2-arm PNIPAM characterisation, a By GPC, b Determined using equation: Mn(th) = 
MNIPAM x conversion x [NIPMA]o/[CTA]o + MCTA,165 c Determined by 1H NMR using equation 3-
1; d Determined by 1H NMR spectroscopy. 
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Figure 3-7 1H NMR spectrum of 2-arm PNIPAM 147 (400 MHz, CDCl3). 
The 1H NMR spectrum of 2-arm PNIPAM 147 (Figure 3-7) shows characteristic peaks at 1.14 
ppm and 4.0 ppm originating from methyl protons H-o and methyline protons H-m NIPAM 
monomer units. Aromatic hydrogen atoms (H-b and H-a) belonging to RAFT end groups were 
observed at 7.22 and 8.75 ppm.  
Mn(NMR) of polymer 147  was calculated based on equation below, where I4.01 ppm  is the integral 
of peak responsible for H-m at 4.01 ppm, and I3.44 ppm  is the integral of peak responsible for H-
h at 3.44 ppm. MNIPAM = 113.18 g.mol-1, MCTA 146 = 741 g.mol-1. 
𝑀𝑛(𝑁𝑀𝑅) =  
𝐼4.01 𝑝𝑝𝑚
𝐼3.44 𝑝𝑝𝑚
4⁄
 ×  𝑀𝑁𝐼𝑃𝐴𝑀 +  𝑀𝐶𝑇𝐴 𝟏𝟒𝟔     Equation 3-4 
The GPC trace of 2-arm PNIPAM 147 is depicted in Figure 3-8 and shows a unimodal peak 
with narrow MM distribution albeit with a tail presumably representing small MM by-
products.168  
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Figure 3-8 GPC trace of 2-arm PNIPAM 147 
This also explained the fact that Mn(GPC) and Mn(th) values were relatively close but both were  
higher than Mn(NMR) value. These small MM species could be the monofunctional RAFT 
polymers as displayed below: 
 
Figure 3-9 Monofunctional PNIPAM by-products 
3.4 Synthesis of PNIPAM-self assembling peptide conjugates  
3.4.1 First synthetic approach  
In the first approach, the conjugation ma-FEFEFKFK 131 to 3-arm star PNIPAM was 
performed via a two-pot method, in which aminolysis of the trithiocarbonate groups was carried 
out separately to yield thiol-terminated PNIPAM. The purified thiol polymer was subsequently 
reacted with ma-FEFEFKFK 131 via either Michael thiol-ene reaction or radical-initiated thiol-
ene reaction as shown in Scheme 3-16. The results for the synthesis of peptide 131 and star 
PNIPAM-FEFEFKFK conjugates will be discussed in the subsequent sections. 
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Scheme 3-16 Synthetic route for 3-arm PNIPAM-FEFEFKFK 150 via two-pot method of 
aminolysis and thiol-ene reaction with ma-FEFEFKFK 131 via (i) Michael addition or (ii) 
radical-mediated thiol-ene reaction. 
3.4.1.1 Synthesis of peptide ma-FEFEFKFK  
The Fmoc/tBu method used for the synthesis of ma-FEFEFKFK peptide 131 is shown in 
Scheme 3-17. Methacrylamide functional group was added to the N terminal via coupling of 
methacrylic acid to the peptidyl resin following the same condition for other amino acid 
couplings. The final peptide was precipitated from cold diethyl ether several times and dried 
under vacuum. The crude peptide was re-dissolved in water for lyophilisation. 1H NMR, HSQC, 
13C NMR and FT-IR spectra were obtained to confirm the structure of the peptide. 
 
Scheme 3-17 Fmoc/tBu solid phase peptide synthesis of ma-FEFEFKFK 131. Reaction 
conditions: (i) Fmoc-Lys(Boc)-OH, DIC, DMAP, DMF (ii) a) 20% piperidine, DMF b) Fmoc-
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Phe-OH, TBTU, DIPEA, DMF (iii) 20% piperidine, DMF b) Fmoc-Lys(Boc)-OH, TBTU, 
DIPEA, DMF (iv) a) 20% piperidine, DMF b) Fmoc-Phe-OH, TBTU, DIPEA, DMF (v) a) 20% 
piperidine, DMF b) Fmoc-Glu(OtBu)-OH, TBTU, DIPEA, DMF (vi) a) 20% piperidine, DMF b) 
Fmoc-Phe-OH, TBTU, DIPEA, DMF (vii) a) 20% piperidine, DMF (b) Fmoc-Glu(OtBu)-OH, 
TBTU, DIPEA, DMF (viii) (a) 20% piperidine, DMF (b) Fmoc-Phe-OH, TBTU, DIPEA, DMF 
(ix) (a) 20% piperidine, DMF (b) methacrylic acid, TBTU, DIPEA, DMF (x) 95% TFA, 2.5% 
TIS, 2.5% H2O 
468 mg of peptide 131 was collected from 500 mg Wang resin (71.6%) based on theoretical 
yield as displayed in the equation 3-5, where the loading of Wang resin is 1.1 mmol.g-1. Mpeptide 
131 = 1189.38 g.mol-1 
𝑇ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙 𝑦𝑖𝑒𝑙𝑑 = 𝑅𝑒𝑠𝑖𝑛 𝑙𝑜𝑎𝑑𝑖𝑛𝑔 (𝑚𝑚𝑜𝑙. 𝑔−1) × 𝑚𝑟𝑒𝑠𝑖𝑛(𝑔)  × 𝑀𝑝𝑒𝑝𝑡𝑖𝑑𝑒 (𝑔. 𝑚𝑜𝑙
−1)    
%𝑦𝑖𝑒𝑙𝑑 =  
𝑚𝑐𝑟𝑢𝑑𝑒 𝑝𝑒𝑝𝑡𝑖𝑑𝑒
𝑇ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙 𝑦𝑖𝑒𝑙𝑑
      Equation 3-5 
LC-MS of the crude product showed [M+2H]2+ ion peaks at m/z 595.6, indicating the presence 
of the desired peptide (Appendix A48). In the 1H NMR spectrum, characteristic signals for vinyl 
protons (H-n1, H-n2) with integrals of 0.88 each showed at 5.3 and 5.6 ppm. α–CH protons 
(H-f) of phenylalanine residues were observed at 4.52 ppm integrating to 3.88 protons. α–CH 
protons (H-a2, H-h) of the glutamic acid residues and the internal lysine residue overlapped 
with each other at 4.22 ppm integrating to 3 protons (Figure 3-10). The peak at 4.05 ppm 
originated from the α–CH proton of the terminal lysine.229 The highest peak, integrating to 20 
protons, at 7.24 ppm was assigned to the aromatic protons (H-p).  
FT-IR showed characteristic absorption bands at 3057 cm-1 for =C-H stretch, 1649 cm-1 for 
C=O stretch (Appendix A47). 
The peptide 131 was used as it was without further purification. 
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Figure 3-10 1H NMR spectrum of ma-FEFEFKFK 131 (400 MHz, DMSO-d6). 
3.4.1.2 Synthesis of 3-arm PNIPAM-FEFEFKFK 
Post-polymerisation modification of star R-RAFT polymers has not been reported before. In 
this thesis, the conjugation of peptide ma-FEFEFKFK 131 to 3-arm PNIPAM polymer 134 was 
first performed using two-pot methods following the conditions optimised for production of the 
3-arm PHPMA-a-LPETGG conjugate 114 (section 2.6.2, page 81) through Michael thiol-ene 
reaction or radical-mediated thiol-ene reaction.  
In the first step, the terminal trithiocarbonate groups were aminolysed. In this, the polymer 
solution turned from light yellow to white. Thiol-terminated 3-arm PNIPAM 148 was collected 
by precipitation in cold ether and it was subsequently reacted with peptide 131 via the Michael 
addition or radical-mediated thiol-ene reaction as shown in Scheme 3-18. UV-Vis 
spectroscopy confirmed the consumption of trithiocarbonate end groups by the disappearance 
of the absorption band at 309 nm. DMSO was used as a solvent for both reactions because 
the complete solubility of self-assembling peptide 131 could only be achieved in this solvent. 
TCEP.HCl was used in the thiol-ene reaction to limit disulfide formation. For purification, the 
reaction mixture was diluted 5 times in water before dialysing in a 3,500 MWCO membrane 
against water for a week. The final polymer was lyophilised to yield a white powder. 
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Michael thiol-ene addition of ma-FEFEFKFK 131 to thiol-terminated PNIPAM 149 is presented 
in Scheme 3-18. 
 
Scheme 3-18 Two-pot method of aminolysis and Michael thiol-ene reaction for the synthesis 
of 3-arm PNIPAM-FEFEFEKFK 150 
The conditions for the Michael thiol reaction are listed in the table below: 
Entry Method [SH]/[peptide]/[TCEP.HCl]/[ACVA] t (h) Coupling efficiencya 
1 Michael thiol-ene  1 : 10 : 10 : n/a 24 0% 
Table 3-4:  Michael thiol-ene addition of 3-arm PNIPAM-SH 149 and ma-FEFEFKFK 131. a 
Determined by 1H NMR spectroscopy using equation 3-5. 
1H NMR spectra of the purified polymers obtained from the two methods showed no presence 
of vinyl hydrogen atoms belonging to starting self-assembling peptide 131, indicating that 
unreacted peptide was completely removed by dialysis (Figure 3-11). 
The Michael thiol-ene reaction was not successful according to 1H NMR (Figure 3-11 B). There 
was no presence of any α-CHs from the peptide in the region from 4.15 – 4.56 ppm or aromatic 
hydrogens at around 7.2 ppm. The failure of the reaction can be rationalised by the fact that 
methacrylamide group is not very reactive in thiol-ene reaction due to the less electron 
deficient nature of C=C bonds in the methacrylamide derivative.194,195  
For the radical thiol-ene pathway, thiol-terminated PNIPAM was dissolved in DMSO with 
peptide 131 and AIBN initiator in the presence of reducing agent TCEP.HCl. The solution was 
heated at 60 °C for 3 h (Scheme 3-19).  
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Scheme 3-19 Two-pot method of aminolysis and radical thiol-ene reaction for the synthesis 
of 3-arm PNIPAM-FEFEFEKFK 150 
Reaction conditions are listed in Table 3-5. 
Entry Method [SH]/[peptide]/[TCEP.HCl]/[ACVA] t (h) Coupling efficiencya 
1 Radical-initiated thiol-ene 1 : 10 : 10 : 1 3 300% 
Table 3-5 Radical thiol-ene addition of 3-arm PNIPAM-SH 149 and ma-FEFEFKFK 131. a 
Determined by 1H NMR spectroscopy using equation 3-5. 
In the 1H NMR spectrum of radical thiol-ene addition product, α-CH protons from peptide 
sequence were observed in the region from 4.15-4.55 ppm along with a broad peak 
corresponded for thioether protons at 2.63 ppm for (-S-CH2-CH2-C=O), which demonstrated 
the successful incorporation of peptide to the polymer (Figure 3-11C). The coupling efficiency 
of peptide to polymer was calculated based on 1H NMR spectroscopy of the conjugate 150 
(Figure 3-11C) using the equation derived below, where I4.0 ppm is the integral of peak at 4.0 
ppm derived from the methine protons of the isopropyl groups, I4.5 ppm is the integral of peak at 
4.5 ppm derived from the α-CH protons of the phenylalanyl unit on the conjugated peptide, 
and n is the number of monomer units in the polymer. 
% 𝑐𝑜𝑢𝑝𝑙𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑒𝑝𝑡𝑖𝑑𝑒𝑠
3×𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 3-𝑎𝑟𝑚 𝑠𝑡𝑎𝑟 𝑝𝑜𝑙𝑦𝑚𝑒𝑟𝑠
× 100  
% 𝑐𝑜𝑢𝑝𝑙𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 =
𝐼4.5 𝑝𝑝𝑚
4
3 ×
𝐼4.0 𝑝𝑝𝑚
𝑛
× 100   
% 𝑐𝑜𝑢𝑝𝑙𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 =
𝑛
12
×
𝐼4.5 𝑝𝑝𝑚
𝐼4.0 𝑝𝑝𝑚
× 100                             Equation 3-6 
The calculated coupling efficiency was 300%, which suggested that multiple peptide units 131 
had been added to the star PNIPAM-SH 149. A similar result was observed previously for the 
synthesis of the linear PHPMA-GGKE conjugate 111 via radical-initiated thiol-ene addition. 
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Homopropagation was thought to be the reason behind the addition of oligopeptides to the 
polymer arms (, page 80). 
 
Figure 3-11 1H NMR spectra of (A) ma-FEFEFFKFK 131, (B) PNIPAM-peptide conjugate via 
Michael addition pathway, (C) PNIPAM-peptide conjugate via radically initiated thiol-ene 
click reaction, (D) 3-arm PNIPAM polymer 134. 
Multiple addition of the peptide to the polymer arms would potentially result in different self-
assembling patterns when being doped into a peptide hydrogel matrix in comparison to the 
conjugate with a single peptide attached to each arm. Therefore, an alternative conjugation 
method was investigated to produce well-defined star PNIPAM-FEFEFKFKK conjugates as 
will be described in the next section. 
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3.4.2 Second synthetic approach 
In this second approach, thiol-vinyl sulfone was chosen as the polymer end groups for the 
preparation of star PNIPAM/self-assembly peptide conjugates. Previous studies by Grover et 
al.217, Bae et al.230, and Vanparijs et al.231 have reported using one-pot an aminolysis/thiol-ene 
click reaction for the preparation of vinyl sulfone modified polymers. In this current work, a 
two-pot synthesis was employed to prevent possible side reactions resulting from aminolysed 
thiol by-product as discussed earlier in previous chapter (Scheme 2-21, page 84). Star 
PNIPAM 134 (Mn(GPC) = 43,165 Da, Ð = 1.09) was firstly aminolysed with n-butylamine for 3 h 
and purified by precipitation before reacting with excess divinyl sulfone to obtain vinyl sulfone 
functionalised polymers 151.216,217,231 Vinylsulfone terminated PNIPAM 151 was purified by 
dialysis against water for 2 days and subsequently reacted with thiol containing peptide 
CFEFEFKFKK 132 (Scheme 3-21).  
 
Scheme 3-20 Synthesis of 3-arm PNIPAM-CFEFEFKFK conjugate  
The thiol group on cysteine is widely used as a target for polymer/biomolecule conjugation.232 
Hence, a cysteine was added to the N-terminus of the self-assembly peptide to provide thiols 
for the coupling reaction (Scheme 3-21). 
 
Scheme 3-21 Structure of CFEFEFKFKK 132 
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3.4.2.1 Synthesis of thiol containing peptide CFEFEFKFKK  
Self-assembling peptide CFEFEFKFKK 132 was prepared on Wang resin using the Fmoc/tBu 
solid phase method (Scheme 3-22).  
 
Scheme 3-22 Fmoc/tBu solid phase peptide synthesis of CFEFEFKFKK 132. Reaction 
conditions: (i) Fmoc-Lys(Boc)-OH, DIC, DMAP, DMF (ii) a) 20% piperidine, DMF b) Fmoc-
Lys(Boc)-OH, TBTU, DIPEA, DMF (iii) a) 20% piperidine b) Fmoc-Phe-OH, TBTU, DIPEA, 
DMF (iv) 20% piperidine, DMF b) Fmoc-Lys(Boc)-OH, TBTU, DIPEA, DMF (v) a) 20% 
piperidine, DMF b) Fmoc-Phe-OH, TBTU, DIPEA, DMF (vi) a) 20% piperidine, DMF b) 
Fmoc-Glu(OtBu)-OH, TBTU, DIPEA, DMF (vii) a) 20% piperidine b) Fmoc-Phe-OH, TBTU, 
DIPEA, DMF (viii) a) 20% piperidine, DMF (b) Fmoc-Glu(OtBu)-OH, TBTU, DIPEA, DMF (ix) 
(a) 20% piperidine (b) Fmoc-Phe-OH, TBTU, DIPEA, DMF (x) (a) 20% piperidine, DMF (b) 
Fmoc-Cys(Trt)-OH, TBTU, DIPEA, DMF (xi) 95% TFA, 2.5% TIS, 2.5% H2O. 
The crude peptide was re-dissolved in water and lyophilised under vacuum. MS of the crude 
product showed a [M+2H]2+ ion peak at m/z 677.2, indicating the presence of desired peptide 
(Appendix A52). MS chromatogram also showed peaks for impurities. Peaks at m/z 1249.8 
and 625.5 were responsible for [M+H]+ and [M+2H]2+ ions  derived from a cysteine missing 
peptide sequence FEFEFFKFKK. Other impurities were unable to identify. 
1H NMR, HSQC, 13C NMR and FT-IR were obtained to characterise the structure of the crude 
peptide. The 1H NMR spectrum is shown in Figure 3-12. Characteristic signals for aromatic 
protons (H-p) of phenylalanine residues were observed at 7.21 ppm integrating to 20 protons. 
129 
 
The peak at 4.55 ppm integrating to 3.94 protons originates from the α–CH protons of the 
phenylalanine residues. α–CH protons (H-a, H-h) of glutamic acid and lysine residues 
overlapped with each other at 4.22 ppm integrating to 3.79 protons.  The α–CH proton 
belonging to the N-terminal cysteine residue was observed at the lower chemical shift of 3.89 
ppm.  
The peptide 132 was used as it was for the next step synthesis without further purification.  
 
Figure 3-12 1H NMR spectrum of CFEFEFKFKK 132 (400 MHz, DMSO-d6). 
3.4.2.2 Vinyl sulfone-functionalised 3-arm PNIPAM 
The vinyl sulfone functionalisation of 3-arm PNIPAM 134 was carried out via the Michael 
addition to divinyl sulfone as shown in Scheme 3-23.  
 
Scheme 3-23 Modification of 3-arm PNIPAM-SH 149 with divinyl sulfone 
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The reactions were carried out at room temperature using different base catalysts in DMF for 
24 h. The final products were purified by dialysis against water for 2 days and were later 
lyophilised to yield dry polymers. The results are listed in Table 3-6. 
Entry Catalyst [SH]/[TCEP.HCl]/[DVS]/[Catalyst] Mn(GPC) (kDa) Ð Coupling efficiency 
1 TEA 1 : 10 : 100 : 20 - - 0% 
2 hexylamine 1 : 10 :100 : 20 - - 0% 
3 NaOH 1 : 10 : 100 : 20 40.2 1.18 80% 
Table 3-6 Synthesis of 3 arm PNIPAM-VS. Mn(GPC) of starting 3-arm PNIPAM 134 was 43,165 
Da, Ð 1.09 (entry 2, Table 2-2) 
The first attempt was performed under similar conditions as reported elsewhere in which TEA 
was used as a base catalyst.104,217,231 Li et al. reported a similar system in which they 
functionalised linear RAFT PNIPAM 59 with maleimide via base catalysed Michael thiol-ene 
addition as shown in Scheme 3-23.104 They achieved 80% maleimide terminal 
functionalisation. 
 
Scheme 3-24 Synthetic route to linear PNIPAM-BSA, by Li et al., conjugation via RAFT 
polymerisation, end group modification, and grafting-to via thiol-maleimide Michael addition. 
Adapted from reference 104 
Using TEA as a base catalyst, the vinyl sulfone functionalisation to 3-arm PNIPAM 134 was 
not successful according to 1H NMR spectroscopy (Figure 3-14A). As demonstrated 
elsewhere, factors governing the rate of base-catalysed Michael thiol-ene addition are  (i) the 
basicity of the catalyst, (ii) the acidity of the thiol, (iii) the steric accessibility of the thiols and 
(iv) the electrophilicity of the vinyl group.187 Maleimide and vinyl sulfone are the most efficient 
thiol-reactive groups,187 thus a problem relating to inefficient thiol reactivity can be ruled out. 
For the star system, it is possible that the thiol termini were hindered by surrounding polymer 
arms, limiting its accessibility from divinyl sulfone. 
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Scheme 3-25 Mechanism of base-catalysed and nucleophile-catalysed Michael thiol-ene 
reaction. EWG = electron withdrawing group. Reproduced from reference 187 
Chan et al. have shown that the rate of the Michael thiol-ene reaction is very much affected 
by the catalyst used in the reaction between hexanethiol and hexyl acrylate.193 In their study, 
the rate catalysed by hexylamine was three orders of magnitude higher than that catalysed by 
TEA. The high activity of alkylamine was simply due to its nucleophilic characteristic (Scheme 
3-25).193 Therefore, the second attempt in this work used hexylamine as a nucleophilic catalyst 
but the functionalisation was still unsuccessful.  
It was later attempted to boost the addition of divinyl sulfone to the thiol groups on the polymer 
arms was to efficiently deprotonate the –SH groups by using a stronger base catalyst.233,234 
For example, Mahou and Wandrey reported the conjugation of divinyl sulfone to different star 
PEG polymers 152, using sodium hydride as a base catalyst to abstract hydrogen from thiol 
groups.234 They achieved degrees of functionalisation of 91-98% based on 1H NMR. Yu and 
Chau performed as a similar modification of a linear PEG polymer with divinyl sulfone using 
0.1 M NaOH at 6% w/v as a base catalyst (Figure 3-13).233 Hydroxyl groups are less acidic 
than thiols (pKa of thiols < pKa of hydroxyl),235 and based on these literature precedents, it was 
proposed that, in this thesis project, the use of a strong base catalyst such as NaOH or sodium 
hydride in the Michael thiol ene reaction with divinyl sulfone could work for 3-arm PNIPAM-
SH.  
 
Figure 3-13 Vinyl sulfone functionalised PEG 
132 
 
Thus, in the third attempt, 0.1 M NaOH aqueous solution was added to a solution of 3-arm 
PNPAM-SH  following the conditions reported by Yu and Chau.233 The mixture was stirred for 
2 h then added slowly to divinyl sulfone solution in DMF. The reaction was allowed to stir for 
another 24 h at room temperature. The final product was purified by dialysis against water for 
2 days before lyophilisation to yield a white powder (95%). 
1H NMR and FT-IR confirmed the success of vinyl sulfone conjugation to the polymer chains 
(Figure 3-14B). The FT-IR spectrum showed a band at ~3080 cm-1 corresponding to =C-H 
stretching.   
 
Figure 3-14 1H NMR spectra of 3-arm PNIPAM-VS 151. 
Characteristic signals for vinyl protons (H-g, H-h) were observed at 6.35 and 6.80 ppm, 
indicating the conjugation of vinyl sulfone onto the polymer.217 Proton H-h1, in the trans 
position to H-g, exhibited larger coupling constant (J = 16.7 Hz) with H-g in comparison to H-
h2 (J = 9.95 Hz) in the cis position to H-g. The chemical shifts at 2.75 and 3.30 ppm originated 
from thioether protons H-e and H-f respectively.217 The coupling efficiency of vinyl sulfone 
conjugation was 80% based on 1H NMR using the equation below, where I6.7 ppm is the peak 
area of vinyl proton H-g. I3.76 ppm is the peak area of methine proton H-c of the isopropyl group. 
The number of monomer units (n) was determined by 1H NMR (Table 3-1). 
%coupling efficiency = 100 ×
numberof vinylsulfone
3×number of 3−arm PNIPAM
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%coupling efficiency = 100 ×  
𝐼6.71 𝑝𝑝𝑚
3×𝐼3.76 𝑝𝑝𝑚
𝑛⁄
          
 %𝑐𝑜𝑢𝑝𝑙𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 = 100 ×
𝑛 × 𝐼6.71 𝑝𝑝𝑚
3×𝐼3.76 𝑝𝑝𝑚
                Equation 3-7 
The GPC trace of the product 151 showed a similar MM distribution to the GPC trace of the 
starting polymer 134 (Figure 3-15). This implied that dimerised polymer by-products did not 
form. 
  
Figure 3-15 GPC traces of 3-arm PNIPAM 134 and 3-arm PNIPAM-VS 151 
The same conditions optimised above were later applied to a series of varying MW 3-arm and 
4-arm PNIPAM-VS. Sample details are displayed in Table 3-7. 
Sample System Starting polymer 
Mn(GPC) starting PNIPAM 
(kDa) 
Mn(GPC)  
(kDa) 
Mn(NMR) 
(kDa) 
Ð 
Coupling 
efficiency 
151 3 arm 134 43.1 40.2 36.7 1.12 77% 
153 3 arm 136 10.9 10.6 11.2 1.27 85% 
154 3 arm 137 8.5 8.9 8.5 1.18 94% 
155 4 arm 138 22.7 21.9 21.6 1.14 85% 
156 4 arm 139 14.8 13.8 12.9 1.08 80% 
157 2 arm 146 2.4 4.4 2.4 1.20 60% 
Table 3-7 Characterisation data of various star PNIPAM-VS samples. 
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3.4.2.3 Synthesis of 3-arm PNIPAM-VS-CFEFEFKFKK 
The subsequent step was the conjugation of self-assembly peptide onto PNIPAM-VS polymer 
as shown in Scheme 3-26.  
 
Scheme 3-26 Michael addition of HS-CFEFEFKFKK 132 to 3-arm PNIPAM-VS 151.  
The reaction was carried out in DMSO in the presence of TCEP.HCl to limit disulfide formation. 
A trace amount of n-butylamine served as a nucleophilic catalyst. The mechanism for 
nucleophile catalysed Michael thiol-ene was discussed earlier in (page 73). After 24 h, the 
reaction mixture was diluted 10 times in deionised water before dialysing against water in a 
3,500 MWCO membrane for 7 days. The complete removal of unreacted peptide was 
assessed by comparing the mass of starting PNIPAM-VS and the mass of final lyophilised 
product.  
As can be seen from Figure 3-16, 1H NMR spectrum of the conjugate 151 contained signals 
originating from α-CH protons of the peptide 132 in the region from 4.25 to 4.6 ppm. 
Additionally, the disappearance of vinyl protons around 6.5 and 7.0 ppm indicated that all the 
vinyl bonds had completely reacted with the peptide. Michael thiol-ene addition between thiol 
terminated PNIPAM to divinylsulfone did not work even though the conditions using 
hexylamine as a catalyst was similar to the conditions described in this section. It was thought 
that because pKa of the thiol group on cysteine, in the range from 8.0 to 9.0, is lower than 
aliphatic pKa of thiols on polymers, in the range from 10.0 to 11.0 that makes the formation of 
thiolate ions from the cysteine containing peptide faster and more favourable (Scheme 
3-25).187 Moreover, thiols on the smaller peptide molecules would have more mobility to take 
part in the reaction whereas thiol termini on the polymer might be hindered within polymer 
arms and their mobility is more restricted. 
The star PNIPAM/self-assembling peptide conjugates were only soluble in acidic solvent at 
pH 2.5 and the available GPC instrument ran in DMF. Due to the complex aggregation of the 
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star PNIPAM-peptide conjugates in DMF, Mn(GPC) was not obtained and Mn(NMR) was used for 
data analysis. 
                    
Figure 3-16 1H NMR spectra (400 MHz, DMSO) of CFEFEFKFK peptide 132, PNIPAM-VS 
polymer 151, and PNIPAM-CFEFEFKFK conjugate 158. 
The collection of PNIPAM-peptide conjugate samples prepared are listed in Table 3-8, below: 
Sample System Starting polymer PNIPAM-VS Mn(NMR) (Da) 
158 3 arm 134 151 46,431 
159 3 arm 136 153 15,193 
160 3 arm 137 154 13,609 
161 4 arm 138 155 26,172 
162 4 arm 139 156 17,884 
163 2 arm 146 157 4,439 
Table 3-8 Prepared star PNIPMA-CFEFEFKFKK conjugate samples.  
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
CFEFEFKFK
PNIPAM-VS
PNIPAM-CFEFEFKFK
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3.5 PNIPAM-composite hydrogels 
3.5.1 Sample preparation 
As discussed in section 3.1, page 104, Maslovskis et al. investigated a series of composite 
hydrogels containing linear PNIPAM-FEFEFKFK conjugates and FEFEFKFK peptide 35.3 The 
experiments in this study were designed following their conditions. 
For thermal behaviour testing, solutions of PNIPAM-peptide conjugates at a concentration of 
3.0 mg.mL-1 in water were prepared. The pH was adjusted to 4.0 by addition of 1 M NaOH as 
reported by Maslovskis et al.3 However, aggregation was observed at pH 4.0 for all star 
PNIPAM conjugates which is in contrast to the reported linear PNIPAM-FEFEFKFK 
conjugates which were soluble at pH 4.0 according to Maslovskis et al.3 Complete 
solubilisation of the star conjugates was achieved at the lower pH of 2.0. 
This was rationalised by the fact that peptide CFEFEFKFK 132 carries a different total net 
charge to peptide FEFEFKFK 35. It has been demonstrated previously that the carried charge 
of a peptide plays a vital role in the gelation and self-assembly of the family of this peptide.236 
The net charge Z of CFEFEFKFKK peptide 132 at a specific pH is depicted in Figure 3-17 
according to equation 3-8.236 Where Ni is the number of amine groups  present on the N-
terminus and lysine side chains, Nj  is the number of carboxylic acid groups present on the C-
terminus and glutamic acid side chains and pKai/j are the pKa values of the basic (i, amine 
groups) and acidic (j) groups present on the peptide. 
|𝒁| =  √(∑ 𝑵𝒊
𝟏𝟎𝒑𝑲𝒂𝒊
𝟏𝟎𝒑𝑯+ 𝟏𝟎𝒑𝑲𝒂𝒊
− ∑ 𝑵𝒋
𝟏𝟎𝒑𝑯
𝟏𝟎𝒑𝑯+ 𝟏𝟎
𝒑𝑲𝒂𝒋𝒋𝒊
)𝟐    Equation 3-8236 
According to the equation, FEFEFKFK peptide 35 carries charges of 1.5 and approx. 3.0 at 
pH 4.0 and 2.0 respectively,236 whereas peptide CFEFEFKFKK 132 carries charges of 1.0 and 
2.8 at the same pH values (Figure 3-17). The lower net charge of peptide CFEFEFKFKK 132 
at pH 4.0 would result in less electronic repulsion between peptide sequences while 
hydrophobic interactions between the peptide sequence and the polymer cores would become 
more predominant.236 This is thought to have consequently led to aggregation of the 
conjugates in water. 
137 
 
 
Figure 3-17: Theoretical charge |Z| of conjugated CFEFEFKFKK peptide 132. (Plotted in 
Matlab) 
Solution of CFEFEFKFKK peptide at concentration of 10 mg.mL-1 at pH 4.0 formed translucid 
hydrogels. Mixtures of PNIPAM-CFEFEFKFKK conjugates (3 mg.mL-1) and CFEFEFKFKK 
132 (10 mg.mL-1) were also found to form translucid hydrogels at pH 4.0  despite the 
insolubility of the conjugates at pH 4.0 (Figure 3-18). This could be rationalised that self-
assembly of unmodified CFEFEFKFKK 132 and the conjugated peptide facilitated the 
solubility of the PNIPAM conjugates. Sample names are listed in Table 3-9. These conditions 
were chosen because the critical gelation concentration (CGC) of FEFEFKFK peptide at pH 
4.0 is in the range of 10 mg.mL-1 to 20 mg.mL-1.3,236 
Sample Hydrogels Mn of conjugate (Da) 
CFEFEFKFKK/Conjugate 158 S1-3arm-46k 46,431 
CFEFEFKFKK/Conjugate 159 S2-3arm-15k 15,193 
 CFEFEFKFKK/Conjugate 160 S3-3arm-13k 13,609 
CFEFEFKFKK/Conjugate 161 S4-4arm-26k 26,172 
CFEFEFKFKK/Conjugate 162 S5-4arm-17k 17,884 
CFEFEFKFKK/Conjugate 163 S6-2arm-4k 4,439 
Table 3-9 Composite hydrogels of CEFEFKFKK 132 (10 mg.mL-1) and polymer conjugate (3 
mg.mL-1) mixtures at pH 4.0. 
3.5.2 Thermal behaviour  
Thermal analysis of aqueous star PNIPAM-peptide conjugate solutions and PNIPAM-peptide 
conjugate/CFEFEFKFKK composite gels was performed to investigate the effect of peptide 
self-assembly on the phase separation of the PNIPAM conjugate, the reversibility of the phase 
transition, and possible melting and re-gelation of the hydrogels in response to temperature. 
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Firstly, macroscopic phase behaviours were recorded visually in a controlled water bath at 5 
°C intervals during a heating/cooling cycle from 25 to 45 °C with 5 min equilibration time at 
each interval. This temperature range was chosen because the cloud point of PNIPAM was 
reported to be in this region. 43, 147,220 Secondly, the thermal behaviour of the hydrogels was 
monitored using micro DSC to quantify the Tc and examine the reversibility of the phase 
transition during cycles of heating and cooling in the range of 20 – 80 °C.3 
3.5.3 Phase transition by visual observation 
Macroscopic phase separation of samples below and above the cloud point are represented 
in Figure 3-18. For both conjugate aqueous solutions and the composite gels, the samples’ 
appearance turned from transparent at 25 °C to opaque at around 36 °C for all samples most 
likely due to the collapse of the polymer chains.43 
 
Figure 3-18 Phase behaviour of PNIPAM-conjugate solutions (top) and composite gels 
(bottom). Samples are numbered according to Table 3-9. 
3.5.3.1 Micro DSC 
The phase transition of the conjugate aqueous solutions and the composite gels were also 
monitored and quantified using micro DSC. Due to limited time, thermal analysis was only 
performed on hydrogels S1-3arm-46k and S4-4arm-26k, and the conjugate solution of 158. 
Thermal transitions of conjugate 158 (Mn(NMR) = 46.4 kDa) solution and 3-arm PNIPAM-VS 151 
solution (Mn(GPC) = 40.3 kDa, Ð 1.12) are depicted in Figure 3-19. Upon heating, a sharp 
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exothermic transition was observed at ~30 °C for pure star PNIPAM-VS 151 solution. 
Interestingly, a broader exothermic transition was observed at the higher temperature of ~35 
°C for conjugate 158. 
The literature value for Tc of linear PNIPAM is 32 °C.147,220 It was reported that the Tc of 
PNIPAM was not dependent on concentration, however, it may change if there is a shift in 
hydrophobic/hydrophilic balance.144,218,237,238 Previous studies concluded that increased 
hydrophobic interactions result from the presence of hydrophobic end groups and these 
groups suppress the Tc whereas hydrophilic end groups increase Tc.152,238 For the star 
PNIPAM-VS polymer 151, the polymer chains are tethered to a hydrophobic core, increasing 
the polymer-polymer interactions but decreasing the solvation of the molecule. In 
thermodynamic terms, water binding to hydrophobic regions is entropically unfavourable, thus 
less hydrated polymers provide a more negative entropy term T∆Smix and therefore more 
positive free energy ∆Gmix = ∆Hmix - T∆Smix. In order to make the dissolution process 
spontaneous, lowered temperature is required. For the PNIPAM-peptide conjugates, the 
presence of peptide chains provide more hydrogen donor (-NH) and acceptor (-C=O) groups, 
creating more hydrogen bonds with water molecules making the enthalpy (∆Hmix) more 
negative upon mixing.  Therefore, to manifest the desolvation process, higher temperature is 
required for the overall entropy term to counteract the negative value of ∆Hmix. In addition, the 
charged peptides can interfere with the collapsing of polymer arms through repulsion as these 
peptides brought closer to each other, hence increasing the Tc.219,239 Figure 3-19 also shows 
the reversibility of phase separations upon cooling for both samples.  
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Figure 3-19: microDSC graphs of conjugate 158 solution (3 mg.mL-1) and 3 arm PNIPAM-VS 
151 solution (10 mg.mL-1) 
Macroscopic phase transitions of CFEFEFKFKK peptide-based hydrogel and two composite 
gels S1-3arm-46k and S4-4arm-26k are depicted in Figure 3-20. Unmodified peptide hydrogel 
did not show any transitions in the region from 30 to 45 °C while composite gels S1-3arm-46k 
and S4-4arm-26k showed phase separations at 35 °C and 37 °C respectively. It also 
suggested that the influence of peptide chains on the polymer ends in four arm PNIPAM-
conjugate became more pronounced in the Tc in comparison to that of 3-arm conjugate. The 
Tc of these composite hydrogels were very close to physiological temperature. This suggested 
that these hydrogels have a great potential for applications in human body. 
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Figure 3-20 MicroDSC analysis of CFEFEFKFKK peptide gel and composite gels S1-3arm-
46k and S4-4arm-26k. 
3.5.4 Mechanical properties of peptide hydrogels 
The viscoelasticity of peptide hydrogels doped with star PNIPAM-peptide conjugates were 
measured by oscillatory rheometer. Pure CFEFEFKFKK peptide hydrogel (10 mg.mL-1) was 
also measured for comparison. Firstly, strain amplitude sweeps were performed to determine 
the linear viscoelastic region (LVER) of all samples. Secondly, frequency sweeps were carried 
out at constant strain within the LVER to examine the storage modulus G’ and loss modulus 
G’’ of each sample. Lastly, the effect of temperature on the mechanical performance of 
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hydrogels was also studied by running temperature sweeps from 20 to 80 °C at constant strain 
within the LVER.3 
3.5.4.1 Linear viscoelastic region 
It is vital that rheological measurements are made within the materials’ linear viscoelastic 
regions.240 In the LVER, applied stress is insufficient to cause structural breakdown (yielding) 
of the structure and hence microstructural measurements are being measured.241 In this 
experiment, an amplitude sweep was performed at a constant frequency of 1 Hz and at strain 
varying from 0 to 100%. The dependence of the complex moduli G’ and G’’ on strain amplitude 
is depicted in Figure 3-21.  
 
Figure 3-21 Amplitude sweeps of peptide-based hydrogels 
For all samples except for S1-3arm-46k (black lines) and S5-4arm-17k (orange lines), the 
LVER ended at 30% strain. Yield strain of samples S1 and S5 shifted to a lower value at 
around 6% strain. This suggested that S1-3arm-46k and S5-4arm-17k gel networks were more 
brittle compared to the unmodified peptide hydrogel presumably due to the formation of thicker 
fibres. Moreover, only gel samples S1-3arm-46k, S4-4arm-26k, S5-4arm-17k, and S6-2arm-
4k displayed higher storage moduli G’ compared to pure peptide hydrogels. This suggested 
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that these samples were more elastic than the pure peptide hydrogel. More information on the 
mechanical properties of these hydrogels will be provided in the frequency sweeps study in 
the next section. 
3.5.4.2 Frequency sweeps 
Frequency sweeps (ω = 0.1 to 10 Hz) were performed at a constant strain amplitude of 0.2% 
(well within the LVER for all gels as determined above) at 20 °C.3  
Figure 3-22, Figure 3-24, and Figure 3-24 show the storage moduli, G’, and loss moduli, G’’, 
obtained for all composite hydrogels and pure peptide hydrogels as a function of frequency. 
Overall, the storage moduli G’ of all samples were stable over the tested range. Moreover, the 
storage moduli, G’ values, were about ten times higher than the loss moduli, G’’ values. This 
suggests that all samples behaved like soft solid-like materials, in other words, gels.3 It was 
speculated that the presence of star PNIPAM-peptide conjugates in the peptide fibrillar 
network would provide cross-links between peptide fibres through the self-assembly of the 
conjugated peptides as illustrated in Scheme 3-3 and Scheme 3-4, and consequently improve 
the viscoelasticity of the resulting gels.  
 
Figure 3-22 Shear moduli G’ & G’’ obtained for CFEFEFKFKK peptide hydrogel and 
composite gels S1-3arm-46k (peptide 132 10 mg.mol-1, conjugate 158 3 mg.mol-1), S2-
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3arm-15k (peptide 132 10 mg.mol-1, conjugate 159 3 mg.mol-1), and S3-3arm-13k (peptide 
132 10 mg.mol-1, conjugate 160 3 mg.mol-1) containing 3-arm PNIPAM-peptide conjugate. 
For 3-arm the PNIPAM conjugates, gel S1-3arm-46k exhibited a higher G’ storage modulus 
(445 Pa at 1 Hz) compared to the pure peptide hydrogel (282 Pa at 1 Hz), indicating S1-3arm-
46k was a stronger gel (Figure 3-22). In contrast, gels S2-3arm-15k and S3-3arm-13k, 
containing lower MM conjugates 159 and 160 showed slightly weaker elasticity (lower storage 
modulus G’) compared to the pure peptide hydrogel. Because the amount of the polymer 
conjugates for each hydrogel sample was the same 3 mg.mL-1, the higher the MM of the 
conjugate, the lower the moles of polymer conjugate and the lower the cross-linking points 
through conjugated peptides (Table 3-10).   
Hydrogels Mole of cross-linking points (mmol) 
S1-3arm-46k 0.175 
S2-3arm-15k 0.557 
S3-3arm-13k 0.573 
S4-4arm-26k 0.350 
S5-4arm-17k 0.552 
S6-2arm-4k 0.912 
Table 3-10 Moles of cross-linking points in each hydrogel sample. 
According to Maslovskis et al., the doping of a linear PNIPAM-FEFEFKFK conjugate at various 
concentrations into FEFEFKFK 35 peptide hydrogels all resulted in an improvement in 
elasticity (higher G’ storage modulus).3 Their experimental analysis suggested that the linear 
PNIPAM chains incorporated into the peptide network by covering around the peptide fibres 
and this resulted in their stiffening, and hence higher elasticity of the gel. Based on this, for 
gel S1-3arm-46k, the strengthening in elasticity of the hydrogel after doping with the conjugate 
indicated strong interactions between the polymer chains and peptide fibres. This correlated 
well with data from the amplitude sweep implying that gel S1-3arm-46k consisted of thicker 
fibres compared to pure peptide hydrogels.   
However, it was not expected there was a decrease in shear moduli (G’ and G’’) of S2-3arm-
15k and S3-3arm-13k because these hydrogels contained higher moles of polymer conjugate 
as well as higher number of cross-linking points. It could be explained that conjugate 159 and 
160 did not seem to incorporate with peptide fibres for some reason and possibly diluted the 
hydrogel network rather than participating in the self-assembly.3  This matter requires further 
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investigation which can be done by using imaging techniques such as AFM and TEM to 
examine the morphology of the fibres.   
For the 4-arm conjugate systems, gel S5-4arm-17k containing lower MM polymer conjugate 
162 exhibited a higher storage modulus G’ while a minor decrease in storage modulus was 
obtained for gel S4-3arm-26k. Again, previous amplitude sweep data showed that the S5-
4arm-17k network appeared to be more brittle compared to the unmodified peptide hydrogel 
suggesting the peptide fibres became stiffer due to the incorporation of polymer chains. 
Further investigations are required to get an insight into this matter. 
 
Figure 3-23 Shear moduli G’ & G’’ obtained for CFEFEFKFKK peptide hydrogel (10 mg.mol-
1) and composite gels S4-4arm-26k (peptide 132 10 mg.mol-1, conjugate 161 3 mg.mol-1) 
and S5-4arm-17k (peptide 132 10 mg.mol-1, conjugate 162 3 mg.mol-1) containing 4-arm 
PNIPAM-peptide conjugate as a function of frequency. 
Composite gel S6-2arm-4k containing bifunctional PNIPAM conjugate exhibited enhanced 
mechanical properties compared to the unmodified peptide hydrogel. This results agrees well 
with the findings from amplitude sweep test discussed above. Increase in G’ modulus of the 
hydrogels could be resulted from the participation of conjugated peptide 163 in the self-
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assembly of the unmodified peptide 132 as well as the association of PNIPAM chains with the 
peptide fibres through hydrogen bonding interactions.3 
 
Figure 3-24 Shear moduli G’ and G’’ obtained for bifunctional PNIPAM-peptide 
conjugate/peptide hydrogel S6-2arm-4k (peptide 132 10 mg.mol-1, conjugate 163 3 mg.mol-
1) and free CFEFEFKFKK peptide hydrogel as a function of frequency. 
3.5.4.3 Temperature sweeps 
In order to investigate whether the phase transition of a PNIPAM conjugate is related to the 
mechanical properties of its composite gel, temperature sweeps in the range of 20 - 80 °C 
were performed, firstly on sample S1-3arm-46k at a constant strain amplitude (ɣ = 0.01, ω = 
1 rad-1).3 Figure 3-25 shows the trend of shear moduli across the temperature range.  
It can be seen from the graph (Figure 3-25) that dramatic increase in viscoelasticity was 
observed upon heating, indicating a stiffening of the gel. The storage modulus G’ gradually 
increased from 325 Pa at 20 °C and reached a plateau of 650 Pa at 75 °C and started to 
decrease at 80 °C. Moreover, there were obvious transitions in the storage modulus G’ at 35 
°C, 45°C and 70 °C where a sharp increase in G’ was observed. This finding is contrast to the 
experimental results reported by Maslovskis et al.3 for their linear PNIPAM-peptide conjugate 
and peptide composite gels. They found that the phase transition of PNIPAM polymer has 
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minimal effect on the rheological properties of composite gels.3 They concluded that in the 
case of linear PNIPAM-peptide conjugates, the strong interactions between the fibres and the 
linear polymer chains (leading to the collapse of PNIPAM polymer chains around the peptide 
fibres) at the phase transition did not significantly affect the mechanical properties of the fibres 
and hence the hydrogels.  
For the star system described in this study, upon increasing the temperature, the water is 
expelled and PNIPAM arms collapse which pulls the anchored peptide fibres towards the core 
of the polymer, leading to possible enhancement of fibril-fibril interactions and hence a denser 
network. The first transition at 35 °C where there was a sharp increase in G’ indicated the Tc 
was taking place. This Tc correlated well with the Tc previously determined for gel S5 by µDSC 
and by visual observation (section 3.5.3.1, page 138). A gradual increase in G’ after 35 °C 
represented a further shrinkage of PNIPAM polymer chains. The decrease in mechanical 
properties after 80 °C could be due to the aggregation of PNIPAM and possibly a slight 
macroscopic melting of the gel.  
                
Figure 3-25 Shear moduli of gel S1-3arm-46k (peptide 132 10 mg.mol-1, conjugate 158 3 
mg.mol-1) at a constant strain amplitude (ɣ = 0.01, ω = 1 rad -1) as a function of temperature. 
Transitions are pointed out by arrows. 
This study also investigated the recovery of the elasticity of two composite gels S1-3arm-46k 
and S5-4arm-17k after two heating/cooling cycles. The experiments were only performed on 
these samples because they exhibited stronger mechanical properties than unmodified 
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peptide hydrogel. Measurements were carried out in the temperature range of 20 to 45 °C with 
heating rate 1 °C/min. Both gel samples exhibited a dramatic increase in storage moduli G’ as 
shown in Figure 3-26.   
 
Figure 3-26 Shear moduli obtained for S1-3arm-46k (peptide 132 10 mg.mol-1, conjugate 158 
3 mg.mol-1) and S5-4arm-17k (peptide 132 10 mg.mol-1, conjugate 162 3 mg.mol-1) over two 
heating/cooling cycle from 20 to 45 °C. Transitions are pointed out by arrows. 
The drawback of NIPAM-based hydrogel system is the thermodynamic instability of the 
hydrogels according to Mikos et al.157 Syneresis is usually obseverd as the temperature 
increased above the cloud point temperature. However, in this study, insignificant syneresis 
was observed over time upon heating/cooling process. Low degree of syneresis is of high 
importance for in situ gelation for cells scaffolds or drug delivery applications.152 This again 
indicated that the physically-cross-linked thermo-responsive hydrogels can be a potential 
candidate for biomedical applications. 
Upon the 1st cooling cycle, G’ of S1-3arm-46k only showed a slight decrease in value after 
the 1st heating and did not return to the initial G’ value before heating. It can be postulated that 
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the polymer chain collapse during the phase transition process possibly caused some 
rearrangement of peptide fibres as discussed earlier; upon cooling, the re-swelling or 
rehydration process of the polymer chains may not take place fast enough and not necessarily 
lead to peptide fibres return to their initial position, hence the hydrogel elasticity could be 
expected to be higher than before heating. After 2nd heating/cooling cycle, G’ value (400 Pa) 
was still higher than initial G’ value (280 Pa). 
Mechanical diagrams of gel S5-4arm-17k showed a similar pattern to gel S1-3arm-46k. 
However, there was a more abrupt increase in elasticity of S5-4arm-17k compared to S1-
3arm-46k after the 1st heating cycle, where G’ value jumped from 290 Pa at 20 °C to ~ 950 
Pa at 45 °C. It could be rationalised that 4-arm PNIPAM conjugate 162 in gel S5-4arm-17k 
possessed higher arm numbers than 3-arm conjugate 158 in gel S1-3arm-46k, thus the 
collapse of PNIPAM conjugate 158 during the phase transition would bring about more peptide 
fibre rearrangement and a denser network, hence a stiffer gel. After 2nd heating/cooling cycle, 
G’ reached higher value 450 Pa in comparison to initial G’ of 290 Pa before heating.  
In a study by Cheng et al., they investigated the dissociation and association of linear PNIPAM 
in dilute aqueous solution by FTIR and dynamic light scattering.242 As expected, in the heating 
process, the polymer chains contracted due to dehydration and formed stable aggregates at 
temperature much higher than Tc of the polymer. Upon cooling, the aggregates reswelled 
however the chains did not dissociate. It was explained that upon heating, as the waters 
expelled hydrogen bonds between C=O and H-O-H molecules broke but at the same intra- 
and interchain hydrogen bonds between >C=O and >N-H formed, resulting in coil-to-globule 
transition. These remaining hydrogen bonds inside the aggregates were thought to be the 
reason behind the uneven reswelling of the aggregates upon cooling.242  
This rationale can also be applied to explain the substantial increase in hydrogel strength of 
the composite hydrogels (S1-3arm-46k and S5-4arm-17k) after two heating/cooling cycles. 
Overall, this experimental data supported the proposed self-assembly scheme for the 
composite gel containing 3-arm PNIPAM-peptide conjugate (Scheme 3-3). These composite 
hydrogels were stable, visco-elastic and thermo-responsive and these properties make them 
potential for application in tissue engineering and drug delivery. 
3.5.5 Hydrogel network morphology 
Due to limited time, AFM and TEM imaging were not performed to investigate the incorporation 
of star PNIPAM conjugates to the fibrillar network.  
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3.6 Summary and conclusions 
The star (bifunctional, 3-, 4-arm) conjugates PNIPAM-CFEFEFKFKK were successfully 
synthesised through RAFT end-group modifications. The MM distributions of all polymer 
samples were relatively narrow (Ð<1.25), however there was the presence of star-star by-
products in all samples due to radical termination events. Vinyl sulfone modified star PNIPAMs 
were firstly prepared via Michael addition of divinyl sulfone to the free thiol ends of PNIPAM 
polymer with a coupling efficiency generally above 75%. The successful conjugation of thiol 
containing self-assembling peptide CFEFEFKFKK 132 to the polymer chain ends was 
confirmed by 1H NMR, which showed the disappearance of vinyl protons in the region from 
5.5 to 6.5 ppm indicating that all the vinyl sulfone functional group were incorporated onto the 
peptide molecules. However, the average MMs of these conjugates could not be determined 
by GPC analysis in DMF as the products were only soluble in very acidic conditions (pH 2.0).  
A series of conjugate/peptide mixtures were prepared at pH 4.0 with bifunctional, 3-, 4-arm 
star PNIPAM–CFEFEFKFKK conjugates at 3 mg.mL-1 and free CFEFEFKFKK peptide 132 at 
10 mg.mL-1. Gelation was observed for all mixtures, indicating that conjugated peptide did not 
interfere with the self-assembly of unmodified peptide in the mixture. Cloud points Tc of 
aqueous conjugate solutions and composite gels were firstly collected by visual observation 
using a temperature controlled water bath. Obvious phase transitions were observed for all 
samples at ~ 36 °C. More quantitative Tc data was attained by using µDSC and these values 
were in good agreement with previous visual observation. Micro DSC showed that star 
PNIPAM conjugates in both aqueous solutions and in composite gels exhibited higher Tc 
values in comparison to Tc of unconjugated star PNIPAM and Tc literature values of linear 
PNIPAM. This could be ascribed to the presence of charged peptide molecules on the end of 
the polymer arms that made the star conjugates better hydrated thus increasing the LCST of 
the system. The Tc of these composite hydrogels were very close to physiological temperature. 
Therefore, these hydrogels are very promising for applications in human body. 
Rheological data showed that incorporating star PNIPAM conjugates into the peptide 
hydrogels only resulted in increased gel strength (G’ of composite gels > G’ of CFEFEFKFKK-
only gel) for gel S1-3arm-46k (containing 3-arm conjugate star 153, 46.4 kDa), S5-4arm-17k 
(containing 4-arm conjugate star 157, 17.8 kDa), and S6-2arm-4k (containing bifunctional 
conjugate star 158, 4.6 kDa). Interestingly, the rest of the hydrogel samples showed weakened 
elasticity (smaller G’ than G’ of CFEFEFKFKK-only gel). It can be postulated that participation 
of star polymer conjugates were only obtained with conjugates 153, 157, and 158 while other 
conjugates 154, 155, and 165 did not take part in the self-assembly of free peptide for some 
reason, and hence only diluted the fibre network. This result correlated with data collected 
from the amplitude sweep study in which it showed that gel S1-3arm-46k and S5-4arm-17k 
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displayed lower yield strains compared to others, suggesting that the gels were more brittle 
due to the presence of thicker fibres or more cross-linked networks. 
Hydrogel S1 showed an increase in elasticity (higher G’ moduli) upon heating from 20 to 80 
°C. This can be attributed to the formation of a more entangled network as a result of PNIPAM 
collapse upon heating. Mechanical behaviours of gel S1-3arm-46k and S5-4arm-17k were 
also studied in order to better understand the effect of star PNIPAM conjugates on the peptide 
hydrogels. The shear moduli (G’ and G’’) of S1-3arm-46k and S5-4arm-17k were obtained as 
a function of temperature after two cycles of heating and cooling. Both gels showed an 
increase in elastic modulus G’ and viscous modulus G’’ upon heating. Upon cooling, the phase 
transition is reversible as the polymers became rehydrated, however storage moduli did not 
reach the initial values.  
Although further investigations are required to achieve more conclusive results, experimental 
data presented in this study did support the earlier hypothesis that star PNIPAM conjugates 
would participate in the self-assembly of peptides, creating cross-links between fibres and 
consequently increasing the hydrogel stiffness. These composite hydrogels were stable, 
visco-elastic and thermo-responsive and these properties give them potential for application 
in tissue engineering and drug delivery. 
3.7 Future work 
Although 3- and 4-arm PNIPAM prepared using multifunctional RAFT agents displayed narrow 
polydispersity, high MM radical termination by-products were detected by GPC analysis. 
Therefore, future work would be to optimise the PNIPAM RAFT polymerisation. A study by 
Bian et al. reported the preparation of well-defined 4-arm PNIPAM (Ð<1.2) using 4-arm 
trithiocarbonate macro RAFT agent.168 They performed the polymerisation using thermal 
initiation (100 °C) instead of using a thermal radical initiator and achieved high monomer 
conversion of 89% in 2 h while high MM by-products were hardly detected by GPC. 
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Scheme 3-27 R-RAFT polymerisation of NIPAM using 4-arm macro RAFT agent.168 
Further future work would be to characterise the star PNIPAM/self-assembling peptide 
conjugates using MALDI-TOF because  the self-assembling nature of the peptide in solution 
makes GPC analysis complicated. 
Future investigation into the hydrogel morphology using imaging techniques such as TEM and 
AFM would also provide an insight into how star conjugates are incorporated into the peptide 
fibres and result in the changes in mechanical properties discussed above.
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4 Chapter IV: Experimental and Methods 
4.1 Materials 
2,2’-Azobisisobutyryonitrile (Aldrich, 98%) and 4,4’-azobis(4-cyanovaleric acid) (Aldrich, 98%) 
were recrystallised from methanol. N-isopropylacrylamide (Aldrich, 97%) was recrystallised 
from hexane. Solvents and other reagents were used as supplied. Anhydrous DCM for solid 
phase peptide synthesis was obtained from a dry solvent machine. 
4.2 Nuclear Magnetic Resonance 
Deuterated solvents were purchased from Cambridge Isotopes Laboratories, Inc. 
NMR spectroscopy was performed on a 300 MHz Bruker AV-300 NMR, 500MHz Bruker 
ADVANCE NMR or 400 MHz Bruker NMR spectrometer at the University of Surrey. All 
chemical shifts are expressed as parts per million relative to tetramethylsilane (δH = 0.00 ppm) 
and coupling constants are given in Hertz to the nearest 0.5 Hz.  1H-NMR spectra are 
referenced either to TMS at 0 ppm or to residual protic solvent: 2.50 ppm for DMSO, 4.75 ppm 
for D2O or 7.26 ppm for CDCl3. The data is reported as follows: chemical shift (δ) in ppm, 
multiplicity, integration, coupling constants J (Hz), assignment. 13C-NMR spectra were 
recorded at 126 MHz, 101 MHz or 75 MHz. They are referenced to CDCl3 at 77.0 ppm or 
CD3OD at 49.0 ppm. The data is reported as follows: chemical shift (δ) in ppm, multiplicity (s, 
singlet; d, doublet; t, triplet; q, quartet; p, pentet; m, multiplet), integration, coupling constant(s) 
(J in Hz accurate to 0.5 Hz), assignment. For peptide characterisation, peaks were assigned 
using COSY, HSQC and HMBC 2D NMR spectroscopy. 
4.3 Gel Permeation Chromatography (GPC) 
GPC analysis was performed on the Viscotek 270 GPCmax with Viscotek 270 Dual Modular 
GPC Detector (i.e. viscometer detector, light scattering detector) and VE3580 Viscotek RI 
concentration detector. Samples were prepared by dissolving around 5 mg of polymer in 1ml 
solution of DMF and 0.01 M LiBr and filtering through 0.45 µm filter prior to analysis. GPC 
measurements were performed at 0.7 ml/min flow rate at 50 °C. 
4.4 Liquid Chromatography- Mass Spectrometry (LC-MS) 
 LC-MS was performed on a Waters 2695 LC coupled to a Waters 2487 Dual λ Absorbance 
Detector and a Micromass Quattro Ultima Triple Quandrupole Mass Spectrometer using 
electrospray ionisation (positive mode). LC conditions were as follows: inj. vol. 10 µL, column 
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Phenomenex Onyx Monolithic C18 (100 mm x 3 mm), column temp. 30 °C, flow rate 1 mL 
min-1, acetonitrile (containing 0.1% formic acid) in water (containing 0.1% formic acid), 
gradient 0-0.4 min, 5%; 0.4-2  min, 5-20%; 2-3.5 min, 20-100%; 3.5-5 min, 100%; 5.5-6 min, 
100-5%, 6-7 min, 5%. The instrument was based at University of Surrey. 
Peptide samples were analysed on Agilent 1100 LC-MS using positive ion ESMS. LC 
conditions were as follows: Phenomenex Kinetex 2.6 µm XB-C18 100 Å 50x4.6 mm, column 
temp. 20 °C, flow rate 1.5 mL min-1, mobile phase (positive mode) acetonitrile (containing 
0.1% formic acid) in water (containing 0.1% formic acid), gradient 0-2 min, 0%; 2-10  min, 0-
80%; 10-11 min, 80-100%; 11-13 min, 100%; 13-14 min, 0%. The service was provided by 
Peptide Protein Research Ltd in Southampton. 
4.5 Fourier Transform Infrared Spectroscopy (FT-IR) 
Infrared spectra were recorded using Agilent technologies 640 FT-IR spectrometer with MKII 
Golden Gate Single Reflection ATR System.  
4.6 Gel imager 
SDS-PAGE gels were photographed using OdysseyR Fc Imaging system. 
4.7 UV-VIS microplate reader 
For quantification of protein samples, absorbance of standards and samples in 96 well-plates 
was measured at 590 nm on a Labsystems Multiskan RC microplate reader. 
4.8 Fluorescence Microplate reader 
Fluorescence-based assays were measured using a FLUOstar Omega plate reader. 
4.9 Micro differential scanning calorimeter (micro DSC) 
Thermal analysis was performed on a micro differential scanning calorimeter III (SETARAM, 
France). A certain amount of sample approx. 5 mg was dissolved in 1 mL of deionised water. 
The sample was directly weighed in the experimental cell prior to analysis and the cells were 
sealed hermetically. Deionised was used as a blank reference. Heating scans were recorded 
from 20 – 80 °C at a heating rate of 1 °C min-1. The heating and cooling cycles were repeated 
four times to examine the reversibility of the phase transition observed.  
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4.10 Oscillatory rheometer 
Mechanical studies were performed on a stress-controlled Bohlin C-CVO rheometer, equipped 
with a Peltier device to control the temperature. A parallel plate geometry (Ø = 20 mm, 0.5 
mm gap) was covered with a solvent trap to minimise evaporation. 
Three different rheological experiments were performed. Firstly, a strain amplitude sweep (ɣ 
= 0.001 – 1.0) was performed at a constant frequency (ω = 1 rad s-1) to identify the LVR. 
Secondly, the frequency sweep (ω = 0.1 – 1.0 rad s-1) at a constant strain amplitude (ɣ = 0.01) 
was performed to determine the elastic (G’) and viscous (G’’) moduli within LVR. These two 
experiments were performed at 20 °C. Finally, temperature sweep was performed in the range 
of 20 -80 °C at a constant strain amplitude (ɣ = 0.01, ω = 1 rad -1). Heating/cooling cycles were 
repeated twice. Samples were covered with a lid to minimise evaporation. 
4.11 Solid phase peptide synthesis 
4.11.1 Amino acid coupling to Wang resin 
Wang resin (1.1 mmoL.g-1 loading) was placed in a dry reaction vessel and filled with three 
bed volumes of anhydrous dichloromethane (DCM). The vessel was agitated by bubbling 
nitrogen gas for 30 min. After that, DCM was removed by vacuum filtration and the resin was 
filled with three bed volumes of DMF. The resin was then agitated by bubbling N2 gas before 
a vacuum was applied to drain the resin. The resin was washed thoroughly by repeating the 
cycles five times. 
Fmoc-amino acid (10 equiv. to resin loading) was dissolved in DMF (approximately 1 ml per 
mmol of Fmoc-amino acid) in a dry vessel. N,N’-diisopropylcarbodiimide (DIC) (5 equiv.) was 
added and the solution was stirred for 10 min to form the symmetrical anhydride precipitate. 
The mixture was added to the resin followed by a solution of 4-(dimethyl)aminopyridine 
(DMAP) (0.1 equiv.) in DMF. The reaction was mixed by bubling N2 through the solution for 2 
h. After 2 h the residual reactants and solvent were removed from the resin by vacuum filtration 
and the process was repeated once with new reagents. The resin was washed 5 times with 
DMF as described above. 
The Fmoc group was subsequently removed by adding 20% (v/v) piperidine in DMF (10 ml 
per g of resin) firstly for 5 min and then, with fresh solvent, for an additional 20 min. After 
removal of the piperidine solution by filtration, the resin was washed 5 times with DMF. Fmoc 
removal was determined qualitatively using the Kaiser test and the TNBS test. Dark blue 
(Kaiser test) for primary amines and orange beads (TNBS test) were considered a positive 
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result for the presence of resin-bound free amine. Proline being a secondary amine does not 
yield a positive result.  
For the subsequent coupling, Fmoc-amino acid (5 equiv.) and N,N,N′,N′-tetramethyl-O-
(benzotriazol-1-yl)uronium tetrafluoroborate (TBTU) (4.9 equiv.) were dissolved in DMF 
(approximately 1 ml per mmol of Fmoc-amino acid). N,N-diisopropylethylamine (DIPEA) (10 
equiv.) was then added to the solution and mixed thoroughly. The solution was then added to 
the resin and mixed for 1 h. After 1 h, a small amount of resin (around 10 beads) was 
transferred to a small glass fritted funnel. The resin was washed 5 times with DMF and 
methanol before drying under the vacuum. The extent of acylation was determined using the 
Kaiser test and the TNBS test (section 4.11.3 and 4.11.4). Colourless beads indicated the 
absence of resin-bound free amine and showed complete coupling. If coloured beads were 
produced the resin was allowed to react for an additional hour. After 2 h if coloured beads 
were again produced, the unreacted solution was removed and the process was repeated with 
new reagents. The resin was washed 5 times with fresh DMF and unreacted amine was 
capped with a solution of 50% acetic anhydride, 50% DCM (v/v) for 3 min. The resin was 
drained by filtration and treated with fresh solvent for another 7 min. The cycle of deprotection 
and coupling described above was repeated to add the additional amino acids.  
4.11.2 Cleavage and isolation of Wang resin peptides 
The resin was washed five times with each solvent DMF, DCM, and methanol before drying 
under vacuum for 30 min. The resin was then filled with cleavage mixture of 95% TFA, 2.5% 
TIS, and 2.5% H2O (v/v) (1mL per 100 mg of resin). The mixture was agitated for 3 h. After 
this, the cleavage mixture was collected into a 10 fold excess volume of cold diethyl ether. 
The resin was washed 3 times with concentrated TFA (1ml per 500 mg of resin). The resulting 
precipitated peptide was isolated by centrifugation at 4500 rpm for 5 min. The ether was 
carefully decanted off before fresh ether was added to re-suspend the peptide. The cycle of 
centrifugation and re-suspension was repeated four times before the peptide was dried under 
vacuum. The dried peptide was dissolved in water and lyophilised to yield a powder. 
4.11.3 TNBS test 
A small sample (approximately 10 beads) of the solid phase resin was washed several times 
with DMF. The beads were then suspended in DMF and one drop of both TNBS test solution 
A and B (see below) was added and the solution left for 10 minutes.  
The beads were washed with DMF and examined. The presence of an exposed amine 
(positive result) was indicated by intense orange/red beads, a negative test was indicated by 
colourless beads. 
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TNBS solution A: 10% (v/v) DIPEA in DMF 
TNBS solution B: 1% (w/v) 2,4,6-trinitrobenzene sulfonic acid (TNBS) in water.      
4.11.4 Kaiser test 
Two drops of each Kaiser test solutions A, B and C (see below) were added to a small sample 
(approximately 10 beads) of the solid phase resin in a small test tube. This was then placed 
in a heating block at 110 °C for 5 minutes. The presence of an exposed amine (positive result) 
was indicated by a purple colour, a negative test was indicated by an orange colour. 
Kaiser test solution A: 5% (w/v) ninhydrin in ethanol  
Kaiser test solution B: 80% (w/v) phenol (80 g, 0.425 mol) in ethanol 
Kaiser test solution C: 0.001M aqueous potassium cyanide (2 ml, 2 µmol) was added to 
pyridine (98 ml, 1.21 mol).  
4.11.5 N-Methacryloylleucylprolylglutamylthreonylglycylglycine (ma-LPETGG) 
                                      
Wang resin 500 mg 
1st Coupling Amino acid quantity (g) DIC (µl) DMAP (mg) 
Fmoc-Gly-OH 1.63 214.0 6.7 
Coupling Amino acid quantity (g) TBTU (g) DIPEA (ml) 
Fmoc-Gly-OH 0.76 0.865 0.958 
Fmoc-Thr(tBu)-OH 1.09 0.865 0.958 
Fmoc-Glu(OtBu)-OH 1.17 0.865 0.958 
Fmoc-Pro-OH 0.92 0.865 0.958 
Fmoc-Leu-OH 0.97 0.865 0.958 
Methacrylic acid 0.24 0.865 0.958 
Table 4-1: Masses of reagents for the synthesis of ma-LPETGG 
Yield: 221.5 mg 
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1H-NMR (DMSO-d6, 400 MHz): δ 0.88, (dd, 3H, J = 6.5, 8.5 Hz, H-k1 or H-k2), 0.90 (dd, 3H, 
J = 6.5, 8.5 Hz, H-k1 or H-k2), 1.03 (d, 3H, J = 6.5 Hz, H-c), 1.41 (m, 1H, H-i), 1.63 (m, 2H, H-
i, H-j), 1.76 (m, 1H, H-f), 1.84 (s, 3H, H-l), 1.94 (m, 5H, H-d, H-f, H-g), 2.03 (m, 1H, H-d), 2.26 
(m, 1H, H-e), 3.51 (m, 1H, H-h), 3.70 (m, 1H, H-h), 3.77 (m, 4H, H-a1, H-a2), 4.0 (qd, J = 4.3, 
6.5 Hz 1H, H-b), 4.18 (dd, 1H, J = 4.1, 7.9 Hz, H-a3), 4.29 (dt, 1H, J = 5.3, 8.2 Hz, H-a4), 4.36 
(dd, 1H, J = 4.2, 8.0 Hz, H-a5), 4.58 (m, 1H, H-a6), 5.32 (s, 1H, H-m1), 5.71 (s, 1H, H-m2), 
7.6 (d, 1H, J = 6.4 Hz, NH), 7.9 (d, 1H, 1H, J = 6.2 Hz, NH), 8.14 (m, 3H, 1H, NH). 
13C-NMR (D2O, 125 MHz):  δ 17.6 (C-c), 18.6 (C-l), 20.5, 22.3 (C-k1, C-k2), 24.4 (C-j), 24.7, 
25.9 (C-g, C-f), 29.2 (C-d), 29.9 (C-e), 38.8 (C-i), 41.2 (C-a2), 42.4 (C-a2), 47.8 (C-h), 50.6 
(C-a6), 53.0 (C-a5), 59.1 (C-a3), 60.5 (C-a4), 67.5 (C-b), 121.4 (C-m), 171.6 (C-n7), 172.1, 
172.2, 173.1, 173.6, 174.3 (C-n2, C-n3, C-n4, C-n5, C-n6), 177 (C-n1, C-n8). 
ESI-MS: m/z 572.2 [M- CH2CONHCH2COOH]+ (25%), 641.3 [M+H]+ (100%). 
FT-IR: νmax 3300 (O-H, N-H stretches superimposed), 3082 (=C-H stretch), 2956 (aliphatic C-
H stretch), 1649 (C=C, C=O stretch), 1528 (N-H bend), 1447 (C-N stretch), 600-700 (N-H out-
of-plane bend). 
4.11.6 N-Acryloylleucylprolylglutamylthreonylglycylglycine (a-LPETGG) 
                                  
Wang resin 500 mg 
1st Coupling Amino acid quantity (g) DIC (µl) DMAP (mg) 
Fmoc-Gly-OH 1.63 214.0 6.7 
Coupling Amino acid quantity (g) TBTU (g) DIPEA (ml) 
Fmoc-Gly-OH 0.76 0.865 0.958 
Fmoc-Thr(tBu)-OH 1.09 0.865 0.958 
Fmoc-Glu(OtBu)-OH 1.17 0.865 0.958 
Fmoc-Pro-OH 0.92 0.865 0.958 
Fmoc-Leu-OH 0.97 0.865 0.958 
Acrylic acid 0.198 0.865 0.958 
Table 4-2: Masses of reagents for the synthesis of a-LPETGG 
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Yield: 211 mg 
1H-NMR (DMSO-d6, 400 MHz): δ 0.88 (d, 3H, J = 6.6 Hz, H-k1 or H-k2), 0.89 (d, 3H, J = 6.6 
Hz, H-k1 or H-k2), 1.02 (d, 3H, J = 6.2 Hz, H-c), 1.46 (m, 2H, H-i), 1.62 (m, 1H, H-j), 1.75 (m, 
1H, H-d), 1.84-2.04 (m, 5H, H-d, H-g, H-f), 2.28 (m, 1H, H-e), 3.51 (m, 1H, H-h), 3.63 (m, 1H, 
H-h), 3.76 (m, 4H , H-a1, H-a2), 4.00 (dq, 1H, J = 3.9, 6.2 Hz, H-b), 4.18 (dd, 1H, J = 3.9, 7.9 
Hz, H-a3), 4.29 (m, 1H, H-a4), 4.36 (dd, 1H, J = 4.1, 8.0 Hz, H-a5), 4.64 (td, J = 8.8, 4.9 Hz,1H, 
H-a6), 5.59 (dd, 1H, J = 2.0, 10.3 Hz, H-l), 6.06 (dd, J = 17.1, 2.0 Hz, 1H, H-m1), 6.31 (dd, J 
= 17.1, 10.3 Hz, 1H, H-m2), 7.43, 7.62 (1H, NH), 7.85 (3H, NH), 8.14 (1H, NH). 
13C-NMR (DMSO-d6, 100 MHz):  δ 19.9 (C-c), 21.9 (C-k1, C-k2), 23.6 (C-i), 24.6 (C-j), 25.0, 
27.4, 29.4 (C- d, C-g, C-f), 30.6 (C-e), 41.02 (C-a2), 42.4 (C-a1), 49.2 (C-a6), 52.5 (C-a4), 
59.1 (C-a3), 59.7 (C-a5), 67.0 (C-b), 126.09 (C-l), 131.74 (C-m), 164.82, 169.62, 170.66, 
171.01, 171.48, 171.77, 172.15, 174.6 (C-n1, C-n2, C-n3, C-n4, C-n5, C-n6, C-n7, C-n8). 
API-ES: m/z 627.3 [M+H]+ (100%). 
FT-IR: νmax 3283 (O-H, N-H stretches superimposed), 3074 (=C-H stretch), 2959 (aliphatic C-
H stretch), 1626 (C=C, C=O stretch), 1535 (N-H bend), 1411 (C-N stretch), 600-700 (N-H out-
of-plane bend). 
4.11.7 Glycylglycyl-N6-methacryloyllysinoglutamic acid (GGK(ma)E)   
                                      
 
Wang resin                   1000 mg 
1st Coupling Amino acid quantity (g) DIC (µl) DMAP (mg) 
Fmoc-Glu(OtBu)-OH 4.68 428.0 13.4 
Coupling Amino acid quantity (g) TBTU (g) DIPEA (ml) 
Fmoc-Lys(Mmt)-OH 1.718 1.730 1.916 
Fmoc-Gly-OH 1.635 1.730 1.916 
Fmoc-Gly-OH 1.635 1.730 1.916 
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Mmt decoupling TFA/TIS/DCM (1:5:94)   
Methacrylic acid 0.473 1.730 1.916 
Table 4-3: Masses of reagents for the synthesis of GGK(ma)E 
Yield: 256 mg 
1H-NMR (D2O, 500 MHz): δ 1.33 (m, 2H, H-e), 1.50 (quin, 2H, J = 7.2 Hz, H-f), 1.68 (m, 1H, 
H-d), 1.73 (m, 1H, H-d), 1.86 (s, 3H, H-h), 1.9 (m, 1H, H-b), 2.2 (m, 1H , H-b), 2.42 (m, 2H, H-
c), 3.20 (t, J = 6.9, 2H, H-g), 3.83 (s, 2H, H-a4), 3.97 (d, J = 2.9 Hz, 2H, H-a3), 4.26 (dd, J = 
8.2, 6.1 Hz, 1H, H-a2), 4.35 (dd, J = 9.1, 5.4 Hz, 1H , H-a1), 5.6 (s, 1H, H-i1), 5.59 (s, 1H, H-
i2). 
13C-NMR (D2O, 125 MHz): δ 18.2 (C-h), 22.5 (C-e), 25.4 (C-b), 28.8 (C-f), 30.7 (C-d), 30.2 (C-
c), 38.9 (C-g), 39.8 (C-a4), 42.2 (C-a3), 52.3 (C-a1), 53.2 (C-a2), 120.9 (C-k), 139,3 (C-i), 
167.7-175.1 (C-j1, j2, j3, j4, j5), 177.2 (C-j6). 
MS: m/z 473.2122 and 458.2 [M+H+] 
FT-IR: 3277 (O-H, N-H stretch superimposed), 3079 (=C-H stretch), 1651 (C=C, C=O stretch), 
1542 (N-H bend), 1416 (C-N stretch). 
4.11.8 Glycylglycyl-N6-acryloyllysinoglutamic acid (GGK(a)E) 
                                 
Wang resin                   1000 mg 
1st Coupling Amino acid quantity (g) DIC (µl) DMAP (mg) 
Fmoc-Glu(OtBu)-OH 4.68 428.0 13.4 
Coupling Amino acid quantity (g) TBTU (g) DIPEA (ml) 
Fmoc-Lys(Mtt)-OH 1.718 1.730 1.916 
Fmoc-Gly-OH 1.635 1.730 1.916 
Fmoc-Gly-OH 1.635 1.730 1.916 
Mmt decoupling TFA/TIS/DCM (1:5:94)   
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Acrylic acid 0.396 1.730 1.916 
Table 4-4: Masses of reagents for the synthesis of GGK(a)E 
Yield: 245 mg 
1H-NMR (D2O, 400 MHz): δ 1.33 (m, 2H, H-e), 1.49 (m, 2H, J = 7.2 Hz, H – f), 1.70 (m, 1H, H-
d), 1.73 (m, 2H, H-d), 1.91 (m, 2H, H-h), 1.93 (m, 1H, H-b), 2.13 (m, 1H , H-b), 2.40 (m, 2H, 
H-c), 3.18 (t, J = 6.7 Hz, 2H, H-g), 3.83 (s, 2H, H-a4), 3.95 (s, 2H, H-a3), 4.23 (t, J = 6.9 Hz, 
1H, H-a2), 4.35 (dd, J = 9.0, 5.0 Hz, 1H , H-a1), 5.85 (d, J = 10 Hz,1H, H-h), 6.14 (m, 2H, H-
i1, H-i2). 
13C-NMR (D2O, 125 MHz): δ 22.5 (C-e), 25.6 (C-b), 27.8 (C-f), 29.9 (C-d), 30.6 (C-c), 39.3 (C-
g), 40.4 (C-a4), 42.1 (C-a3), 51.9 (C-a1), 53.7 (C-a2), 126.9 (C-k), 130.1 (C-i), 167.7-174.7 
(C-j1, j2, j3, j4, j5), 177.1 (C-6). 
FT-IR: 3300 (O-H, N-H stretch superimposed), 3082 (=C-H stretch), 1649 (C=O), 1528 (C-N 
stretch). 
LC-MS: m/z 443.2016 [M]+ and 444.2 [M+H]+ 
FT-IR: 3277 (O-H, N-H stretch superimposed), 3079 (=C-H stretch), 1651 (C=C, C=O stretch), 
1542 (N-H bend), 1416 (C-N stretch). 
4.11.9 N-Methacryloylphenylglutamylphenylglutamylphenyllysinylphenyllysine (ma-
FEFEFKFK)  
 
Wang resin 500 mg   
1st Coupling Amino acid quantity (g) DIPEA (µl)  
Fmoc-Lys(Boc)-OH 1.288 0.958  
Coupling Amino acid quantity (g) TBTU (g) DIPEA (ml) 
Fmoc-Phe-OH 1.065 0.883 0.958 
Fmoc-Lys(Boc)-OH 1.288 0.883 0.958 
Fmoc-Phe-OH 1.065 0.883 0.958 
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Fmoc-Glu(OtBu)-OH 1.170 0.883 0.958 
Fmoc-Phe-OH 1.065 0.883 0.958 
Fmoc-Glu(OtBu)-OH 1.170 0.883 0.958 
Fmoc-Phe-OH 1.065 0.883 0.958 
Methacrylic acid 0.24 0.883 0.958 
Table 4-5 Masses of reagents for the synthesis of ma- FEFEFKFK 131 
Yield: 460 mg 
1H-NMR (DMSO-d6, 400 MHz): δ 1.09, 1.33, 1.48, 1.53 (m, 12H, H-b, H-c, H-d,), 1.70 (m, 2H, 
H-i), 1.75 (s, 3H, H – m), 1.85 (m, 2H, H-i), 2.18 (m, 4H, H-k), 2.74 (m, 12H, H-e, H-g), 3.00 
(m, 5H, H-g, H-n), 4.05 (broad, 1H, H-a1) 4.25 (m, 5H, H-a2, H-h), 4.53 (m, 4H , H-f), 5.29 (s, 
1H, H-n1), 5.56 (s, 1H, H-n2), 7.20 (20H, H-p), 7.81-8.55 (13H, NH, OH). 
13C-NMR (DMSO-d6, 125 MHz): δ 18.98 (C-m), 22.72 (C-b) 27.2 (C-c), 27.9 (C-d), 30.42 (C-
k), 31.78 (C-i),, 37.27 (C-g), 40.1 (C-e) 52.3, 52.9, 53.9, 54.8 (C-a1, a2, a3, f, h), 119.9 (C-t), 
126.7(C-n), 128.5, 129.6, 138.0,138.6, 139.9, (C-p), 167.0, 168.9, 170.0, 173.6, 174.5 (C-q1, 
q2, q3, q4, q5, q6, q7, q8,o1, o2, o3). 
FT-IR: 3300 (O-H, N-H stretch superimposed), 3082 (=C-H stretch), 1649 (C=O), 1528 (C-N 
stretch). 
LC-MS (+ESI): m/z 595.6 [M+2H]2+ 
FT-IR: 3273 (O-H, N-H stretch superimposed), 3057 (=C-H stretch), 2932 (C-H aliphatic 
stretch), 1649 (C=O stretch), 1520 (N-H bend), 1436 (C-N stretch). 
4.11.10 Cysteinylphenylglutamylphenylglutamylphenyllysinylphenyllysinyllysin
e (CFEFEFKFKFKK) 
 
 
Wang resin 500 mg   
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1st Coupling Amino acid quantity (g) DIPEA (µl)  
Fmoc-Lys(Boc)-OH 1.288 0.958  
Coupling Amino acid quantity (g) TBTU (g) DIPEA (ml) 
Fmoc-Lys(Boc)-OH 1.288 0.883 0.958 
Fmoc-Phe-OH 1.065 0.883 0.958 
Fmoc-Lys(Boc)-OH 1.288 0.883 0.958 
Fmoc-Phe-OH 1.065 0.883 0.958 
Fmoc-Glu(OtBu)-OH 1.170 0.883 0.958 
Fmoc-Phe-OH 1.065 0.883 0.958 
Fmoc-Glu(OtBu)-OH 1.170 0.883 0.958 
Fmoc-Phe-OH 1.065 0.883 0.958 
Fmoc-Cys(Trt)-OH 1.611 0.883 0.958 
Table 4-6 Masses of reagents for the synthesis of CFEFEFKFKK 
Yield: 600 mg 
1H-NMR (DMSO-d6, 400 MHz): δ 1.23, 1.35, 1.55, 1.69, 1.84 (m, 22H, H-b, H-c, H-d, H-i), 
2.18 (m, 4H, H – k), 2.74 (m, 11H, H-e, H-g, H-n), 3.00 (m, 5H, H-g, H-n), 3.89 (m, 1H, H-m), 
4.16, 4.25 (m, 5H, H-a, H-h), 4.56 (m, 4H , H-f), 7.20 (20H, H-p), 7.81-8.55 (13H, NH, OH). 
13C-NMR (DMSO-d6, 125 MHz): δ 22.83 (C-b), 27.04, 27.22 (C-c, C-d), 30.61 (C-k), 39.9 (C-
d), 55.3 (C-c), 128.6, 126.6, 128.6, 129.4, 129. (C-g), 167.0, 168.9, 1701.1, 171.3, 129.6 (C-
o1, o2, o3, q1, q2, q3, q4, q5, q6, q7, q8). 
FT-IR: 3300 (O-H, N-H stretch superimposed), 3082 (=C-H stretch), 1649 (C=O), 1528 (C-N 
stretch). 
LC-MS (+ESI): m/z 677.2 [M+2H]2+, 451.8 [M+3H]3+ 
FT-IR: 3273 (O-H, N-H stretch superimposed), 3057 (=C-H stretch), 2932 (C-H aliphatic 
stretch), 1649 (C=O stretch), 1520 (N-H bend), 1436 (C-N stretch). 
4.11.11 N-(2-hydroxypropyl) methacrylamide 
                                                     
Anhydrous sodium hydrogen carbonate (66 g, 1.4 equiv.) was suspended in a solution of 11-
aminopropan-2-ol-aminopropan-2-ol (44 ml, 1equiv) in freshly distilled DCM (160 ml). The 
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suspension was cooled to -20 in an ethanol-dry ice bath.  To this suspension, a solution of 
methacryloyl chloride (50 ml, 0.92 equiv.) from a new, unopened container in DCM (50 ml) 
was added dropwise at a rate of 1 drop s-1. Following addition of the methacryloyl chloride, 
the reaction was held at 15 °C and stirred for a further 30 min. Anhydrous sodium sulphate 
(~20 g) was added to the mixture and left for approximately 1 hr before being filtered off 
(gravity filtration) and the collected filtrate concentrated to half of the original volume using 
rotary evaporation. The resulting solution was placed in a -20 °C freezer.  Crystals were 
collected after 24 h via filtration and rinsed with chilled (4 °C) DCM and dried under high 
vacuum. The powder was purified by recrystallisation from acetone. 
Yield: 37 g (50.7%) 
1H-NMR (CDCl3, 400 MHz): 1.22 (d, J = 6.0 Hz, 3H, H-a), 1.86 (s, 3H, H-h), 3.19 (dd, 1H, J = 
7.0, 13.9, H-c1/c2), 3.21 (dd, 1H, J = 4.8, 14.1 Hz, H-c1/c2), 3.96 (m, J = 3.0 Hz, 1H, H-b), 
5.36 (s, 1H, H-f), 5.63 (s, 1H, H-g). 
13C-NMR (CDCl3, 75 MHz): δ 18.28 (C-a), 21.17 (C-h), 47.33 (C-c), 67.57 (C-b), 120.20 (H-e), 
139.83 (C-g), 169.60 (C-d). 
FT-IR: vmax 3298-3262 (br, O-H, N-H stretch superimpose), 2974-2931 (aliphatic C-H), 1652 
(C=C stretch), 1613 (C=O amide), 1546 (N-H bend). 
4.11.12 N,N'-[1,2-Ethanediylbis(oxy-2,1-ethanediyl)]bis-1-succinimidyl-4cyano-4-
[N-methyl-N-(4-pyridyl) carbamothioylthio]pentanamide 
 
1-Succinimidyl-4cyano-4-[N-methyl-N-(4-pyridyl) carbamothioylthio]pentanoate (400 mg, 1 
equiv)  was dissolved in DCM (2 ml). Triethylamine (194.5 µl, 1 equiv) was dissolved in DCM 
(2 ml) and added dropwise to the solution. The solution of 2,2’-(ethylenedioxy)bisethylamine 
(137.93 µl, 0.945 equiv) was added dropwise to the mixture at 0 °C. The reaction was stirred 
overnight at room temperature after the addition. The mixture was then filtered off by vacuum. 
The filtrate was washed with brine solution three times (3 ml), followed by deionised water 
three times (5 ml). The organic layer collected was dried under sodium sulphate before 
evaporated under the vacuum to yield a light yellow powder (232 mg, 66%).  
1H NMR (CDCl3-d3, 300 MHz): δ 1.75 (s, 6H, H-d), 2.20 (m, 2H, H-e), 2.36 (dd, J = 9.36,  6.36 
Hz,  4H, H-f), 2.53 (m, 2H, H-e), 3.38 (t, J = 5.27 Hz, 4H, H-h), 3.49 (t, J = 5.27 Hz, 4H, H-i), 
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3.55 (s, 4H, H-k), 3.62 (s, 6H, H-c), 6.28 (br, 2H, H-g), 7.17 (dd, J = 4.5, 1.6 Hz, 4H, H-b), 8.69 
(dd, J = 4.5, 1.6 Hz, 4H, H-a). 
13C NMR (CDCl3-d3, 75 MHz): δ 25.23 C-d, 32.16 C-e, 34.7 C-e, 39.51 C-m, 44.89 C-c, 47.06 
C-f, C-h, 69.88 C-i, 70.43 C-k, 120.23 C-a, 121.87 C-n, 151.44 C-p, 152.13 C-b, 170.83 C-l, 
191.88 C-o. 
LC-MS: m/z 730.9 [M+H]+ (60%), 547.4 [M-C7H7N2S2]+ (100%). 
FT-IR: νmax 3301 (N-H), 3077 (aromatic C-H), 2931, 2870 (aliphatic C-H stretch), 2229 (C≡N 
stretch), 1649 (C=O stretch), 1351 (C=C, C=N stretch), 1094 (C-O stretch). 
4.12 General procedure for RAFT homopolymerisation 
In a Schlenk flask, a stock solution of monomer, an initiator (e.g. AIBN or ACVA), and CTA 
was degassed by purging with N2 gas for 30 min. The flask was then transferred to a pre-
heated oil bath for the polymerization. The polymerisation was stopped by exposing the flask 
to the air and simultaneously cooling in liquid N2. The polymer was purified by either dialysis 
in 1,000 Da MWCO membrane or precipitation from cold diethyl ether or hexane for several 
times. The final product was dried under the vacuum for further analysis. 
4.12.1 RAFT homopolymerisation of HPMA with CDTB 
 
Homopolymerisations of HPMA with CDTB were tested in different solvent systems (i.e. DMF, 
and acetate buffer pH 5.0/ 1,4-dioxane 4:1). The polymerization was performed at 70 °C under 
N2 gas. The final polymer was purify by dialysis against deionised water for 2 days and 
lyophilisation to yield a pink powder. 
1H-NMR (D2O, 400 MHz): 0.9 (br, H-e), 1.10 (br, H-h), 1.70 (br, H-d), 2.20-2.37 (H-a+H-b), 
3.10 (br, H-f), 3.84 (br, H-g), 7.4 (H-l), 7.59 (H-m), 7.82 (H-k). 
FT-IR: vmax 3300, 3326 (O-H, N-H stretch superimposed), 3089 (aromatic C-H), 2973, 2931 
(aliphatic C-H stretch), 1653 (C=O amide), 1543 (C-N stretch). 
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4.12.2 RAFT polymerization of HPMA using 3-armed RAFT agent 
 
Polymerization of HPMA with three-arm CTA was performed in DMF/1,4-dioxane (1:1) solvent 
mixture at 60 °C for 6h. The final polymer was precipitated from cold diethyl ether, and isolated 
by centrifugation at 4000 rpm for 10 min. The ether solution was carefully decanted off. The 
precipitate was dissolved in DMF and precipitated again from cold diethyl ether. The process 
of precipitation and isolation was repeated four times. The final polymer was dry under the 
vacuum to yield a yellow powder. 
1H-NMR (DMSO-d6, 400 MHz): δ 0.84 (br s, H-b), 1.02 (br s, H-g), 1.24 (s, 60H, H-h), 1.63 
(br, H-a), 2.91 (br s, H-d), 3.68 (br s, H-e), 4.70 (br s, H-f), 7.17 (br, H-c). 
FT-IR: vmax 3334 (O-H stretch superimposed N-H stretch), 2975, 2931 (aliphatic C-H stretch), 
1628 (C=O amide stretch), 1530 (N-H bend), 1203 (C=S). 
4.12.3 RAFT polymerization of HPMA using 4-arm CTA 
 
Polymerization of HPMA with four-arm CTA was performed in DMF/1,4-dioxane (1:1) solvent 
mixture at 60 °C for 6h. The final polymer was precipitated from cold diethyl ether, and isolated 
by centrifugation at 4000 rpm for 10 min. The ether solution was carefully decanted off. The 
precipitate was dissolved in DMF and precipitated again from cold diethyl ether. The process 
of precipitation and isolation was repeated four times. The final polymer was dry under the 
vacuum to yield a yellow powder. 
1H-NMR (DMSO-d6, 400 MHz): δ 0.81 (br s, H-b), 1.02 (br s, H-g), 1.24 (s, 60H, H-h), 1.63 
(br, H-a), 2.91 (br s, H-d), 3.68 (br s, H-e), 4.69 (br s, H-f), 7.17 (br, H-c). 
FT-IR: vmax 3329 (O-H stretch superimposed N-H stretch), 2973, 2930 (aliphatic C-H stretch), 
1632 (C=O amide stretch), 1526 (N-H bend), 1203 (C=S). 
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4.12.4 RAFT homopolymerisation of NIPAM with bifunctional CTA 
 
Polymerization of NIPAM monomer with bifunctional CTA was performed in THF at 65 °C. The 
polymer was precipitated from cold diethyl ether and centrifuged at 4000 rpm for 10 min. The 
polymer was dissolved in THF and precipitated again from cold ether. This process was 
repeated four times. The final polymer was collected and dried under the vacuum to yield a 
white solid. 
1H-NMR (CDCl3, 400 MHz): δ 1.15 (br s, H-o), 1.68, 1.75 (H-j), 1.90-2.35 (bt, H-l), 3.44 (br, H-
h), 3.56 (br, H-i), 3.62 (br, H-k), 3.74 (br, H-c), 4.01 (br s, H-m), 6.62 (br, HNH),  7.22 (m, H-
b), 8.75 (m, H-a). 
FT-IR: vmax 3334 (O-H stretch superimposed N-H stretch), 2975, 2931 (aliphatic C-H stretch), 
1628 (C=O amide stretch), 1530 (N-H bend), 1203 (C=S). 
4.12.5 RAFT homopolymerisation of NIPAM with 3-arm CTA 
 
Polymerization of NIPAM monomer with three-arm CTA was performed in THF at 70 °C. The 
polymer was precipitated from cold diethyl ether and centrifuged at 4000 rpm for 10 min. The 
polymer was dissolved in THF and precipitated again from cold ether. This process was 
repeated four times. The final polymer was collected and dried under the vacuum to yield a 
white solid. 
1H-NMR (CDCl3, 400 MHz): δ 1.14 (br s, H-e), 1.26 (s, H-f), 1.38-2.14 (br, H-a), 2.23 (br, H-
b), 3.33 (s, H-g), 4.00 (br s, H-c), 6.35 (br s, H-d). 
FT-IR: vmax 3334 (N-H stretch), 2970-2930 (aliphatic C-H stretch), 1633 (C=O amide stretch), 
1526 (N-H bend), 1459 (C-N stretch), 1202 (C=S stretch). 
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4.12.6 RAFT homopolymerisation of NIPAM with 4-arm CTA 
 
Polymerization of NIPAM monomer with three-arm CTA was performed in THF at 70 °C. The 
polymer was precipitated from cold diethyl ether and centrifuged at 4000 rpm for 10 min. The 
polymer was dissolved in THF and precipitated again from cold ether. This process was 
repeated four times. The final polymer was collected and dried under the vacuum to yield a 
white solid. 
1H-NMR (CDCl3, 400 MHz): δ 1.14 (br s, H-d), 1.26 (s, H-f), 1.38-2.14 (br, H-a), 2.23 (br, H-
b), 3.33 (s, H-g), 4.00 (br s, H-c), 6.35 (br s, H-e). 
FT-IR: vmax 3334 (N-H stretch), 2975, 2931 (aliphatic C-H stretch), 1628 (C=O amide stretch), 
1530 (N-H bend), 1203 (C=S). 
4.12.7 RAFT homopolymerisation of NIPAM with bifunctional RAFT agent 
 
Polymerization of NIPAM monomer with bifunctional CTA was performed in THF at 70 °C. To 
a flask, NIPAM (200 mg, 1.76 mmol) was dissolved in THF 2mL with RAFT agent (15.1 mg, 
0.024 mmol), ACVA (0.66 mg, 0.002 mmol) and p-TsOH.H2O (9.13 mg, 0.048 mmol). The 
solution was degassed for 30 min at room temperature before heating at 70 °C for 2h. The 
polymer was precipitated from cold diethyl ether and centrifuged at 4000 rpm for 10 min. The 
polymer was dissolved in THF and precipitated again from cold ether. This process was 
repeated four times. The final polymer was collected and dried under the vacuum to yield a 
white solid. 
1H-NMR (CDCl3, 400 MHz): δ 1.14 (br s, H-o), 1.26 (s, H-j), 1.38-2.14 (br, H-l), 3.44 (br, 4H, 
H-h), 3.56 (br, 4H, H-i), 3.69 (br, 4H, H-k), 3.74 (br, 6H, H-c), 4.00 (br s, H-m), 7.00 (br s, H-
b), 8.75 (br, H-a). 
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FT-IR: vmax 3297 (N-H stretch), 3070 (=C-H stretch), 2971, 2931, 2875 (aliphatic C-H stretch), 
1643 (C=O amide stretch), 1542 (N-H bend). 
4.13 RAFT end-group modification of PHPMA 
The incorporation of peptide to the chain end of PHPMA was achieved by thiol-ene click 
reaction between the free thiol group on the end of polymer chain and the acrylamide or 
methacrylamide functional group on peptide substrates. Various conditions were applied in 
order to optimise the reaction. 
4.13.1 Method 1: Sequential one-pot synthesis of aminolysis and nucleophilic Thiol-
Michael addition of PHPMA and Sortase A peptide substrates. 
In a flask, PHPMA (1 equiv. of RAFT end-group), Sortase A peptide substrate (10 equiv.), and 
TCEP.HCl (5 equiv.) were dissolved in DMF and degassed by purging with N2 gas for 30 min. 
To that solution, n-butylamine (50 equiv.) was added to the solid mixture via a syringe, and 
the mixture was let to stir at room temperature for at least 1 h until the pink colour disappeared. 
The flask was then transferred to a pre-heated oil bath at 60 °C and stirred for 16 h. After 
completion, the polymer was dialysed against water in a 1,000 Da MWCO membrane for 2 
days before lyophilisation to yield a white powder.  
4.13.2 Method 2: Sequential one-pot synthesis of aminolysis and thermally radical 
thiol-ene click reaction of PHPMA and Sortase A peptide substrates 
In a flask, PHPMA (1 equiv. of RAFT end-group), Sortase A peptide substrate (10 equiv.), and 
TCEP.HCl (5 equiv.) were dissolved in an organic solvent of interest (e.g. DMF, PBS buffer, 
etc.) and degassed by purging with N2 gas for 30 min. To that solution, n-butylamine (50 
equiv.) was added to the solid mixture via a syringe, and the mixture was let to stir at room 
temperature for at least 1 h until the pink colour disappeared. A degassed solution of ACVA 
initiator (1 equiv.) was injected to the reaction mixture under N2 gas. The flask was then 
immediately transferred to a pre-heated oil bath at 70 °C and stirred for 3 h. After completion, 
the flask was cooled down in an ice bath and the polymer was dialysed against water in a 
1,000 Da MWCO membrane for 2 days before lyophilisation to yield a white powder.  
4.13.3 Method 3: Two-pot synthesis of aminolysis/ thermally radical thiol-ene click 
reaction of PHPMA and Sortase A peptide substrates 
In a flask, PHPMA (1 equiv. of RAFT end group) was dissolved in DMF and the solution was 
degassed by purging with N2 gas for 30 min. To the flask, n-butylamine (50 equiv.) was added 
via a syringe under N2 gas. The mixture was let to stir a room temperature overnight. The 
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product was purified by precipitation from cold diethyl ether and dried under vacuum to yield 
a white powder. 
In another flask, PHPMA-SH (1 equiv. of SH), Sortase peptide substrates (10 equiv.), and 
TCEP.HCl (5 equiv.) was dissolved in an organic solvent of interest (e.g. DMF, PBS buffer, 
etc.). The mixture was degassed for 30 min under N2 gas and stirred at room temperature for 
1 h. A degassed solution of ACVA (1 equiv.) was injected to the flask via a syringe. The flask 
was immediately transferred to a pre-heated oil bath at 70 °C and stirred for 3 h. After 
completion, the flask was cooled down in an ice bath and the polymer was dialysed against 
water in a 1,000 Da MWCO membrane for 2 days before lyophilisation to yield a white powder. 
4.13.4 PHPMA-LPETGG conjugates 
 
1H-NMR (D2O, 400 MHz): δ 0.90 (br s, H-c), 1.11 (br s, H-f), 1.78 (m, H-b), 2.40 (br, H-a7, H-
a8), 3.01 (br d, H-d), 3.58 (m, H-i), 3.84 (br s, H-e), 3.91-3.94 (m, H-a1, H-a2), 4.17 (br, H-h), 
4.31-4.36 (m, H-a3, H-a4, H-a5), 7.49-7.62 (m, H-g). 
FT-IR: vmax 3335 (O-H, N-H stretch superimposed), 2979, 2929 (aliphatic C-H), 1632 (C=O 
amide stretch), 1528 (N-H bend), 1459 (C-N stretch). 
4.13.5 PHPMA-GGKE conjugates 
 
1H-NMR (D2O, 400 MHz): δ 0.92 (br s, H-c), 1.13 (br s, H-f), 1.71-1.80 (m, H-b), 2.51-2.57 (br, 
H-a5, H-a6), 3.01 (br d, H-d), 3.86 (br s, H-e), 3.99 (s, H-a1, H-a2) 4.26 (br, H-a3, H-a4), 7.52-
7.64 (m, H-g). 
FT-IR: vmax 3340 (O-H, N-H stretch superimposed), 2971, 2330 (aliphatic C-H), 1632 (C=O 
amide), 1529 (N-H bend), 1456 (C-N stretch). 
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4.14 RAFT end-group modification of PNIPAM 
4.14.1 Vinyl sulfone functionalised PNIPAM 
Aminolysed PNIPAM was prepared using the same procedure described in section 4.13.3. In 
a flask, PNIPAM-SH (1 equiv. of SH), divinyl sulfone (10 equiv.), and TCEP.HCl (5 equiv.) was 
dissolved in 2 ml DMF. The solution was degassed by purging with N2 gas for 30 min and 
stirred at room temperature for 1 h. To the solution, 10 µl of 1M NaOH was injected via a 
syringe. The flask was let to stir overnight at room temperature. The mixture was dialysed 
against water for 2 days in 100 Da MWCO membrane prior to lyophilisation to yield a white 
powder. 
4.14.2 Two-arm PNIPAM-VS 
 
1H-NMR (D2O, 400 MHz): δ 1.09 (br s, H-d), 1.54 (br, H-a), 1.96 (br, H-c), 2.36 (br, H-m, H-l), 
2.88 (br, h-b’), 3.07 (br, H-e), 3.33 (br, H-i), 3.44 (br, H-f), 3.57 (br s, H-j), 3.62 (s, H-k), 6.25, 
6.27 (impurities), 6.35 (d, J = 9.9 Hz, H-h), 6.39 (d, J = 16.63 Hz, H-h), 6.79 (dd, J = 10.08, 
16.78 Hz, H-g), 7.57-0.08 ( m, NH). 
FT-IR: vmax 3286 (N-H stretch), 3077 (=C-H stretch), 2972 & 2934 (aliphatic C-H), 1638 (C=O 
amide stretch), 1527 (N-H bend), 1458 (C-N stretch), 1355 &1171 (S=O stretch). 
4.14.3 Three-arm PNIPAM-VS  
 
1H-NMR (D2O, 400 MHz): δ 1.00 (br s, H-d), 1.44 (br, m, H-a), 1.87 (br, m, H-b), 2.75 (br, H-
e), 3.06 (br, H-b’), 3.32 (m, H-f), 3.75 (br, H-c), 3.93 (br, H-i), 6.24-6.33 (H-h), 6.73 (dd, J = 
16.46, 10.04 Hz, H-g). 
FT-IR: vmax 3299 (N-H stretch), 3061 (=C-H stretch), 2972 & 2934 (aliphatic C-H), 1637 (C=O 
amide stretch), 1541 (N-H bend), 1458(C-N stretch), 1350 & 1172 (S=O stretch). 
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4.14.4 Four-arm PNIPAM-VS 
 
1H-NMR (D2O, 400 MHz): δ 1.09 (br, s, H-c), 1.52 (br, m, H-a), 1.95 (br, m, H-b), 2.84 (br, H-
e), 3.15 (br, H-b’), 3.4 1 (m, H-f), 3.83 (br, H-c), 3.99-4.17 (br, H-i), 6.32-6.42 (m, H-h), 6.81 
(dd, J = 16.70, 9.9 Hz, H-g). 
 FT-IR: vmax 3287 (N-H stretch), 3082 (=C-H stretch), 2972 & 2934 (aliphatic C-H stretch), 
1642 (C=O amide stretch), 1527 (N-H bend), 1458 (C-N stretch), 1350 & 1172 (S=O stretch). 
4.14.5 PNIPAM-VS-CFEFEFKFKK 
 
In a flask, PNIPAM-VS (0.005 mmol of vinyl sulfone, 1 equiv.) and TEA (1 equiv.) were 
dissolved in 2 ml PBS buffer pH 8.0. The solution was purged with N2 gas for 30 min to remove 
oxygen. In another flask, CFEFEFKFKK (0.05 mmol, 10 equiv.) and TCEP.HCl (0.25 mmol, 
50 equiv.) were dissolved in 2 ml DMSO. This solution was also degassed for 30 min under 
N2 gas. The peptide solution was then injected to the flask containing polymer via a syringe. 
The reaction was let to stir at room temperature for 48 h. After completion, the reaction mixture 
was diluted down ten times with deionised water prior to dialysis in 3000 Da MWCO membrane 
against water for 10 days. The dialysed solution was frozen in liquid N2 and freeze dried under 
the vacuum to yield a fluffy white powder. 
1H-NMR (DMSO-d6, 400 MHz): δ 1.04 (br, s, H-d), 1.46 (br, H-a), 1.96 (br, H-b), 2.74 (br, H-
e), 3.34 (br, H-c), 3.84 (br, H-b), 4.21 (br, H-g, H-h, 4.47 (br, H-f), 7.2 (br, H-i, NH). 
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 FT-IR: vmax 3280 (N-H & O-H stretch), 3075 (aromatic C-H stretch), 2972 & 2933 (aliphatic C-
H stretch), 1626 (C=O amide stretch), 1538 (N-H bend), 1458 (C-N stretch), 1350 & 1172 
(S=O stretch). 
4.15 Expression of Sortase A enzyme 
• Transformation  
Plasmid containing the Sortase A-His6 sequence (pSOT092, 1µL) was transformed into E. coli 
BL21(DE3) competent cells (Novagen), stirred gently and incubated on ice for 30 min. The 
tube was heated in a water bath at 42oC for 30s. Room temperature Super Optimal Broth 
medium (80 µl) was added to the tube and incubated at 37 °C for 1 h. The culture (50 µl) was 
then plated on to lysogeny broth plates with 100 µg/ml carbenicillin. 
• Protein expression 
10 ml LB broth containing 25 mg/ml carbenicillin was inoculated with 5 colonies overnight 
(250rpm, 16h, 37 °C). The main culture (2.5 L flask, 1 L LB broth, 25 mg/L carbenicillin) was 
inoculated with 3 ml of overnight culture (250 rpm, 4 h, 37 °C, and 70% humidity) to reach OD 
of 0.6. The culture was then induces with 0.1 mM IPTG, and shaked at 250 rpm, 37 °C for 16 
h.  
• Purification of Sortase A enzyme 
The expressed cells were harvested by centrifugation (Sorvall LYNX 4000 Superspeed 
Centrifuge, ThermoFisher Scientific, 5000 x g, 20 min, 4 °C) and kept at – 80 °C until further 
use.  
Cell pellets were thawed on ice for 30 min and re-suspend in lysis buffer 20 mM Tris.HCl, 100 
mM KCl, 8 mM imidazole, and EDTA-free protease inhibitor pH 7.7 (5 ml per gram wet weight). 
Lysozyme was added to the mixture to 1 mg/ml and incubated on ice for 30 min. After that, 
the lysis mixture was sonicated with six 10 second burst at 200 W with a 10 second cooling 
period on ice. Soluble protein in cell lysate was collected by centrifugation (Sorvall LYNX 4000 
Superspeed Centrifuge, ThermoFisher Scientific, 10 000 x g, 30 min, 4 °C). His-tag SrtA 
enzyme was then purified by gravity Ni-NTA resin column (HisPur Ni-NTA resin). The protein 
was concentrated and buffer exchanged with storage buffer (50 mM Tris, 100 mM NaCl pH 
7.5) using Pierce Protein Concentrator 10 kDa MWCO. Final protein solution was kept at -80 
°C.  
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4.16 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein sample (25 µl) was diluted in Laemmli sample buffer 2x (25 µl) and vortexed. The 
sample was denatured at 95 °C for 5 min before loading 20 µl volume of sample on to 
separating gels (PreciseTM 8% Tris-Glycine Gels, 6.8 cm x 8 cm x 1 mm). The running buffer 
was prepared by diluting NovexTM Tris-Glycine SDS running buffer 10x with RO water to final 
1x concentration.  
The protein was separated according to their sizes using Bio-Rad Mini-Protean gel 
electrophoresis unit by applying voltage of 200 A, current of 100 mA for 40 min. After the run, 
the gel was stained with 0.5% Coomassie blue, 50% methanol, and 10% acetic acid stain for 
1 h. The gel was then destained with a solution of 20% methanol, 10% acetic acid for 1h. The 
gel was eventually washed with RO water before being photographed using Li-Cor Odyssey 
Blot Imager. 
4.17 Quantification of SrtA solution 
SrtA concentration was determined using PreciseTM BCA protein assay kits (ThermosFisher 
Scientific). Albumin standard (2000 mg.mL-1) was diluted down in deionised water to 
concentrations of 1500, 1000, 7500, 500, 250, 125, and 25 mg.mL-1. Purified SrtA enzyme 
was diluted 200 and 500 times in deionised water. Working reagent was prepared by mixing 
50 part reagent A with 1 part reagent B (v/v). 25 µL solutions of SrtA and albumin were pipetted 
to 3 wells each concentrations. 200 µL of working reagent was added to each well. The blank 
and controls contained deionised water and working reagents. The plate was gently shaken 
at 37 °C in the dark for 30 min before being measure at 562 nm on a plate reader. 
4.18 Kinetic analysis of Sortase A enzyme 
Kinetic activity of SrtA was examined using SensoLyte® 520 Sortase A activity assay kit 
*Fluorimetric*. 1X assay buffer was prepared by diluting 10 mL 2X buffer to 10 mL deionised 
water. Purchased SrtA was diluted 20 times in 1X assay buffer. SrtA substrate (5-
FAM/QXLTM520) was diluted 100 times with 1x assay buffer. Purified SrtA (500 mg.mL-1) was 
diluted down with 1X buffer to concentration of 2x10-3 mg.mL-1. 50 µL solution of purchased 
and purified SrtA was pipetted to 3 wells for each enzyme. 50 µL solution of diluted SrtA 
substrate was added to each well. Positive controls contained SrtA without SrtA substrate. 
Fluorescence reading was immediately measured after shaking plate for 30s at excitation/ 
emission =490 nm/520 nm every 5 min for 1 h. 
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4.19 Sortase A catalysed cross-linking of PHPMA-LPETGG and PHPMA-GG 
conjugates 
In an Eppendorf tube, 4-arm PHPMA-GG (0.4 mM, 0.9 equiv. of GG functional group), 4-arm 
PHPMA-LPETGG (0.446 mM, 1 equiv. of LPE), and Sortase A from 500 mg/ml stock (4.46 
mM, 10 equiv.) were dissolved in 1 mL volume of Sortase reaction buffer (50 mM Tris, 100 
mM NaCl, 5 mM CaCl2 pH7.5). The tube was incubated at room temperature with shaking at 
250 rpm.  
4.20 Thermo-responsive hydrogels 
4.20.1 Sample preparation 
Samples were prepared by dissolving a desired quantity of materials into 1mL deionised water 
at room temperature. The sample’s pH were adjusted to 4.0 and/or 6.0 by addition of a small 
amount of NaOH 1M solution. The samples were let to equilibrate at room temperature for 12 
h before characterisation. 
Aqueous solutions of PNIPAM-CFEFEFKFKK conjugates were prepare with concentration of 
3 mg/mL at pH 2.0. 
Two series of PNIPAM-conjugates and free peptides CFEFEFKFKK physical mixture with 
concentration of 10 mg/mL peptide and 3 mg/mL polymer-conjugates were prepared at pH 4.0 
and 6.0. 
4.20.2 Phase behaviour study 
Macroscopic phase behaviour of the polymer-conjugate solutions and composite hydrogels 
were studied by placing the samples in a water bath and allowing equilibration for 15 min at 
each temperature (i.e. 20 °C, 35 °C, and 45 °C) before visual inspection.  
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HSQC of ma-LPETGG 85
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13C NMR spectrum of GGK(ma)E 87
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0.514.131.981.171.002.221.091.892.011.850.551.070.160.300.18
Water
0
.9
2
0
.9
4
1
.1
5
1
.2
8
1
.3
0
1
.3
1
1
.4
4
1
.4
5
1
.4
7
1
.4
9
1
.6
5
1
.7
3
1
.9
0
1
.9
2
2
.0
9
2
.1
1
2
.1
3
2
.3
7
2
.3
9
2
.4
0
2
.8
2
2
.8
5
3
.1
5
3
.1
7
3
.1
9
3
.8
1
3
.8
9
3
.9
4
4
.2
1
4
.2
3
4
.2
4
4
.2
9
4
.3
1
4
.3
2
4
.3
3
4
.7
9
4
.8
1
4
.8
2
5
.6
0
5
.6
3
5
.6
6
6
.0
4
6
.0
9
6
.1
0
6
.1
2
6
.1
5
6
.1
7
6
.1
9
7
.5
3
7
.6
9
7
.7
1
7
.8
0
7
.8
2
4.4 4.3 4.2
2.0 1.5
ef
dbb
c
a1 a2
a3 a4
i h
A16
194 
 
13C NMR spectrum of GGK(a)E 88
A17
FT-IR spectrum of GGK(a)E 88
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MS of GGK(a)E 88
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1H NMR spectrum of HPMA monomer 3
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13C NMR spectrum of HPMA monomer 3
A21
FT-IR of HPMA monomer 3
A22
197 
 
1H NMR spectrum of linear PHPMA 92
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FT-IR of linear PHPMA 93
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FT-IR of 3-arm PHPMA-LPETGG 114
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FT-IR of 4-arm PHPMA-LPETGG 115
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A41
13C NMR of bifunctional CTA 146
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FT-IR of bifunctional CTA 146
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COSY of ma-FEFEFKFK 131
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13C NMR of ma-FEFEFKFK 131
209 
 
A47
FT-IR of ma-FEFEFKFK 131
A48
MS of ma-FEFEFKFK 131
210 
 
A49
UV-Vis scan of 3-arm PNIPAM UV-Vis scan of 3-arm PNIPAM-SH 
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FT-IR of CFEFEFKFKK 132
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MS of CFEFEFKFKK 132
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1H NMR of 3-arm PNIPAM-VS 153
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1H NMR spectrum of 4-arm PNIPAM-VS 155
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1H NMR of 4-arm PNIPAM-VS 156
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1H NMR of 2-arm PNIPAM-VS 157
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